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ABSTRACT
HEALTHCARE PROVIDER INFLUENCE
ON HEALTH BEHAVIOR
MODIFICATION IN
GESTATIONAL
DIABETICS

Denise K. Fryzelka, MS, CNM
Marquette University, 2019
The overall aim was to understand the process of healthcare provider influence by
exploring associations between professional influence measures and patient engagement in health
behavior modification in women with Gestational Diabetic Mellitus (GDM). An integrative
literature review resulted in defining and developing the Healthcare Provider Influence (HPI)
conceptual model based on the Integrated Theory of Health Behavior Change and
Transformational Leadership theory. HPI is defined as a process wherein a purposeful
interpersonal interactive, collaborative, and transformative relationship develops between a
patient and a healthcare provider working together toward a specific focus of health behavior
modification outcomes.
Measures for testing the HPI conceptual model were identified, modified, translated, and
content validated. Using an observational, prospective, longitudinal, correlational and exploratory
design, participants in control, non-GDMs (N=117) and study, GDMs (N=78) groups completed
questionnaires at an initial high-risk GDM screening and subsequently at 34-36 weeks gestational
age. To test the relationships in GDM patients, eight healthy eating, physical activity, and glucose
monitoring behaviors were separately regressed on professional influence variables
(social/professional influence, quality of information and interaction). Patient and healthcare
provider characteristics were included in regression models to test for moderating effects. Selfefficacy was examined for a mediating effect. Differences in health behavior modification
outcomes, by time and group (GDM, non-GDM) were explored.
Professional influence by maternity healthcare providers (HPs), and quality of
information and interaction during teaching encounters by HPs and diabetic nurse-educators were
significantly associated with increased breakfast frequency/weekly and self-efficacy (p ≤ .10).
Gender, race and language concordance and HP leadership style and specialty influenced healthy
eating, physical activity and glucose monitoring behaviors (p ≤ .10). Three healthy eating and one
physical activity outcomes differences were found by group and time, for which variance was
explained with small effects (2-9%) by language, race, and GDM history.
Patients’ perception of their healthcare providers’ influence, quality of information and
interaction in teaching encounters and leadership style, and race, language, and gender
concordance influence GDM patients’ engagement in health behavior modifications. Selfreflection on practice, interaction, and leadership style could impact individual professional
transformation and increase influencing potential for patient engagement in health behaviors.
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Chapter 1: Introduction

Diabetes mellitus (DM) and obesity are becoming increasingly prevalent and
correlated global health problems. Type 2 Diabetes Mellitus (T2DM), a sub classification
of DM, and heretofore simply called DM, is one of the top six leading causes of death in
both the United States (US) and Canada with a mortality rate of 3.1% in the US and 3.6%
in Canada, and approximately 40-50% greater than a rate of 1.9% in the rest of the world
(Guariguata, Whiting, Weil, & Unwin, 2011; Toporowski et al., 2012). Globally, the
average rate of obesity is 12%; however, the prevalence is much higher at 24% in the US
and 15.3% in Canada (Toporowski et al., 2012). Obesity increases the risk of DM and is
also one of the major risk factors for developing gestational diabetes mellitus (GDM), a
type of glucose intolerance diagnosed initially in pregnancy (American Diabetes
Association [ADA], 2013; C. Kim, Newton, & Knopp, 2002; Simmons, 2011). More than
60% of child-bearing age women in the US are either overweight or obese, prior to
pregnancy (Center for Disease Control and Prevention [CDC], 2014; Sarwer, Allison,
Gibbons, Markowitz, & Nelson, 2006). A history of GDM in one pregnancy increases the
risk of developing GDM in a subsequent pregnancy and DM later in life (Bellamy, Casas,
Hingorani, & Williams, 2009; Diabetes Prevention Program, 2002). During and
following pregnancy, GDM can have significant consequences for women and children.
Addressing GDM during pregnancy and vigilant follow-up in the postpartum period
provides an opportunity to decrease the prevalence of DM and prevent these
consequences short term during pregnancy and later in life.
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To improve health outcomes in the US, an evidence-based care systems approach
using a simultaneous focus on three aims: improving the experience of care, improving
the health of a population, and reducing the per capita costs of health care costs, has been
recommended as a feasible and effective approach (Berwick, Nolan, & Whittington,
2008). Utilization of treatments and counseling determined to be evidence-based practice
(EBP), including preventative care practices shown to improve patient health outcomes,
care coordination to prevent fragmented care and subsequent complications, and
measures to decrease wasteful spending (Berwick & Hackbarth, 2012) are strategies that
have been suggested to accomplish these aims. On an individual level, these aims can be
addressed in part by exploring the interaction between the patient and the healthcare
provider (HP) and the influence the HP has on the patient’s health behavior modification.
In the case of GDM, the positive influence of the HP on the patient’s modification of
health behaviors, which have been determined to effectively treat and control GDM in
pregnancy, can delay or prevent the future diagnosis of DM and its consequences.
Continuation of these behaviors after pregnancy further contributes to DM prevention.
An increased awareness of the interaction between the HP and the patient can also lead to
improving the patient care experience and improving their health. This subsequently can
reduce higher costs that can result from poor care experiences, including non-adherence,
lack of follow-up, or lack of knowledge of preventative or treatment measures.
Gestational Diabetes Mellitus: A Global Health Problem with Long Term Maternal
and Neonatal Consequences
Gestational diabetes mellitus (GDM) is defined as impaired glucose tolerance
with onset or first recognition during pregnancy (ADA, 2013). Pre-pregnancy obesity and
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increased pregnancy weight gain are associated with increased risk of GDM. The
percentage of GDM that was attributed to overweight and obesity was 46% in one study
(S. Y. Kim et al., 2010), while obesity was found to be a determinant for developing
GDM at rates of 59.2% (p<0.001) when compared to those without GDM in a second
study (Bener, Saleh, & Al-Hamaq, 2011). Results from a meta-analysis including 20
studies found that high maternal weight is associated with substantially higher risk of
GDM: 2.14-fold higher if overweight, 3.56-fold higher if obese and 8.56-fold higher if
severely obese compared to normal-weight pregnant woman (Chu et al., 2007).
Concurrent with the escalation of obesity and DM over the past several decades, GDM
prevalence rates have been reported in the US as approximately 9.2% (DeSisto, Kim, &
Sharma, 2014). The range of GDM is reported to affect 1-19% and steadily rising
incidence rates expected of up to 25% of all pregnancies in the US and 2.28-25.13% of
all pregnancies globally (ADA, 2007; Guariguata, Linnenkamp, Beagley, Whiting, &
Cho, 2014; Hartling et al., 2012; Nicholson et al., 2008; Vandorsten et al., 2013). The
range of rates both in the US and globally depends on the screening and diagnostic
criteria used and the population and demographics. Additional risk factors for GDM are
advanced maternal age, higher parity, a family history of DM, non-white race, lower
economic status, unhealthy eating habits, and lack of physical activity (PA) (Hunsberger,
Rosenberg, & Donatelle, 2010; King, 1998; Ruchat & Mottola, 2013).
The prevalence of GDM is said to reflect the prevalence of DM and certain
subsets of adult populations in the US, such as American Indians/Alaskan Native (15.9
%), Asian/Pacific Islanders (9.0%), African-Americans (13.2%), and HispanicAmericans (12.8%) and subgroups within the latter, Mexicans (13.9%) and other women
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immigrating from Central and South America (8.5%) are more vulnerable and at
disparately higher risk for GDM and DM and the resulting complications (Bermudez &
Tucker, 2003; DeSisto et al., 2014; DHHS, 2014; Ferrara, 2007; Fujimoto, Samoa, &
Wotring, 2013). Other factors such as acculturation also increase the risk of obesity, DM,
and GDM due to U.S. patterns of decreased physical activity levels and a substantial
change in dietary patterns, with the introduction of more processed food, meats, dairy and
sweets, and approximately two-thirds of calories derived from carbohydrates (Bermudez
& Tucker, 2003).
Numerous immediate and long-term maternal and neonatal complications can
result from GDM. These include preterm delivery, polyhydramnios, macrosomia,
possible maternal and fetal birth injury related to shoulder dystocia, neonatal
hypoglycemia, neonatal jaundice, transient neonatal morbidity, ketonemia, urinary tract
infections in mother and infants, increased induction of labor or operative Cesarean
delivery, increased rates of stillbirth or fetal death, and development of obesity later in
baby’s life (Bener et al., 2011; Langer, Yogev, Most, & Xenakis, 2005). Even more
serious complications of maternal hypoglycemia, miscarriage, genetic malformation, and
pre-eclampsia can occur in women who have DM prior to pregnancy. Improperly
managed GDMs experience a four-fold higher rate of infant mortality in the US
(Fujimoto et al., 2013). GDM can reoccur in subsequent pregnancies at a rate of 35-50%
and the risk for developing DM later in life is 15-74% (Bellamy, Casas, Hingorani, &
Williams, 2009; Diabetes Prevention Program, 2002; Kim et al., 2002). Therefore,
addressing GDM adequately in pregnancy and the postpartum period can prevent the
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incidence of GDM or DM in a future pregnancy as well as DM in women and children
later in life.
GDM and DM Prevention: Role of the Patient and the HP
Arriving at the diagnosis and effective treatment of GDM are the mutual
responsibilities of the patient and the HP. During pregnancy, it is important that all
women are tested for GDM. The Gestational Diabetes Act was enacted in August 2012 in
the U.S. to ensure that all pregnant women would receive routine and if high-risk, early
screening for GDM (Fujimoto et al., 2013). Testing for GDM, including type and timing
has been discussed by multiple national and international organizations. Despite
differences in recommendations regarding screening/diagnostic laboratory tests and
results, there is general agreement that routine screening should occur in the second
trimester, after 24 weeks gestation. Women identified as having greater risk factors, such
as, obesity, previous history of GDM, first degree relative with DM, history of previous
stillborn infant should be tested in the first trimester (American College of Obstetrics and
Gynecology [ACOG], 2013; Moyer, 2014; Vandorsten et al., 2013). As soon as the GDM
diagnosis is determined, patients should be informed about the disease, and receive
education and counseling regarding blood glucose monitoring, dietary modifications, and
physical activity (PA) recommendations. Timely implementation of EBP guidelines for
treating GDM in pregnancy and immediate and consistent patient initiation of appropriate
health behavior modifications is recommended and encouraged throughout the pregnancy
to decrease pregnancy-related complications (Ruchat & Mottola, 2013).
Involvement and support from partner and family for health behavior
modification should be evaluated and encouraged as women have identified a lack of
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social support with GDM as a barrier to self-care in pregnancy (Collier et al., 2011).
Strong social supports were identified as key influencers in helping women modify and
maintain their health behaviors through pregnancy and the postpartum period (Collier et
al., 2011). HPs may play a role in providing significant social support if lacking from
partner or family sources.
Health behavior modifications initiated in pregnancy should be continued into the
postpartum period to prevent the development of subsequent GDM and DM later in life
(Ruchat & Mottola, 2013). Education regarding screening for DM in the postpartum
period as well as on a routine basis for life should also be initiated in the pregnancy and
repeated in the postpartum period. Most women who had a diagnosis of GDM reported
that they were unaware of the recommendation for postpartum screening and their future
increased risk for developing DM later in life and thought their diabetes would go away
when they delivered and that they could eat the way they wanted to (Collier et al., 2011;
Stasenko et al, 2010, 2011). Increased counseling efforts have been shown to increase
adherence to postpartum screening follow-up (Stasenko et al, 2010, 2011). HPs should
provide appropriate care and support postpartum as well as between pregnancies to
prevent DM or reoccurrence of GDM (Tieu, Bain, Middleton, & Crowther, 2013).
Other barriers to care that women with GDM identified were HP-related
communication difficulties, including a lack of time for discussion, not being heard about
their needs and inability to control sugars, not receiving enough information verbally or
in written form about how to self-care for GDM, and language barriers (Collier et al.,
2011). A full understanding of HP-patient communication issues that impact health
behavior modification in GDMs is imperative to achieve improved health outcomes.
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Communication and Behavior Modification Outcomes
Extensive research has been conducted on communication in the healthcare
setting involving the HP and patient. Numerous findings have been described regarding
HP-patient non-verbal and verbal communication patterns, interactions, characteristics,
training models and recommendations for improving skills, and barriers. Barriers
affecting HP-patient interaction include insufficient time spent as well as discordance
factors of race, culture, attitude, age, gender, and language. These barriers have
contributed to inequalities in healthcare and outcomes (Akgun, Kostak, Unsar, Kurt, &
Erol, 2012; Durant, Bartman, Person, Collins, & Austin, 2009; Toporowski et al., 2012).
Effective communication and patient-centered (PC) communication have also emerged as
key concepts and strategies to improve the HP-patient relationship and health outcomes.
Effective communication with a strong focus on patient involvement is called
patient-centered (PC) communication. PC care as defined by the Institute of Medicine
(IOM), is care that is respectful and in which patient values guide clinical decisionmaking (National Research Council [NRC], 2001). PC research initiatives have been
implemented to increase health quality outcomes. These require a PC approach,
facilitating patient involvement in asking questions to influence decision-making and
determine outcomes, with an “underlying imperative to improve patients’ care
experience, decision making, and health outcomes” (Selby, Beal, & Frank, 2012; Tinetti
& Basch, 2013). Effective and PC communication are integral to a positive HP-patient
relationship. They have been found to positively correlate to patient satisfaction and serve
as a critical element in improving quality health care and short and long-term outcomes,
addressing disparities, and decreasing costs (Blumenthal, 2012; National Priorities
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Partnership [NPP], 2008). The importance of the emphasis placed on listening and
involvement in PC decision making allows the different perspectives on what is most
important to each individual patient to be heard rather than treating them the same as one
of the other millions of people with the same chronic condition, e.g. DM (Tinetti &
Basch, 2013).
To solve an individual’s healthcare problem and improve outcomes, HPs must be
effective in diagnosing the problem and communicating treatment recommendations to
the patient. However, to improve outcomes, it is also important for patients to adhere to
these recommendations for managing their self-care by modifying health behaviors. In
the clinical setting, experienced HPs see the variety of patient responses to their own and
their professional colleagues’ recommendations for modification. Responses range from
non-adherence or no changes in a patient’s perception, understanding, attitude, or
behavior regarding the diagnosis of a healthcare problem to that of a completely
transformed lifestyle pattern including embracing and modifying every behavior to
optimize sleep, diet, exercise, and therapy. In PC care, “what researchers and clinicians
may consider non-adherence, patients may consider a reasoned decision within the
context of their own priorities and preferences” (Tinetti & Basch, 2013). This presents a
situation of health outcome goal incongruence. Non-adherence can be a patient choice
but non-adherence in health behavior modification is also a significant variable leading to
poorer outcomes. The two cannot co-exist as a solution for the same goal and this
dilemma can add to an already challenging health environment.
Indisputably, research findings endorse the awareness, learning, and utilization of
communication skills by HPs to explore the meaning of illness, to determine patient's
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social and family context, and provide PC and culturally competent care. Despite the
elimination of all barriers including communication issues, and the implementation of
measures and interventions for increasing education and support for improved treatment
adherence, a wide variation of patient responses still occurs. This calls the question as to
whether PC care alone is enough to solve the poor health outcomes that result from
patient non-adherence. The role of PC communication in assisting and motivating
patients to make health behavior modifications has been explored and found to be
effective, however the influence of or by HPs has not been studied. Effective and PC
communication skills may contribute to only part of the process of how a HP can be
influential in health behavior modification.
HPI: A New Framework for Exploring the Impact of HP-Patient Interaction on
Outcomes
A review of the healthcare literature into the role and process by which HPs
influence the health behavior modification and health outcomes of patients with acute or
chronic health problems or diseases revealed a large gap. Many variables have been
found that “influence” outcomes from an action and cause-effect inference but the
process of influence that HPs have on patients’ health behavior modification has not been
described. Social or societal influence has been explored within contexts that have
focused primarily on family, cultural, and colleague or peer influence. HP influence has
not been yet explored as a distinct concept.
To explore the influence that HPs have on patient responses to treatment
recommendations and modification of health behaviors, understand reasons for nonadherence, and contribute to the improvement of health outcomes, it was necessary to

10

name, define and develop a conceptual model to describe the concept. Termed
“healthcare provider influence” (HPI), it is defined as a process wherein a purposeful
interpersonal interactive, collaborative, and transformative relationship develops between
a patient and a HP working toward a specific focus of health behavior modification
(Fryzelka & Weiss, unpublished). HPI is defined, conceptualized and developed as a
framework utilizing a PC approach involving effective communication and incorporating
transformative leadership skills. Transformational leadership theory incorporates the use
of social influence, a form of power that involves the movement of expert power from the
HP to the patient via referent power to bring about behavior modification. A PC
approach was utilized to better understand and explore the role of the HP and the process
of how the HP impacts patient adherence to recommendations (Tinetti & Basch, 2013).
Population outcome disparities, discrepancy in adherence, screening, awareness,
and follow-up, the resistance of some GDM diagnosed women to make health altering
modifications even when barriers are eliminated, and recommendations provided,
stimulated this researcher to pursue exploring the demographic and leadership
characteristics of HPs and the overall influence that they have on the women they are
caring for. The leap from diagnosis to treatment and prevention can at times be more than
some individuals are able to or care to pursue and it is the notion of how HPs influence
the ability or choice of patients to initiate or modify health behaviors necessary for selfcare management that is of utmost interest to this researcher.
This research, utilizing the newly developed HPI conceptual model, was intended
to provide insight on how HPs influence patients to make health behavior modifications
resulting in improvement in their quality of health and overall health outcome indicators.
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It is projected that the HPI conceptual model will be used in several additional research
endeavors. The hope is it will generate opportunities to increase HPs awareness of
patients' knowledge, attitudes, beliefs, biases, and behaviors that may influence their
overall engagement in self-care management. Secondly, the HPI framework may be
effective in assisting HPs to improve their approach in involving, inspiring, motivating,
and altering patients’ perspective, attitude, and approach to health behavior modification
and thus increase the overall quality of care. Finally, it may be useful as a guide to focus
on the process of HPI with several health problems, to increase health quality and
outcomes and decrease disparities for vulnerable populations. Access, advocacy, support,
education and provision of options by the HP to patients is important but the role and
responsibility that come from the influence that a HP can have on a patient may be more
powerful and has the potential for substantial transformation.
Purpose of the Study
The purpose of this research study was to explore the relationship of HPI and
health behavior modification, specifically healthy eating (HE), physical activity (PA),
and glucose monitoring (GM) in women with GDM, a disease where treatment, control,
and prevention center on patient self-management through dietary modifications and
increases in PA. Specific aims were: a) to determine if HPI was associated with patient
engagement in health behavior modification of healthy eating, physical activity and
glucose monitoring in women with GDM; b) to determine if patient characteristics
moderated the relationship between HPI and patient engagement in health behavior
modification of healthy eating, physical activity and glucose monitoring in women with
GDM; c) to determine if healthcare provider characteristics moderated the relationship
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between HPI and patient engagement in health behavior modification of healthy eating,
physical activity and glucose monitoring in women with GDM; d) to determine if selfefficacy mediated the relationship between HPI and patient engagement in health
behavior modification of HE, PA, and GM in women with GDM; and e) to determine if
there were differences in the pattern of patient engagement in healthy eating and physical
activity during pregnancy for women with and without a GDM diagnosis.
Relevance to Nursing Practice, Education, Policy, Research, and Vulnerable
Populations
Nurses make up the largest group of HPs globally and spend the most time
interacting and engaging with, caring for, and teaching patients. Exploring the
correlations of HPI to health behavior modification is beneficial to the patient as well as
to the HP. The patient benefits from improved individual health status and long-term
outcomes by modifying health behaviors. The HPs benefit from an awareness and
understanding of additional processes that can be employed to facilitate improved
individual patient health status and the unique leadership role in which they are able to
engage. Understanding HPI can be instrumental in improving patient relationships,
behaviors, and outcomes for multiple diseases and populations. Understanding the
conceptual model of HPI overall with specific exposure to PC principles fits with current
national research initiatives of improving patient’s experiences of care, improving health
outcomes, and decreasing the cost of healthcare (Berwick et al., 2008).
HPs are taught how to communicate but there is no evidence in the research
literature about understanding and teaching HPs how to influence. Learning to be
influential requires intentional education and practice in transformational leadership
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principles within the context of PC communication. This approach, once validated, could
be incorporated into pre-licensure and HP educational preparation in new strategies for
patient education and behavior modification. Early academic exposure should provide for
more natural and progressive utilization throughout HP students’ education and extend
into their professional careers, setting the stage for the development of strong nursing and
healthcare leaders who may pursue a variety of pathways in their professional careers,
including education, politics and research. Nursing faculty, likewise, with an
understanding of HPI, can adapt and transfer the same principles in the learning
environment to potentiate the modification of student learning behaviors for improved
student personal growth and achievement.
Exploring HPI is a beginning step to grooming nurses to strive to impact future
health outcomes by actively combining the utilization of PC communication and
transformative leadership skills to positively augment and influence the patient’s selfefficacy, motivation, and engagement in health behavior modification. Understanding the
conceptual model of HPI is essential to embrace, instruct, model and direct modifications
in the process of HPI for positively impacting cost, quality, and outcomes of health for
patients.
Finding new measures of incentive for improved health outcomes may affect
insurance, governmental and legislative policy changes. Governmental assistance
programs, such as Women Infants Children (WIC), can perhaps be convinced to modify
the foods distributed and the dissemination of patient GDM-education to match the focus
of dietary modification beneficial for GDM/DMs, including carbohydrate restriction,
protein replacement, increased vegetable intake, and eating breakfast, to enhance the
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process and educational component of HPI. Increased reimbursement to the HP could be
argued because of the mutual HP-patient success of improved health status and outcomes.
Similarly, albeit controversial, patient rewards in addition to the intrinsic value of
improved health outcomes, could be implemented because of engagement in behavior
modifications related to HE and PA. GDM was selected as a good case exemplar for the
exploration of the relationship of HPI to health behavior modification outcomes. More
women are likely to access care during a pregnancy than at any other time of their life.
The diagnosis of GDM allows for measurement of the immediate and short-term health
behavior modifications for proximal outcomes, which are the same ones intended to
continue into the long-term for distal health outcome improvement. Women are more
vulnerable during pregnancy and those with GDM are even more vulnerable due to
potential health consequences to themselves and their fetuses/newborns. It is socially just
and imperative to work toward improving the health status of all, every individual, in all
countries regardless of economic status, racial or ethnic make-up, gender, education, or
any other descriptor. It is even more important in the process to address the needs of
those most affected and vulnerable, to decrease healthcare outcome disparities between
populations. Research efforts utilizing the HPI model can be replicated for improvement
of many other chronic conditions.
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Chapter 2: Review of the Literature

A review of the healthcare literature was conducted to determine whether and
how healthcare providers (HPs) influence the health behavior modification of patients
diagnosed with Gestational Diabetes Mellitus (GDM). Initially, an integrative review of
the literature related to health provider influence was conducted to understand the
definition, concepts and process whereby HPs exert influence. To address the identified
gap in the literature regarding this concept, a conceptual model of healthcare provider
influence (HPI) was developed and serves as the conceptual framework for this study
(Fryzelka & Weiss, 2013) (Appendix B). This integrative review of the literature includes
a definition, description, and conceptual diagram representing the necessary components,
conditions, and outcomes of healthcare provider influence and the theoretical basis for
the model.
In this second chapter, the nursing and socio-psychological theories selected to
provide the foundation and framework for the HPI conceptual model will be described.
Following the development of the conceptual model for HPI, presented in manuscript
format (Appendix B), a literature review was conducted to review and explicate the
additional concepts included in this research proposal, including self-efficacy and health
behavior modification. A review of these concepts in relation to GDM when appropriate
was conducted as well and described in this chapter. Finally, the philosophical
underpinnings, the assumptions for this proposal, and the Conceptual-TheoreticalEmpirical structure (CTES) are also described.
Healthcare Provider Influence
HPI is defined as a process wherein a purposeful interpersonal interactive,
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collaborative, and transformative relationship develops between a patient and a
healthcare provider working together toward a specific focus of health behavior
modification (Fryzelka & Weiss, unpublished). The development of the conceptual model
of HPI is based on two theories, the Integrated Theory of Health Behavior Change
(ITHBC) developed by P. Ryan (2009) and Transformational Leadership (TFL) by Bass
(1985; Bass & Riggio, 2006). The concepts included in HPI conceptual model are
divided into three sections: conditions, components, and outcomes. The condition and
outcomes concepts are specific to the patient, as the primary focus of patientcenteredness is incorporated throughout the model and describe the salient elements
necessary for the HPI to occur: mental/physical resources and the cognitive/psychological
and behavioral/physical benefits of a positive influence. Included in the model are five
components and three process descriptors. The five components are categorized as
logistics, concordance factors, emotive, cognitive, and social/communication. The
process descriptors are interaction, collaboration and transformation. These conditions,
components, process descriptors, and outcomes are unique yet closely linked within the
model.
A full description of the development of HPI is included in an Integrative Review
of the Literature and Development of Conceptual Model of Healthcare Provider Influence
(HPI) Manuscript form (Fryzelka & Weiss, 2013) (Appendix B) for review. A
description and rationale for the selection of the theories are included in the manuscript;
however, each will be more thoroughly described later, as they together provide
explanatory strength to the model and subsequently, the research design.
Theoretical Framework/Conceptual Framework
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There are several theories that provide the framework for this research project as
well as for the development of a conceptual model. The central theory providing the
foundation for this specific inquiry focus is ITHBC (P. Ryan, 2009). The secondary
theory, TFL (Bass, 1985) is a theoretical model that provides the foundation for the
development of the HPI model as well as provides the explanatory basis for the process
of HPI.
Integrated Theory of Health Behavior Change
Following a review and synthesis of the healthcare literature, a lack of a
comprehensive description regarding the process of influence by HPs was discovered.
Reference to social influence, wherein professional influence is a component, however
was found within the work of the ITHBC (P. Ryan, 2009).
The ITHBC was developed following a review of the literature and the resultant
identification of a gap in the comprehensive understanding of health behavior change
including prediction of long-term changes. The ITHBC integrated several theories and
proposed to fill in that gap, explaining the variables involved in health behavior change
or modification. The ITHBC includes theories of health behavior change, self-regulation,
social support theory, and self-management of chronic illness (P. Ryan, 2009).
It was determined that ITHBC could serve as a central foundation for this
research inquiry for several reasons. It provides the foundation and describes the linkage
between health problem to health improvement including a central focus on the patient
and his or her role in changing behaviors while accounting for the number of variables
that also play a role in effecting these changes. It includes an undefined concept within
one of its concepts theorized to play a role in health behavior change, that of social
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facilitation via social influence by professionals or healthcare providers. A more robust
development of the social professional influence component of the ITHBC is needed. The
HPI conceptual model could explicate and complement this integrated theory quite well.
The ITHBC is described as a descriptive middle-range theory. Descriptive midrange theories are “based on deductive and inductive processes and reveal the substance
of a situation yet without structured linkages showing the specific nature of relationships
among components (Rodgers, 2005). Over time, parts of the theories can be explored
further to clarify vague aspects or to identify the scope of the contexts in which it is
reasonable to apply the theory” (Rodgers, 2005). Thus, extracted from a position within
this theory and providing direction, the HPI conceptual model (Fryzelka & Weiss,
unpublished) was conceived and developed to better understand and explain the process
by which the social influence by HPs within their clinical practice setting, in their
professional relationship with patients, impacts the health behavior modification of
individual patients and improves their health outcomes as a result.
The ITHBC is based on several assumptions: “behavior change is a dynamic,
iterative process”; change and progress require desire, motivation and self-reflection;
interventions that are person-centered rather than standardized are more effective; and
social influences and relationships, which are positive, are beneficial in effecting
immediate and sustained health behavior modification and improved health (P. Ryan,
2009). Outcomes are projected to be both proximal, to ensure engagement in selfmanagement behaviors and that the behavior change has occurred, and distal, to ensure
attainment of improved health status (P. Ryan, 2009).
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ITHBC purports that several factors are helpful in and associated within the
facilitation of successful changes in health behavior. Factors include interventions that
address and foster specific knowledge and beliefs, increase self-regulation skills and
abilities, and enhance social facilitation (P. Ryan, 2009). The constructs of the ITHBC
theory include knowledge and health beliefs that are linked to engagement in selfregulation. Engagement in self-regulation behaviors increases skills and abilities, which
enhances self-efficacy and leads to engagement in and enhancement of self-management
behaviors and when enhanced by social facilitation has a direct and positive effect on
health status (P. Ryan, 2009; P. Ryan & Sawin, 2009). The concepts of social facilitation,
specifically social influence, self-efficacy, and health behavior modification from the
ITHBC provide the focal interest of this study.
The concept of “social facilitation” includes the concepts of social influence,
social support, and negotiated collaboration between individuals and families and
healthcare professionals” (P. Ryan & Sawin, 2009). The component of social influence
encompasses the potential influences and influencers of the individual patient’s
engagement in health behavior change. Influencers identified include parents, siblings,
peers, and professionals. There are undoubtedly many variables and personal
relationships that comprise influences on individual behavior, including but not limited to
parents, siblings, peers, and professionals. People experience social influence when there
is an attempt to alter, modify, or change their attitudes, reactions or behaviors by another
(Gabel, 2012a). If this person is knowledgeable or in a position of perceived authority
and they sway the thinking and motivation of another leading to engagement in behavior
(P. Ryan, 2009), then this demonstrates social influence from a leadership perspective
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(Gabel, 2012a). One of the potential sources of social influence is the healthcare provider
(HP) who via means of emotional, instrumental, and informational social support
facilitates engagement in health behavior (P. Ryan, 2009). Social influence and the
recently developed conceptual model of Healthcare Provider Influence (HPI), selfefficacy, and health behavior modification are described later in greater detail.
As a middle- range theory, the ITHBC is meant to guide clinical practice
(Higgins & Moore, 2000) and specifically, this theory was conceptualized to guide the
facilitation of patient health behavior change for improved outcomes (P. Ryan, 2009).
The ITHBC is applicable to individuals in the healthcare clinical practice setting. ITHBC
is intended to describe the components involved in the facilitation of health behavior
change related to management of chronic conditions and health promotions (P. Ryan,
2009). In addition, ITHBC explains how health behavior change is facilitated via the
interrelatedness of these components. Despite the population to be studied having GDM,
although not considered chronic, is highly correlated to increased future risk of a
progression to its chronic form, Diabetes Mellitus (DM) (Tieu et al., 2013). The proximal
outcomes of patient self-management of health behavior modification, specific to GDM,
were healthy eating/diet per dietary recommendations, increased physical activity, and
adherence to glucose monitoring.
A number of research studies have been conducted using the ITBHC framework
as a guide. Weight retention and weight management have been studied in postpartum
women using the ITHBC (Ohlendorf, 2014; Ohlendorf, Weiss, & Ryan, 2012; P. Ryan,
Weiss, Traxel, & Brondino, 2011). The use of a cardio-metabolic health nurse to manage
comorbid physical and mental health was evaluated (Happell, Stanton, & Scott, 2014). A
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smoking cessation self-management intervention in construction workers was explored
using ITHBC, as well (Bondy & Bercovitz, 2013). ITHBC guided the designing and
testing of a computerized intervention for prevention of osteoporosis and selfmanagement applications for intake of vitamin D and calcium (P. Ryan, Maierle, Csuka,
Thomson, & Szabo, 2013; P. Ryan, Pumilia, Henak, & Chang, 2009).
For purposes of this research study and for the development of the HPI model, the
ITHBC was selected as an appropriate framework because of its concentration on the
individual and related health behavior change outcomes. An additional theory was chosen
to provide an explanatory basis for the process of HPI.
Transformational Leadership
HPI, consistent with and situated within ITHBC, is centrally based on a leadership
theory derived from work within the field of social psychology called Transformational
Leadership (TFL) (Bass, 1985). A detailed description of TFL is warranted, as it
provides a strong basis for the research inquiry and assumptions of this project.
Several leadership theories have emerged over the years describing and
classifying leadership as a trait, a style, and a behavior (Northouse, 2007). Extensive
research has been undertaken within many disciplines, including the following:
healthcare, politics, education, military, business, and other realms, wherein leadership
styles have been described and correlated to performance and behavior change (Bass &
Riggio, 2006; Northouse, 2007). Different leadership styles have been found to correlate
with various behaviors towards subordinates and colleagues. One of these leadership
theories, called TFL, was first named by Downton in 1973, however did not emerge until
the work of Burns approximately five years later in 1978 (Northouse, 2007). Shortly
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thereafter, other social psychology researchers reintroduced TFL and have continued to
explore, define, and refine TFL (Bass, 1985; Bass, 1998; Bass & Avolio, 1995; Bass &
Riggio, 2006). This major work related to TFL was continued by Bass and several
colleagues in their efforts to distinguish it from all other classifications of leadership,
including transactional leadership. It has been described as similar to charismatic
leadership but later described as encompassing charisma as one of its essential elements
(Bass, 1998; Conger & Kanungo, 1988)
According to Burns (1978), leadership was well differentiated from power;
however, those who continued the work of describing TFL could not do so without
describing the concept of power as not only necessary but fundamental to leadership
(Bass, 1998). French and Raven (1959) defined and described the many sources of
power: legitimate, reward, coercive, expert, and referent. TFL is based on the two latter
components of expert power and referent power (Bass, 1998). Expert power refers to
having the expertise or knowledge in how to do your work. Referent power refers to the
power that is referred from the expert and results in empowerment. Social influence
requires referent power, the transfer from one to another. Power has been defined as
social influence (Raven, 2008). Authentic TFL is also referred to as socialized leadership
(Howell & Avolio, 1993). TFL characterizes leadership wherein a leader responds to the
follower’s needs, aligns goals and objectives, and though empowerment stimulates,
inspires and moves followers to meet and exceed performance expectations as well as to
strive for higher levels of potential (Bass & Riggio, 2006).
The current description and model of TFL, after several modifications over the
past several decades, is currently described as consisting of four different components:
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idealized influence and charisma, inspirational motivation, intellectual stimulation, and
individual consideration (Bass & Riggio, 2006). Idealized influence or charisma
describes leaders who act as strong role models for followers, are deeply respected and
trusted by followers who want to emulate the leaders who provide them with a vision and
mission (Bass & Riggio, 2006). Inspirational motivation or inspiration is descriptive of
leaders who communicate high expectations to followers and inspire them through
motivation to become committed, focusing their efforts to achieve more than they would
if on their own (Northouse, 2007). Intellectual stimulation incites followers to be
creative, innovative and to challenge their beliefs and values, as well as encourages them
to think things out and engage in problem-solving (Northouse, 2007). Finally,
individualized consideration provides a supportive environment in which the leader
listens carefully to the need of the individual follower (as a coach and advisor), while
assisting him or her in becoming fully actualized either with caring, strong affiliation, or
specific directive (Northouse, 2007). TFL emphasizes these four components and
requires leaders to be aware of how their own behaviors relate to the needs of their
subordinates (Northouse, 2007). These are representative of a positive trajectory of TFL.
When TFL is inauthentic, instead of positive characteristics it can have negative ones
(Howell & Avolio, 1993).
Relevant to this research and to HPI, the HP is the expert, has expert power, is the
social source of referent power, and is the socializing leader. The expert power results
from the visibility of the HP’s advanced education and knowledge of disease pathology
and related prevention and treatment measures, as well as the quality, depth and
demeanor of the HP’s interaction with the patient. Due to having and utilizing TFL
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skills, the HP can transfer or refer this expert power to the patient. This transfer of power
from the expert to others can affect several potential variables that can improve one’s
health outcome and status, including knowledge, internal motivation, and self-efficacy
(Gabel, 2012a). When this transfer of power results in an ability or increased ability to
and engagement in healthy behavior modification, this is called referent power (Gabel,
2012a). TFL emphasizes internal motivation and follower development and implies that a
process that changes and transforms people is concerned with emotions, values, ethics,
standards, and long-term goals, includes followers’ motives, satisfying their needs and
treating them as full human beings (Northouse, 2007).
The Full Range of Leadership (FRL) Model was designed to include three types
of leadership and presents them in a continuum to differentiate their characteristics and
effectiveness (Antonakis, Avolio, & Sivasubramaniam, 2003). TFL, described as
producing greater effects than the other two as well as more than is expected, sits on a
continuum at one end with transactional leadership in the middle and laissez-faire
leadership, essentially described as the absence of leadership or non-leadership on the
other end (Bass, 1985; Bass & Avolio, 1990).
TFL styles have been found to correlate highly with positive individual and group
behavior modification (Bass & Avolio, 1995). In management literature, results from
outcome studies have found that different components of TFL predict or positively
correlate to effectiveness or satisfaction between leaders and employees (Bass & Avolio,
1994; Bryman, 1992).
Substantial work evaluating the TFL qualities of HPs in healthcare settings in
management roles and inter-professionally among colleagues in both nursing and
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medicine has also been undertaken (Bycio, Hackett, & Allen, 1995; Gellis, 2001). Using
the TFL model in the development of physician leadership has been recommended to
improve health care quality and cost control (Xirasagar, Samuels, & Stoskopf, 2005).
However, a gap was identified in the literature in regard to evaluating TFL and patients,
and the relationship between HP’s leadership style and patients, including their
engagement in health behavior modification in response to either preventative or curative
treatment recommendations. No research has been found in which patients were asked
their perception or assessment of their HP’s leadership characteristics. Gable (2012a,
2012b), recognizing the lack of leadership research in the healthcare setting involving
patient and HPs, recommended exploring the use of Bass’s TFL model in the medical
arena. The incorporation of power and leadership study into medical education has been
proposed, as well as, strategies recommended to achieve this (Gable, 2012a, 2012b). Use
of TFL and evaluation of TFL in physicians for improvement in patient health outcomes
have also been recommended (Gable, 2012a, 2012b).
Other transformational leadership perspectives have been presented in the
literature (Northouse, 2007). Strategies used by leaders with followers in transforming
organizations have been described (Bennis & Nanus, 1985). Practice guidelines for how
to behave as an effective leader to accomplish extraordinary things using five
fundamental practices include: model the way, inspire a shared vision, challenge the
process, enable others to act, and encourage the heart (Kouzes & Posner, 1987, 2002) has
also been described (Northouse, 2007). These were reviewed for appropriateness of fit for
this research. However, they are not as relevant to the HP-patient relationship and
personal or individual patient outcomes, nor as thorough and comprehensively used for
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research as the theory selected, as they are more focused on organizational outcomes and
more suitable and effective for training and development purposes (Northouse, 2007).
Self-Efficacy
Self-efficacy is a concept that was explored in this research. Although not
explicitly included in the conceptual model of HPI, self-efficacy is encompassed within
its emotive/cognitive component as well as a cognitive/psychological outcome. Selfefficacy is also a component of the ITBHC under the category of knowledge and beliefs
(P. Ryan, 2009). It is described within that model as affected by knowledge, beliefs, and
practice of skills, and augmented as a result of self-regulation (P. Ryan, 2009). It is
purported to enhance engagement in health behavior modification (P. Ryan, 2009).
Self-efficacy theory, a form of social cognitive theory was developed and
described by Bandura to describe the relationship between the necessary but insufficient
components of how knowledge, transformational operations, and constituent skills
progress into performance or action (Bandura, 1986). “Perceived self-efficacy is defined
by people’s judgments of their capabilities to organize and execute courses of action
required to attain designated types of performances,” and addresses the process of how
personal judgments or sense of capability affect motivation and behavior to do what they
need to do or can do to control whatever affects their lives with the skills they have
(Bandura, 1986, p. 391). People tend to do those things they think they are capable of and
avoid doing those things that they do not think they can do, or which will take significant
effort. People must make decisions in many aspects of their lives, one of which involves
their health. To do so, they must exercise efficacy, the belief in their capability to
exercise control over their own motivation and behavior (Bandura, 1991). Beliefs are one
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determinant for behavior, thoughts and reactions. Self-efficacy is one of the psychosocial
determinants regulating psychosocial functioning and impacts health status by
influencing biological functioning (Bandura, 1986). Competent functioning requires both
skills, social, behavioral, and cognitive as well as the self-efficacy beliefs to use or
organize them effectively to accomplish an outcome if the person judges that he or she
can or wants to.
It is important to distinguish the difference between self-efficacy and outcome
expectation. An outcome expectation is a judgment of the likely consequence the
behavior will produce, therefore not the act but its consequence (Bandura, 1986). How
one behaves largely determines the outcomes one experiences; however, it is not the
performance that is generally measured or cared about, but rather the outcome. Since
outcomes are contingent on performance, the perception of what one can do or whether
he or she is able to achieve the outcome will likely determine what actions are taken.
Strategies or ways to alter a people’s self-efficacy can occur because of cognitive
processing when information is communicated actively, vicariously, physiologically or
persuasively. These strategies are performance attainment/skills mastery, vicarious
experience/modeling, physiological states/reinterpretations of symptoms and
verbal/social persuasion (Bandura, 1986). Mastery experiences will instill a strong sense
of efficacy; with each success a more robust sense is built. Modeling is when people
judge their own capabilities by comparison with what others can do or the opinion of
others. They increase their own beliefs and self-efficacy when they see or experience
vicariously through others. The opposite is also possible in that a decrease in beliefs of
capability can result if they see others fail. Reinterpretation of symptoms involves
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providing people with the skills to reduce physiological reactions to modify how they
interpret somatic information. Finally, social persuasion is used via influence to convince
people they have the capability to achieve and succeed. When the objectives are realistic,
the influence can lead to great success. The strength of belief in one’s capacity to do a
specific task is a good predictor of motivation and behavior. Enhanced perceived selfefficacy is the belief that the self has the capability to mobilize the motivation, cognitive
resources, and course of action needed to meet situational demands and leads to improved
behavior, motivation, thinking patterns, and emotional well-being (Bandura, 1986).
Performance attainment or actual experience of the success of one’s actions is the most
influential source of self-efficacy beliefs because it is based on actual skill mastery.
Theory and research have linked self-efficacy and TFL. Self-efficacy has been
suggested as a possible mediating mechanism through which transformational leadership
affects followers’ performance in the self-concept motivation theory of leadership work
of Shamir, House, and Arthur (1993). Leaders with TFL are said to enhance a follower’s
perceived self-efficacy and role commitment by communicating high performance
expectations and positive visions, providing training, coaching and opportunities for
development, and expressing confidence in their abilities to contribute to the mission and
goals of their organization (Shamir et al., 1993). Leaders with TFL were believed to
increase self-efficacy, leading to higher team morale, which resulted in greater team
innovation directly benefitting patients in a teaching hospital (Wilson-Evered, Hartel, &
Neale, 2001). In a study of bankers, TFL was also found to positively and significantly
relate to self-efficacy (p≤.05) in regard to individual job performance (Walumbwa,
Avolio, & Weichun, 2008). Increasing follower’s self-efficacy, along with performance
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goals, was found to mediate the relationship between leader TFL factors and increased
performance in business students (N=282) (Kirkpatrick & Locke, 1996). When leaders
understand how their followers view themselves and providing regular and adequate
feedback, this can transform a follower’s belief that they can be successful at more
challenging tasks.
Self-efficacy has been explored in relation to self-management. It refers to the
confidence and beliefs that contribute to self-management of behaviors, such as health
behavior modification. Health behavior modification is a major outcome variable in selfefficacy research as well as the outcome for this research study. Bandura’s self-efficacy
theory provides the framework for much of the research regarding self-management
interventions (Lorig et al., 1996). Multiple self-efficacy instruments for several chronic
health conditions, as well as related health behavior measures have been developed and
used in research demonstrating repeatedly the correlation between the two concepts of
self-efficacy and self-management of health behavior modification (Lorig & Holman,
2003; Lorig, Ritter, & González, 2003). Health behavior modification, such as in diet
management and physical activity is increased when self-efficacy is enhanced (Lorig,
González, & Ritter, 1999; Lorig, Ritter, & Jacquez, 2005; Lorig, Ritter, Villa, & Armas,
2009).
Self-Management Health Behavior Modification
Self-management refers to the process of engaging in specific behaviors
enhancing a person’s ability to manage an illness, usually chronic in duration and nature,
or risk behaviors. Self-management includes learning tasks such as medical or
behavioral management, role management, and emotional management (Lorig &
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Holman, 2003). Five core skills include problem-solving, decision-making, resource
utilization, forming a patient-HP partnership, and taking action (Center for the
Advancement of Health, 2002). The fourth skill is consistent with the interactive and
social communication within the HP-patient relationship and the patient-centeredness of
the HPI conceptual model. Health behavior modification is a central concept included as
an outcome in the behavioral/physical component of the HPI model. Health behavior
modification is used synonymously with health behavior change. Engagement in selfmanagement behaviors is one of the proximal outcomes of the ITHBC (P. Ryan, 2009).
Self-management for the individual is the primary focus in the work of Lorig, rather than
family or community (P. Ryan & Sawin, 2009). Self-management tasks described as
maintaining good nutrition and appropriate diet and maintaining adequate exercise and
physical activity (PA) (Lorig et al., 1996) represent the outcome measures for health
behavior modification in this proposal. For the purposes of this proposal, health behavior
modification was defined as “the adaptation or changes made to current practices that
affect one’s health and overall outcomes, such as healthy eating and physical activity
(PA)” (Fryzelka & Weiss, 2013).
Health behavior modification has been studied extensively throughout the
healthcare professions in relation to many chronic diseases or preventative health
promotion strategies. The predominant foci of self-management of health behavior
modification research are correlation studies with health outcomes that usually involve
chronic conditions or diseases, such as DM, arthritis, asthma, hypertension, and cancer
(Heisler, Smith, Hayward, Krein, & Kerr, 2003; Lorig et al., 2003; Lorig et al., 2005;
Lorig et al., 2009). In addition to the two most commonly identified areas of health
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behavior change or modification, dietary or eating pattern changes and exercise or
physical activity changes, others include smoking or drug and alcohol cessation, stress or
pain management, and coping strategies. Health behavior modification among all of
these, but especially smoking or drug and alcohol cessation has been increasingly shown
to prevent or delay the onset of chronic health problem diagnoses as well as improve or
slow deterioration once they occur (Lorig et al., 1996). Treatment and prevention
programs usually aim at least some efforts toward health behavior modification (Lorig et
al., 1996). Improving healthy behaviors can improve physical, mental and social health
and functioning, while prolonging and prompting independence and autonomy (Lorig et
al., 1996).
Several variables representing health behaviors that have been studied in
correlation with self-efficacy including diet and exercise (Lorig et al., 1996) in people
with DM (Kara, van der Bijl, Shortridge-Baggett, Asti, & Erguney, 2006; Leung Hui,
Sevenhuysen, Harvey, & Salamon, 2014; Lorig & González, 2000; Rapley, Passmore, &
Phillips, 2003). To engage in health behavior modification, individuals must perceive
that they can do so, they need to perceive themselves at risk, and they need to see more
benefits than costs in making the changes. HPs can enhance patient self-efficacy by
providing information actively, vicariously, physiologically, and persuasively. This can
lead to influencing and empowering them, increase their controllability along with their
knowledge, beliefs, confidence and success regarding health behavior modification. This
can in turn increase physical and emotional well-being and contribute to prevention of
further sequelae or future disease.
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Regarding GDM, it has been suggested that it is important to help patients
increase their perception of their ability to deal with GDM before communicating risk
information (Snoek & Rubin, 2005). Women with recent GDM diagnosis pass through a
period of transition requiring knowledge about the disease and treatment, with the
potential for conflicting self-perception about their capability to modify their behaviors
and their body’s response (Leung Hui et al., 2014; Parsons, Ismail, Amiel, & Forbes,
2014). To treat GDM or prevent future DM, the patients need to perceive that they can do
what is needed regarding health behavior modification of diet and physical activity to
achieve that outcome. In postpartum women with a recent diagnosis of GDM,
engagement in healthy dietary behaviors were found to positively correlate with social
support, and engagement in sufficient or increased physical activity levels were positively
correlated with high self-efficacy and high social support, often reported to be verbal
encouragement from family and friends or someone exercising with them (Kim,
McEwen, Kieffer, Herman, & Piette, 2008; Smith, Cheung, Bauman, Zehle, & McLean,
2005). Decreased self-efficacy for PA related to time pressures and fatigue and barriers to
PA reported were a lack of childcare and insufficient time (Smith et al., 2005). Women
with GDM have experienced stress over losing control of GDM by not being able to
follow recommendations or success in achieving glucose targets with dietary
management (Leung Hui et al., 2014). Factors negatively affecting patient engagement
self-management in DMs include inadequate self-efficacy, ineffective HP relationships,
limited DM knowledge, inadequate family and community support among others
(Rodriguez, 2013). These results support the notion of exploring measures to increase
GDM/DM self-efficacy by developing a trusting HP relationship and consistent

33

information, support, knowledge, goals and use of verbal persuasion to build self-efficacy
to promote healthy behaviors in this patient population (Rodriguez, 2013).
Physical activity has been found to be effective in preventing and managing GDM
(Ruchat & Mottola, 2013). However, understanding women’s beliefs about and behaviors
related to exercise as well as barriers and sources of social influence were deemed
important to develop interventions to increase exercise in GDMs (Symons Downs &
Ulbrecht, 2006). A diabetes prevention program found that in cases of people diagnosed
with impaired glucose tolerance and thus determined to be at high risk of developing
DM, implementation of interventions that modify health behaviors and lifestyles have
been shown to significantly reduce the incidence of DM and all the social and human
costs (Snoek & Rubin, 2005). Patients with GDM who were expected to have had more
difficulty in controlling their blood sugars because of physiological glucose impairment
usually had better-controlled blood sugars with greater motivation (Snoek & Rubin,
2005). It also found that barriers to prevent onset or delay diagnosis of DM were
attributed to a lack of knowledge among the public and physicians about the correlation
between impaired glucose tolerance and previous GDM diagnosis and the risk of
developing DM (Jones, Roche, & Appel, 2009; Snoek & Rubin, 2005). The perception of
general risk versus personal risk of future DM in postpartum women varied in two studies
(C. Kim et al., 2007; Zera, Nicklas, Levkoff, & Seely, 2013). Most postpartum women
with recent GDM, 90-95%, were aware, that previous GDM was a risk for DM but only
16% that believed they were personally at risk for developing DM in the future.
Increased knowledge and motivation certainly play a role in health outcome
improvement via health behavior modification. Motivational interviewing has been
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highly efficacious for behavior changes in smoking cessation, alcoholism, and dietary
adherence and physical activity for diabetics (Leyva-Mora, 2007). However, reported
conclusions from self-management research findings indicate that knowledge alone is
insufficient as a predictor of these changes; motivation is not always inherent in those
diagnosed or at risk for acute or chronic illness and disease, and readiness or ability to
make changes that are necessary to prevent or treat illness is not a given (Lorig et al.,
1996).
A concept related to self-efficacy that is prevalent in health behavior modification
research is patient activation, extensively studied by Hibbard and colleagues (Hibbard,
Stockard, Mahoney, & Tusler, 2004; Lorig et al., 2009; Hibbard & Greene, 2013;
Hibbard, Greene, & Overton, 2013). Patient activation is used to describe the skills and
confidence that equip patients to become more actively engaged in their healthcare and is
defined as “understanding one’s own role in the care process and having the knowledge,
skills, and confidence to take on that role” (Hibbard et al., 2004; Hibbard, Greene, &
Overton, 2013). Patient activation, in multiple studies, has been found to lead to
improved health outcomes, decreased healthcare costs, and increased patient care
experiences (Hibbard & Greene, 2013). Patient activation has been studied in research
involving healthy behaviors, DM and in multiple populations (Lorig et al., 2009; Rask et
al., 2009; Hibbard & Greene, 2013).
Patient activation is measured by a 13-item tool called patient activation measure
(PAM), developed to measure four domains: confidence, beliefs, knowledge, skills.
Scores increase as levels of activation increase from least to most activated and testing
reflects strong psychometric properties (Hibbard et al., 2004; Hibbard, Mahoney, Stock,
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& Tusler, 2007). PAM was linked to health behavior activation and better health
outcomes, including biometric measurements of hemoglobin A1c (Hibbard & Green,
2013). In one study, very low activation levels were significantly associated with higher
health care costs and predictive of higher future costs. On the contrary, higher activation
levels and more confidence, knowledge and skills in health self-management increased
navigation of health care system and incurred less costs (Hibbard, Greene, & Overton,
2013). Higher PAM scores were significantly correlated with health and preventative
behaviors in multiple studies including eating a healthy diet, increasing physical activity,
and avoiding health-damaging behavior (Hibbard et al., 2004; Hibbard, Mahoney,
Stockard, & Tusler, 2005).
Due to the proximity in conceptual construction and fair amount of overlap
between patient activation and self-efficacy, it was necessary to determine which one
would be a better fit for this study’s conceptual design. Both include elements of
knowledge, skills and confidence. Both have engagement in health behavior modification
as their end. Both have been studied in patient populations similar to the sample of this
study, as well as in patients with DM. The difference between the two at initial glance
appears to be related to “perception of beliefs in one’s capability” present in self-efficacy
versus “understanding one’s role” in patient activation. As a mediating variable in this
study the self-efficacy appears to have a better fit with transformative leadership and
patient activation with transactional leadership. This interpretation may result in part due
to the different strategies recommended for increasing engagement suggested by Bandura
for self-efficacy (performance mastery, modeling, re-interpretation of symptoms, and
social persuasion), which are consistent with TFL, and by Hibbard for patient activation,
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(interventions and system support). Self-efficacy represents a process of transforming
the individual’s cognitive-psychological perception of capability in psychosocial
interaction with others, thus fits better with the social influence component of the ITHBC
model, described “when a knowledgeable person in a position of perceived authority,
such as a HP, sways their thinking and motivation leading to engagement in behavior” (P.
Ryan, 2009). The focus of this research was on the influence of patient engagement in
health behavior modification via a collaborative-psychosocial interaction involved in the
HP-patient relationships leading to transformation in the patient’s emotive-cognitive and
physical-behavioral status. This focus encompassed the perception of capability that
affects motivation and engagement in behavior modification, consistent with selfefficacy. The HPI conceptual model includes this strong link to self-efficacy as well as
multiple other inter-related components that via utilization of transformational leadership
skills by the HP may increase patient engagement. Differentially, patient activation
relates more to cognitive-only and is focused more on the individualinstitutional/organization interaction versus person-person with utilization of strategies of
interventions and support to increase their understanding of their role. Patient activation
has a better fit with the social support component of the social facilitation aspect of the
ITHBC, consisting of “emotional, instrumental, or informational support, which
facilitates engagement in a health behavior” (P. Ryan, 2009) rather than the inter-personal
social influence aspect.
Despite the use of self-efficacy and patient activation with similar research
objectives and goals, such as health care reform, the improvement of health outcomes,
decreasing associated costs, and utilizing a patient-centered (PC) care focus, self-efficacy
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is determined to be a better fit for this research purpose. In summary, patient selfefficacy, that is the self-perception of their capability, including knowledge, beliefs, and
confidence, that can transform into skills and taking opportunities to engage in health
behavior modification is a more suitable measure with this study than assessing their
“understanding of their role in the process”, consistent with patient activation.
The patient’s perception of their HP’s role and TFL characteristics were assessed
and tested in association with outcomes of patient engagement, health behavior
modification. Patient self-efficacy was also assessed for a mediating effect on the
relationship between HPI and outcomes of patient engagement, health behavior
modification. Measurements for self-efficacy specific to the context of the study, GDM,
the Diabetes Self-Efficacy Scale (DSES), are readily available; however, there is no
measure of PAM specific to diabetes or gestational diabetes.
Gaps
A gap identified in the research is the need for HPs to better understand how
health behavior change is made and their role in facilitating and supporting change as
well as understanding how to maintain these behavioral changes over time (P. Ryan,
2009). A similar recommendation from the patient activation research called for a focus
on the HPs role for patient engagement in health behavior modification (Hibbard &
Greene, 2013). This research was proposed to better understand the role and influence of
HPs via the patients’ perception of their HP’s leadership characteristics and the
association with their engagement in health behavior modification. As has been
described, several studies have found a correlation between increased self-efficacy and
increased engagement in health behavior modification. This proposed study incorporated
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a measure of self-efficacy and addressed whether the degree of self-efficacy affected the
relationship between HPI and patient engagement in health behavior modification.
Additional research recommendations have been proposed due to the gaps related to TFL
leadership research involving patients and HPs. The evaluation and development of TFL
skills in HPs for use in their relationship with patients may have an impact on the
improving health outcomes, containing/decreasing healthcare costs, and improving
healthcare quality (Gabel, 2012a, 2012b; Xirasagar et al., 2005). These suggestions from
individuals involved in health behavior modification research and P. Ryan’s
conceptualization of the ITHBC (2009) that provided the space for HPI to emerge and
develop, all serve to confirm the gap in the literature about the process of HPI and its
relationship to patient health behaviors and outcome.
This study intended to not only fill in some of those gaps, but also to provide an
opportunity for initial testing of the newly-developed HPI conceptual model, a new
structure and perspective from which to explore the range of factors that could contribute
to improvement in patient health status and outcomes. This allowed for inquiry into the
role and responsibility of the HP from a social leadership lens, which has not yet been
described in the literature. Additionally, it provided a foundation for future research into
how to augment engagement in the self-management of health behaviors, as well as
perceived self-efficacy to drive self-directed modification of health-promoting behaviors.
Furthermore, it had and still has the potential to guide curriculum and professional
development and augments HP-patient communication in the clinical setting.
Additionally, it contributed to increased increases in the efficiency and effectiveness of
the HP-patient interaction.

39

Research Purpose/Aims
The purpose of this study was to explore the relationship of HPI and health
behavior modification, specifically healthy eating, physical activity, and glucose
monitoring in women with GDM, a disease where treatment, control, and prevention
center on patient self-management through dietary modifications and increases in PA.
The specific research aims were: a) to determine if HPI was associated with patient
engagement in health behavior modification of healthy eating, physical activity, and
glucose monitoring in women with GDM; b) to determine if patient characteristics
moderated the relationship between HPI and patient engagement in health behavior
modification of healthy eating, physical activity, and glucose monitoring in women with
GDM; c) to determine if healthcare provider characteristics moderated the relationship
between HPI and patient engagement in health behavior modification of healthy
eating/diet, PA, and glucose monitoring in women with GDM; d) to determine if selfefficacy mediated the relationship between HPI and patient engagement in health
behavior modification of healthy eating, physical activity and glucose monitoring in
women with GDM; and e) to determine if there were differences in the pattern of patient
engagement in healthy eating and physical activity during pregnancy for women with and
without a GDM diagnosis.
Philosophical Underpinnings for the Study of Healthcare Provider Influence
Reflection on the philosophical paradigms underlying this research revealed that
the overarching paradigm or worldview from which this research inquiry initially arose
within the researcher was from critical social theory (CST). With a major focus on health
outcome improvement from an individual concentration graduating to a community and
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ultimately, a global one, the intent of the researcher is to address in the social setting and
within social institutions, such as within health care, measures to improve or encourage
opportunities for patient self-empowerment and self-actualization as a result of exploring
and correcting power issues. In this inquiry, interest in how HPs influence patient
engagement in healthcare behavior modification emerged from the desire to understand
how HPs, those with expert power, using transformational leadership can or should
transfer their power to the patient for improvement in healthcare status. Toward this end,
a review of the literature and conceptualization of the HPI model ensued. Historically and
socio-politically, CST sets the paradigm for a more negative and destructive form of
power; however, the perspective in this case is to recognize that there exists a power
differential and to effect movement of the power for positive and transformative
purposes. These power concepts are included in the TFL theory that provided the
foundation for the HPI conceptual model. CST is concerned with the study of social
institutions, issues of power and alienation, and envisioning new opportunities (Gillis &
Jackson, 2002). Personal meaning is shaped by societal structure of the healthcare setting
and communication processes (Campbell & Bunting, 1991). Both the setting and the
social-communication interaction between the HP and the patient are components of the
HPI conceptual model. The empowerment of patients to increase their engagement in
health behavior modification to improve health outcomes and the opportunity to
experience transformation because of their experiences and interaction with expert
leaders all appear to be a good fit for CST. The research inquiry, the intentions of the
researcher, the ontology of critical realist, the outcomes related to the process of the
inquiry and potential results, and finally, the future intervention studies all appear
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consistent with the tenets of CST. However, despite all these considerations, the
epistemology and methodology do not support this paradigm specific to this specific
inquiry. The epistemology, the nature of how the knowledge is learned was not subjective
and the researcher and participant were not engaging in a participatory manner. Nor was
the methodology, how data was collected, analyzed, and selected for this research design,
consistent with CST (Guba, 1990).
The paradigm that motivated this specific proposal, with consideration of the
ontology, epistemology, and methodology aligned with post-positivism on all three of
these levels. Post-positivism began emerging as a group of philosophers questioned and
rejected the notion that acquisition of all knowledge be reduced or deduced, and derived
by reasoning and strict objectivity alone, as is reflected rigidly with the positivist stance.
Although initially accepted due to its philosophical foundation for much of medical
research, positivism has historically been questioned from a global nursing perspective as
to whether it was even an appropriate fit for this discipline. The major critique is due to
the lack and devaluing of holism, patient-centeredness, and humanity, which are critical
tenets of nursing (Guba, 1990).
The ‘objectivist’ epistemology of positivism was critiqued and a post-positivist
“modified objectivist” epistemology proposed as an alternative. Regarding the modified
objectivist, it is suggested that knowledge, while objectively acquired by sensory
experience, is biased in that the researcher knows and believes also because of what they
perceive or feel. “Perception is partly a function of prior knowledge” wherein
presuppositions and theory play a role and result in the reality that observations become
theory-laden (McErlean, 2000, p. 3). The researcher brings several assumptions or biases

42

that served a pivotal role in structuring the research conceptual-theoretical-empirical
statement research structure (Fawcett, 1999). The major assumptions in this research
proposal were that HPs play an expert role that via interaction with patients can refer that
power or empower them, utilizing TFL skills to increase their engagement in health
behavior modification. This assumption was based on the researcher’s previous
experience in both a HP and patient role. Additional assumptions will be detailed later.
Ontologically, positivism and post-positivism support realism, with the latter
described as taking on a critical realist stance, similar to CST (Guba, 1990). Reality is
derived from natural laws and is used to predict and control phenomena according to
positivism; however, as a result the findings are not generalizable as reality is constantly
changing (Guba, 1990; Monti & Tingen, 1999). Reality cannot be completely objective
as many factors and dimensions affect reality from variations between person, time,
environment, and context. The reality of every patient will be different based on the
interplay between variables of influence and outcomes; however, a consensus will result,
representing a modified objectivist view, from multiple perspectives, in this case by
asking who is influential and what about them or their actions is influential. Both the HPI
conceptual model and the ITHBC are patient-focused involving human behaviors,
reactions, and perceptions, also with elements of patient-centered communication and
care. In this case, the patient was not constructing or defining her own reality, which
would be consistent with constructivism.
The post-positivist paradigm was also aligned with the methodology, the means
used to gather and analyze data to create knowledge, selected for this research. The
methodology is also consistent with positivism, but the interrelated theories are not

43

positivistic. This was a quantitative empirical study looking for observations and
associations, between multiple variables, HP and patient characteristics, patient
perceptions of HP influence and HP leadership characteristics, delivery and content of
information, self-efficacy, and patient health behavior modification. Correlations were
hypothesized to exist between the independent and dependent variables. The nature of
psychosocial objective measurements of perceptions and behavioral outcomes was
consistent with post-positivism. Theory testing and application of the ITHBC, and the use
of valid and reliable measures to examine phenomena of HPI were representative of
objectivity, present in the positivist and post-positivist paradigms. In this case, the
objectivity was “modified”, in that knowledge was acquired as objectively as possible
and according to rules and guidelines for validity, reliability, and use for generalizability.
Furthermore, the proposition was derived with bias and preconceived notions about the
association between the variables. These factors all support post-positivism.
Assumptions of the study
Ideological
1. Persons with illness or disease are influenced in their decisions regarding health
behavior modification by relationships with others, one of whom is their HP.
2. HPI describes a transformative process by which patients can engage in health
behavior modification.
3. Self-efficacy can explain some of the effect of HPI on patient engagement in
health behavior modification.
Procedural
1. HPI can be assessed by patient’s completion of questionnaires and surveys
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2. TFL characteristics of HP can be assessed by the patients for whom they provide
care by completion of a survey.
3. Patient self-efficacy can be assessed by completion of a survey.
4. Social influence, measured as HPI, is a stable condition and only needs to be
measured once (Champion, 1994).
5. Patients can recall and report their healthy eating/diet, PA and glucose monitoring
behaviors accurately from the past week.
The assumptions are based on the review of the literature regarding patientcentered communication and results of TFL, primarily, in the organizational setting. One
of the hypotheses for this research, that HPI augments the engagement of patients in
health behaviors that are positive and beneficial to improve their health status when the
HP has higher levels of TFL skills/characteristics is based largely on these assumptions.
Conceptual-Theoretical-Empirical Structure (CTES)
As soon as a research purpose was identified, and questions formulated, it was
important to determine what the concepts were, how they were linked together, what they
were based on, and how the concepts were to be measured (Fawcett, 1999). Concepts
should be well described and transparency in how they are merged is deemed important
for those researching and those who intend to understand the theory and findings. Each
research proposal should be linked to an existing nursing theory to further explain,
expound on, modify, or refute it (Fawcett, 1999). A means to facilitate this is by
designing a conceptual-theoretical-empirical structure (CTES) (Figure 1) (Fawcett,
1992). Although there is a level of clarity intended by developing a CTES, due to the
multiple descriptors, designations, and naming of conceptual models and theories, it is
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not always necessary or possible to describe all the multiple levels of theories for each
research proposal or determine just one theory that provides the foundation for the
research.
Conceptual Framework
The conceptual framework used for the development of the HPI conceptual model
and subsequently this research is based on two theories, the ITHBC and the TFL. The
ITHBC has been described as a descriptive middle-range theory (P. Ryan, 2009). As a
middle range theory, it is testable and is limited in scope and number of variables, in
terms of not addressing the full scope of nursing’s concerns; however, it does have a
broad scope in relation to the types of clinical problems and patient types that could be
considered, and therefore it is both sufficiently general yet specific enough to be used in
research (Fawcett, 1999). In addition, it directs and is tested by practice (Fawcett, 1999).
HPI represents an extraction from the social facilitation-social influence-professional
influence component of the ITBHC.
The second theory contributing to the conceptual framework for HPI is TFL. The
socializing aspect of TFL is conceptually aligned with the social facilitation-social
influence component of the ITHBC. TFL serves as the process theory whereby the HP is
an effective and positive social influencer. The emphasis on intrinsic motivation needed
for behavior modification is consistent with the motivational aspects of TFL. The
individualized consideration within TFL is consistent with the patient or person-centered
approach of the ITHBC. The combination of the two theories of ITHBC and TFL
provides a strong basis for the development and testing of the HPI model, with the
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specific focus of exploring the correlation between HPI and health behavior modification
engagement in this and future research.
Theoretical Framework\
Theories are interrelated concepts and statements that are testable, described as
less abstract, often in the form of middle- range, micro-range, and situation-specific
theories, and contribute to the intermediate level of the CTES (Fawcett, 1999; Hardy,
1978; Higgins & Moore, 2000). The HPI conceptual model represents the theoretical
level as a practice theory, focusing on a specific population or situation, in this case
GDMs (Walker & Avant, 2005). A conceptual model contains a set of relatively abstract
and general concepts, as well as the propositions that link or describe those concepts and
is intended to provide the context for theory testing (Fawcett, 1989, 1999). It can be used
to represent ideas relevant for all healthcare professionals, especially their largest group,
nursing, HPI describes the components and process of influence involving HPs and
patients in regard to improved health outcomes via engagement in health behavior
modification, which was tested for the first time. HPI is a construct of several concepts
that are operationally defined and represented by several independent variables that were
tested to verify the correlation between concepts within the model and the links within
the integrated theory (Walker & Avant, 2005) to determine if the proposed relationship
among concepts could be validated. While the construct is relatively abstract, selected
components are being drawn on as they relate to concepts from the two conceptual level
theories, ITHBC and TFL. Testing these concepts also works simultaneously to test and
validate the shared components of these theories (Walker & Avant, 2005).
Empirical Level
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Empirics describe the methods used to collect and analyze the data and represent
the most concrete level of the statement (Fawcett, 1999). The empirical level represents
the most concrete level of the structure and contains the measurements of the variables
representing or providing the operational definition of the concepts interlinked in the
research statement. A total of nine measures contributed to this empirical level which
were linked to the theoretical and conceptual levels in the discussion to follow.
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Conceptual Constructs
*Integrated Theory of Health
Behavior Change (ITBHC)
*Transformational Leadership
Theory (TLT)
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Patient
Characteristics
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Figure 1: Conceptual-Theoretical-Empirical Structure
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The HPI model was pulled from and essentially explicates the social influence
concept, a component of social facilitation from the ITHBC. Social influence is also
represented from the TFL theory. In this study, social influence was represented by two
concepts from the HPI model: concordance-logistics and social-communication.
Concordance-logistics was operationalized as patient and HP characteristics, including
HP leadership and measured using the Patient Demographic Questionnaire (PDQ), the
HP Demographic Questionnaire (HPDQ) and the Multifactor Leadership Questionnaire5X (MLQ). Social-communication was operationalized as HP social influence measured
by the Social Influence Questionnaire-GDM (SIQ) and the quality of interaction and the
informational content received-delivered measured by the Quality of InformationInteraction-GDM (QOII). Other ITHBC components were linked to the HPI concepts.
Self-efficacy is a component of knowledge-beliefs, a process construct of the ITHBC as
well as the primary operational definition of the emotive-cognitive concept of HPI. It was
measured by the Diabetes Self-Efficacy Scale (DSES). The SIQ and the QOII are also
linked to the knowledge-beliefs concept on the conceptual level and the emotivecognitive concept on the theoretical level. Finally, proximal health outcomes, a
component of the ITHBC was represented by the behavioral-health behavior modification
HPI concept and measured by the Eating Breakfast Questionnaire (EBQ) +1, the Physical
Activity Scale (PAS) and the Glucose Monitoring Questionnaire (GMQ).
Summary
A summary of the review of the literature related to the concepts included in the
research proposal has been presented, as well as a description of theories that provided a
foundation for the development of a conceptual model, HPI and testing of the proposition
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based on assumptions that HPI increases patient engagement in health behavior
modification. A gap in the healthcare literature was identified necessitating the need for
the model due to a lack of an existent one. The post-positivist philosophical paradigm
that underlies these theories and research and as well as the conceptual-theoreticalempirical statement has been described including the theories, ITHBC and TFL, and a
description of the characteristics of the instruments selected for the study variables.
Assumptions related to the research study have also been reported. The following
chapter addresses the design, aims, related hypotheses and research questions,
methodology, recruitment, and implementation of the study.
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Chapter 3: Research Design and Methods

Research Purpose
The goal of the research was to explore the relationship of healthcare provider
influence (HPI) and health behavior modification, specifically healthy eating (HE),
physical activity (PA), and glucose monitoring (GM) in women with GDM. This research
project was designed and structured as a primary means of testing the relationship
between components of a newly developed conceptual model for HPI. The overarching
research question is “What is the relationship of HPI to health behavior modification of
healthy eating, physical activity and glucose monitoring behaviors in women with
GDM?”
Research Aims, Hypotheses (H) and Questions (RQ)
The specific research aims with their corresponding hypotheses (H) and a
question (RQ) were:
Aim 1) to determine if HPI was associated with patient engagement in health
behavior modification of HE, PA, and GM in women with GDM.
H1) HPI, specifically, SIQ and QOII will be positively correlated with an
improvement in HE, an increase in PA and adherence to GM recommendation behaviors
in women with GDM.
Aim 2) to determine if patient characteristics moderated the relationship between
HPI and patient engagement in health behavior modification of HE, PA, and GM in
women with GDM.
H2) Patient factors, specifically, race/ethnicity, primary language, and
personal/family history GDM/DM, will have a moderating effect on the relationship
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between HPI, specifically, SIQ and QOII and HE, PA, and GM behaviors in women with
GDM; the relationship will be stronger with race concordance, primary language
concordance, and a positive personal/family history of GDM/DM (GDMPFH)
Aim 3) to determine if healthcare provider characteristics moderated the
relationship between HPI and patient engagement in health behavior modification of HE,
PA, and GM in women with GDM.
H3) HP factors, specifically, gender, HP specialty, HP leadership style (MLQ)
will have a moderating effect on the relationship between HPI, specifically, SIQ and
QOII, and HE, PA, GM behaviors in women with GDM; the relationship will be stronger
with gender concordance, HP transformational leadership style (MLQ) but not differ
based on HP specialty.
Aim 4) to determine if self-efficacy mediated the relationship between HPI and
patient engagement in health behavior modification of HE, PA, and GM in women with
GDM.
H4) Patient self-efficacy will have a mediating effect on the relationship between
HPI specifically, SIQ and QOII and HE, PA, and GM behaviors in women with GDM.
Aim 5) to determine if there were differences in the pattern of patient engagement
in HE, PA during pregnancy for women with and without a GDM diagnosis.
RQ1) Were there differences in patient engagement in health behavior
modification of HE and PA as a result of time (Phase 1, during high-risk screening and
Phase 2, near the end of pregnancy) or diagnosis of GDM (control group: non-GDMs and
GDMs)? and b) were there differences in patient engagement in health behavior
modification of HE and PA as a result of time (Phase 1, during screening and Phase 2,
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between 34-36 weeks gestational age) or diagnosis of GDM (control group: non-GDMs
and study group: GDMs) when adjusting for three covariates: race/ethnicity, primarily
language and personal/family history of GDM/DM?
Research Design and Method
In planning a study to answer the proposed research question and validate the HPI
conceptual model, it was necessary to select a design, determine sample selection
including inclusion and exclusion criteria, estimate a sample size, develop a research
procedure and protocol, including consideration of human subjects protection, select and
test instruments used to measure variables within the study, and address threats to internal
and external validity. Additionally, consideration and relevance to the theoretical and
philosophical underpinnings was important.
The primary research design selected was an observational, prospective,
longitudinal, correlational exploratory design. A correlational design was determined
appropriate for inquiry investigating the association between two or more variables
(Hulley, 2007). This type of design explains if there is and what the association is and
how strong the relationship is between predictor or independent variables (IVs) and the
outcome or dependent variables (DVs). In this research, components of HPI, specifically
HP leadership characteristics, HP specialty, gender, race/ethnicity, and language used and
patient characteristics, specifically race/ethnicity, primary language, and personal/family
medical history were explored for their association with patient health behavior
modification of healthy eating, physical activity and glucose monitoring in women with
GDM. The association was explored within the natural setting and occurrences without
an attempt to control, modify, or affect the situation, thus was observational and
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exploratory (Hulley, 2007). Elements of timing contributed to the prospective and
longitudinal nature of the design. Participants were followed from enrollment during
early to mid- pregnancy through near the end of pregnancy, at approximately 34-36
weeks gestational age, thus observed prospectively (Hulley, 2007). Longitudinally, an
effect or change in the outcome variables of HA and PA was assessed over time, at two
different time frames, with the same sample (Mertler & Vannatta, 2001). This research
design was a fitting selection, as it was consistent with theory testing of the proposed
relationships in the HPI framework and addresses research aims 1 through 4 involving
the components of cognitive, behavioral and social factors of participants and HPs, as
well as the outcomes of health behavior modification embedded within the HPI
conceptual model (Hulley, 2007).
In addition to the correlational design, a quasi-experimental comparative design
was used for Aim 5, to explore differences in health behavior modification of HA and PA
in pregnancy for women at high risk for GDM but were not diagnosed with GDM (nonGDMs) and those who were diagnosed with GDM (GDMs). A repeated measures
approach was used to compare changes in HE and PA behaviors during pregnancy at two
times (Phase 1 occurring at the time of initial high-risk GDM screening test, and Phase 2,
near the end of pregnancy at approximately 34-36 weeks gestational age) in women with
GDM and high risk non-GDMs.
Quantitative methodology is an appropriate fit for this observational, prospective,
longitudinal, correlational, and explanatory design that proposes to explain phenomena
and associations, test hypotheses, and explain, in measurable increments, the change in
outcomes between time periods (Mujis, 2010). The process involved data collection using
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instruments/ questionnaires and statistical analyses utilizing correlation and regression
coefficients to test the recently designed HPI conceptual model and associations between
variables. This research method was suitable for the post-positivist philosophical
underpinnings of this research purpose and inquiry as it was intended not only to
construct knowledge but also to increase the meaning and deepen the understanding
regarding the process of HPI and its association with patient health behavior
modification. Analyses included multiple IVs and several DVs, denoting the
consideration of the complexity of associations influencing multiple outcomes, rather
than just one, as the population and representative sample participants were likely to be
affected in more than one way (Guba, 1990). This allowed for a more comprehensive
inquiry, analyses and interpretation of findings (Stevens, 1992). Quantitative methods are
commonly used in social science research focusing on findings related to specific health
behavior outcomes, and used to explain and affect future social change, as future research
was projected following this discovery (Mujis, 2010; A. B. Ryan, 2006). All these factors
are consistent with post-positivist philosophy (A. B. Ryan, 2006; Mujis, 2010).
Population Sample
The population for this study was pregnant women identified as at high-risk for
GDM. Sample inclusion criteria for participation were pregnant women, 18 years and
older, who underwent diagnostic testing for GDM, either in early pregnancy as a result of
meeting a criterion for higher risk, or as a result of routine mid-pregnancy screening,
prior to receiving a diagnosis of or counseling for GDM from any type of HP during the
current pregnancy. All races and ethnicities were included and encouraged for purposes
of evaluating diverse patient characteristics as moderating variables. The sample included
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both English and Spanish speakers, with sufficient literacy levels to comprehend and
complete instruments.
Participants who meet these criteria and were diagnosed with GDM were included
in the GDM group. Participants who were determined to be at high-risk in early
pregnancy or had an initial elevated routine mid-pregnancy screening result but were
subsequently not diagnosed with GDM following diagnostic testing made up the control
group (non-GDMs) for Aim 5. Participants were excluded if they had a diagnosis of DM
prior to pregnancy.
Setting and Selection of Sample Participants
Much consideration was given as to the optimal location for study
implementation, including clinical setting and site, feasibility for quantity and diversity of
participant recruitment, and timing related to data collection. The sample was obtained
using a convenience sampling approach from various maternity prenatal clinic settings in
a Midwestern US city. Seven clinic practice settings were utilized for recruitment of
participants and data collection, including federally qualified health centers, large
university hospital-based teaching clinics, and private practice clinics. There are a variety
of healthcare providers (HPs) that provide maternity care for these patient participants,
including advanced practice nurses, such as nurse practitioners (NPs) and Certified
Nurse-Midwives (CNMs), and physicians, such as osteopathic/medical doctors (MDs),
specializing in Family Practice or Obstetrics/Gynecology. The desire was to have as
diverse as possible a sample in regard to maternity care provision based on HP specialty
as one of the major foci of the research. A major consideration for this was that different
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HP specialties may have or use different leadership skills, affecting HPI and its
association with patient health behavior modification.
Sample size estimation
Accurate sample size estimates were needed to plan for adequate power to obtain
statistically significant and meaningful results. Factors such as disease prevalence, lack of
access, and feasibility issues may ultimately affect the sample size to be recruited for the
study (Munro, 2001). The sample size estimate is affected by selection of the desired
power, the effect size, the statistical significance level and the number of IVs tested. A
power of 0.80 is generally accepted as sufficient and reasonable in behavioral science
research (Cohen, 1987; Ferguson, 2009; Munro, 2001). A moderate effect size of 0.15 is
generally desired for correlational research designs (Munro, 2001). The significance level
(α) expressed as the probability (p) value ranges from 0.00 to 1.0; the generally accepted
standard for statistical significance has been a p-value of 0.05. It is important to note that
the statistical significance level is however not equal to the clinical or practical
significance level especially regarding behavioral research (Thompson, 2002). In cases of
preliminary research, therefore, when there is no specific recommendation for a desired
p-value, the p-value should be based on the feasibility of obtaining an adequate sample
size, which may be restricted when the prevalence rate of disease in the population is
low, and on the consideration of error type and risk. In these cases, a larger p-value for
significance may be chosen (Munro, 2001). Regarding this study, GDM occurs in
approximately 9.2% of pregnancies in the US (DeSisto et al., 2014; Hartling et al., 2012),
limiting the accessible patient population. Because the risk of Type 1 error holds less risk
of harm to patients involved in social cognitive behavioral research than in medical
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intervention research (Hulley, 2007) and because the sample is somewhat difficult to
access, a p-value of .10 was selected for this exploratory, observational study.
Nonetheless, increasing the error and risk margins of a Type 1 error can pose limitations
by increasing the threats to validity. Measures to address limitations and threats including
the selection of analyses were considered. For example, rather than large multivariate
analytic model, multiple analyses were conducted to explore each hypothesized
relationship separately with fewer variables to address the limitation of a smaller
accessible sample that can limit power when large numbers of variables are entered
(Munro, 2001).
A power analysis for this research project was conducted using Gpower statistical
program (Faul, Erdfelder, Lang, & Buchner, 2007, 2009), for a desired power of 0.80,
moderate effect size ƒ ² of 0.15, and a significance level, p-value of .10. A power
analysis for each of the four hypotheses was conducted separately (Table 2). Hypothesis
1 had a total of two predictor variables (SIQ composite score, QOII total score) for a
multiple linear regression analysis. Hypothesis 2 has two predictor variables (SIQ
composite score, and QOII total score and three dichotomous moderating variables (race
concordance, primary language concordance, and personal or family history of
GDM/DM). The two predictor variables, one of the three moderating variables, and the
interaction between the predictors and the moderating variable will be analyzed for each
of the moderating variables separately with each of the eight dependent variables lending
to a total of five tested variables, e.g. SIQ composite score, the QOII total score, race
concordance, the SIQ composite score X race concordance, and finally, the QOII total
score X race concordance. Primary language concordance and personal or family history
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of GDM/DM will be analyzed in the same manner described above for this multiple
linear regression analysis. Hypothesis 3 had two predictor variables (SIQ composite
score, and QOII total score and three dichotomous moderating variables (gender
concordance, HP specialty, and HP leadership style). The two predictor variables, one of
the three moderating variables, and the interaction between the predictors and the
moderating variable will be analyzed for each of the moderating variables separately with
each of the eight dependent variables lending to a total of five tested variables, e.g. SIQ
composite score, the QOII score, gender concordance, the SIQ score X gender
concordance, and finally, the QOII score X gender concordance. HP specialty, and HP
leadership style (MLQ) were analyzed in the same manner as described above for this
multiple linear regression analysis. Hypothesis 4 contains two predictor variables (SIQ
composite score and QOII total score), which will be combined separately and together
with one mediating variable (DSES) for a total of three tested variables for this multiple
linear regression analyses. The power analysis was based on the selected method of
analyses that contained the largest number of tested variables, equaling five.
Based on the results of the power analyses with predetermined power, effect, and
significance level and the largest number of tested predictor and total tested variables; a
sample size of 75 participants was estimated to be adequate for the study group: GDMs
Phase 2 completers and data analyses. Recruitment continued until fulfilling the
predetermined sample size, using face-to face data collection and verification of data
completeness for the Phase 2 data collection and initial analysis has been accomplished.
This resolved any concerns or threat of insufficient sample size that could have resulted
from participant discontinued involvement due to preterm delivery or other reason for
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withdrawal prior to or during Phase 2, incomplete data collection, and elimination of
outliers.

Figure 2. Research Hypotheses and Measures

Measures
A total of nine instruments and questionnaires (Appendix D) were selected or
developed to empirically measure research concepts and for data collection (Table 1).
Figure 2 depicts the hypothesized relationships between study variables and measures.
Measures include: the Multifactor Leadership Questionnaire-5X-Short Form (MLQ); the
Social Influence Questionnaire-HP-GDM (SIQ), Quality of Information/InteractionGestational Diabetes Mellitus (QOII); Diabetes Self-efficacy Scale (DSES); the Eating
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Breakfast Questionnaire (EBQ) +1, the Physical Activity Scale (PAS), the Glucose
Monitoring Questionnaire (GMQ), the Participant Demographic Questionnaire (PDQ),
and finally, the HP Demographic Questionnaire (HPDQ). The PDQ and the HPDQ were
developed for this study to collect pertinent patient and HP demographics and
descriptors. Modifications were made to the MLQ, the SIQ, QOII, the DSES and the
GMQ to address content specific to patients, HPs and GDM, which will be described
individually in detail below.
All the instruments are currently available in both English and Spanish language
following translation for this study or previously translated and used in Spanish speaking
populations for other research purposes. Those previously translated include the MLQ,
the PAS, the EBQ, and the DSES. Translations for the other five instruments were
conducted by certified medical interpreters and underwent both forward and back
translations methods prior to testing for validity and for use in the pilot and main study.

Instrument
(reference)

Multifactor
Leadership
Questionnaire5X (short form)
(MLQ)
(Antonakis et al.,
2003; Avolio &
Bass, 2004; Bass
& Avolio, 1997;
Bass & Riggio,
2006)

Table 1: Instrument Matrix
Reliability and Validity

Original MLQ: Test-retest (n=193).52-.82
MLQ-5X: α > 0.80 for all scales
External validity: Tested and used in
research across large samples
internationally over > 15 years, with many
cultures, populations, languages (N >
15,000)
Construct validity- Factor analyses
supports full nine-factor structure FRL
CFA goodness of fit= .93
Predictive validity- meta-analyses:
multiple- support TFL model
Multiple meta-analyses with strong
positive correlations with objective and
subjective measures of performance.

Scoring / Level of
Measurement

45 items
Rated on 0-4 Likert
scale
Initial analysis:
1 final leadership
style score:
3 categories, 2
variables
Categorical
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Quality of
InformationInteractionGDM
(QOII)
(Weiss et al.,
2008; Weiss &
Lokken, 2009;
Weiss et al.,
2007)

Social Influence
QuestionnaireGDM (SIQ)
(Champion,
1994; Ohlendorf,
2014)

Diabetes SelfEfficacy Scale
(DSES)
(Lorig &
González, 2000 ;
Lorig et al.,
2003 ; Lorig et
al., 2005 ; Lorig
et al., 2009)

Eating
Breakfast
Questionnaire +
Portion of
vegetables
(EBQ+1)
(Lorig &
González, 2000;
Lorig et al.,
2005)

Modified for patient GDM population
Original QDTS tested in multiple
populations including medical surgical
(MS) (N=147) postpartum (PP) parents of
hospital children (PHC) (N=135)
Reliability coefficient: α > .80 for all
scales and subscales
Total content (content received + delivery)
scale: α = .87 (PP), .89 -.90 (combined
samples); .92 (MS).88 (PHC)
Validity established with large study
sample
EFA: 2 factor structure (content and
delivery) account for 54. 2% of scale
variance
Modified for GDM population
Original (social influence scale): tested in
middle aged women (n=301); α =.83
Goodness of Fit chi-square p<=.78
Model chi-square p≤.01
Modified instrument used in postpartum
mothers (n=124): α =.84
Content validity testing
Modified for GDM population
Internal consistency,
α =.83 (English) (N=109, 186)-.85
(Spanish) (N =147) DMs
Test-retest validity, r = .80 (n=20 Spanish)
Face and content validity with multiple
focus groups (DMs, Diabetic
Educators/nutritionists)
Reported item convergent and discriminant
validity testing but not described
Forward/back translation for the Spanish
measures
EBQ: Used with English (n=123) and
Spanish (N= 315; 317; 109) DMs
Portion of vegetables (N=109)
Single items internal consistency and testretest were not reported/not applicable
Face and content validity with multiple
focus groups (DMs, DEs)
Forward/back translation for the Spanish
measures

17 items: 6 paired
(content received and
needed) and 11 for
delivery
Rated on 0-10 Likert
scale
1 total score
(content + delivery)
Interval

3 items
Item 1: categorical
Items 2 and 3
rated on 1-5 Likert
scale
Analysis:1 final
score: total HP social
influence score
Categorical/ Interval
8 items
Range of 1-10 Likert
scale
Analysis: 1 total
mean score, 8 items
Interval

3 items
Analysis: 3 scores
Item 1: range 0-7
Item 2: 0 (no) -1 or
more (yes)
item 3: 0-no upper
limit
Interval
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Physical
Activity Scale
(PAS)
(González,
Stewart, Ritter,
& Lorig, 1995;
Lorig et al.,
2003; Lorig et
al., 2005; Lorig
et al., 1996;
Ohlendorf, 2014)

GMQ
(Lorig &
González, 2000 ;
Lorig et al., 2003
Lorig et al.,
2005 ; Lorig et
al., 2009)

Used with chronic disease, including DM,
English and Spanish speaking, and
postpartum women (PP) (N=124)
Tested in English (N =1127-1130) Spanish
(N =270) - retested in English (n=51) and
Spanish (n=25) for
strengthening/stretching,
r =.56 (English) -.91 (Spanish) and
aerobic exercise, r =. 72 (English) -.89
(Spanish)
Face Validity: items address components
of physical activity/exercise
Construct validity testing:
test-retest .86;
correlation of .29 was found between Item
1 and Items 2-6.
Translation/back translation for the
Spanish measures
Item 1: English (N=62) and Spanish
(N=109; 142-speaking DMs
Psychometric testing reports single-items
internal consistency reliability; test-retest
reliability not reported/ not applicable
Face and content validity with multiple
focus groups (DMs and Des)
Forward/back translation for the Spanish
measures

6 items
Analysis: 2 scores
Item 1: range 0-180
Item 2-6: range 0-900
Interval

4 items
Analysis: 3 scores +1
Items 1-2: Range 0-7
Item 3: Range 0-28
Item 4: open-ended
Interval/Narrative

Instruments Description
Multifactor Leadership Questionnaire-5X
The Multifactor Leadership Questionnaire-Short form-5X (MLQ) was used to
measure the patient’s perception of the leadership characteristics or qualities of their HP
that could affect self-efficacy and patient engagement in health behavior modifications.
The MLQ was selected as the measure for Transformational Leadership (TFL) due to its
strong foundational basis within TFL theory, consistent with one of the central tenets of
the HPI conceptual model.
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The MLQ was developed to measure the concept of TFL (Bass, 1985; Bass,
1998). TFL “is the process in which leaders change their associate’s awareness of what is
important and move them to see themselves and the opportunities and challenges of the
environment in a new way” (Avolio & Bass, 1995). TFL characterizes leadership wherein
a leader responds to the follower’s needs, aligns goals and objectives, and though
empowerment stimulates, inspires and moves followers to meet and exceed performance
expectations as well as to strive for higher levels of potential (Bass & Riggio, 2006). The
original MLQ, a 73-item instrument measuring five factors was constructed by Bass
following a series of interviews with over 70 senior professional and business executives.
The MLQ has undergone many revisions over the past several decades and has been
modified following multiple content and factor analyses. It has been tested in many
settings and with many international populations, numbering well over 15,000 subjects in
different countries as well as has been translated into several languages (Antonakis et al.,
2003; Bass & Riggio, 2006). The MLQ has been used in multiple industries including
education, military, healthcare, and politics and “the most widely accepted instrument to
measure to TFL” (Bass & Riggio, 2006). The most current revision is a reduced version
named the MLQ-5X (Avolio & Bass, 1995) which will be used for this research. There
are two forms of the MLQ, the Leader and Rater Forms. For the purposes of this
research, the Rater form will be utilized and described.
The MLQ is a 45-item questionnaire, written at a 9th grade level, although used
previously in less educated populations, and takes approximately 15 minutes to complete
(Bass & Riggio, 2006). The Rater Form is most commonly used in research to measure a
follower’s perception of a leader’s behaviors in nine leadership domains representing the
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nine factors in the Full Range of Leadership (FRL) model (Bass & Avolio, 1994). The
FRL model includes characteristics of TFL as well as transactional leadership (TAL) and
laissez-faire non-leadership (LFNL). TFL is represented and measured by five factors:
idealized influence/charisma, which divides into two subcategories idealized attributes
and idealized behaviors; inspirational motivation; intellectual stimulation; and
individualized consideration. Transactional leadership characterizes leadership through
social exchange wherein the leader rewards or disciplines based on performance (Bass &
Riggio, 2006). The two factors that represent transactional leadership are contingent
reward and management-by-exception-active. Laissez-faire leadership or non-leadership
is “the avoidance or absence of leadership” (Bass & Riggio, 2006). The two factors that
represent laissez-faire are passive/avoidant behavior and management-by-exceptionpassive. The nine factors are each represented by four items, amounting to 36 items.
Incorporated into the MLQ are three leadership outcomes: extra effort; effectiveness; and
satisfaction, represented by nine items amounting to a total of 45 items (Bass & Riggio,
2006). These outcomes have been found to positively correlate to the five TFL factors
and contingent reward (Bass & Riggio, 2006). Outcome item data will be collected but
not used for hypotheses testing in this study. The items are scored on a 5-point Likert
scale ranging from “not at all” to “frequently, if not always”. Each of the nine factor
subscale scores are computed as the mean score of the four item scales. If an item is left
blank, the mean score is calculated from the answered items. Three leadership composite
scores are computed as the sum the related factor subscales pertaining to each leadership
type, divided by the number of factors. The highest of the composite scores, an interval
level score, is used to categorize the type of leadership as transformational, transactional,

64

or laissez-faire. The three levels of leadership were examined using two variables or
vectors. Transformational and transactional categories were coded as dichotomous
variables as the third type, laissez-faire was not determined to be sufficient to analyze
(n=1) in the regression analysis.
The MLQ has been widely used in research over a 15-year period and earlier
versions expand over 25 years. Reliability and validity testing were conducted in earlier
versions of the MLQ as well as the MLQ-5X. The test-retest reliability of the earliest
version of the MLQ Rater Form (N=193 ranged from .52-.82 after six months), as
reported in the unpublished work of Pile (Bass & Riggio, 2006). The MLQ-5X has
demonstrated high reliability and validity across large samples (Avolio & Bass, 1995).
Good to excellent internal consistency with α coefficients > 0.80 resulted for all nine
MLQ-5X factor scales and leadership composite scores (Avolio & Bass, 2004; Bass &
Avolio, 1997; Bass & Riggio, 2006). The MLQ-5X has undergone numerous validity
testing including convergent and divergent validity testing and construct validity,
determined with multi-dimensional confirmatory factor analyses (CFA) of the FRL
theory and found to support the full nine-factor structure of the MLQ-5X (Antonakis et
al., 2003; Bass & Avolio, 1997). CFA goodness of fit = .93 (Avolio & Bass, 2004; Bass
& Riggio, 2006). The average variance extracted from each factor was > .50 and factor
loadings were found to be satisfactory (Avolio, Bass, & Jung, 1995).
Predictive validity was determined by multiple meta-analyses using leadership
type composite scores and found to have strong positive correlations with objective and
subjective measures of performance to support the TFL model (Bass & Riggio, 2006).
Substantial evidence has been reported that TFL is positively correlated with measures of
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leadership effectiveness (Bass & Riggio, 2006). A meta-analysis including 20 studies
separated TFL and transactional leadership into two composites and found that with
corrected means TFL was correlated at r=.76, .71, and .88 with effectiveness, satisfaction
and extra effort while transactional leadership correlated at r= .27, .22, and .32 with the
same three outcomes, respectively in followers (Gasper, 1992). Permission was obtained
for the use, modification and reproduction of the MLQ-5x following purchase of license
(Appendix D). The MLQ-5X was minimally altered, not for domain or content, but for
eight minor stem changes to pertain to patient’s perceptions of HPs rather than use by
colleagues or subordinates. The results of content validity testing indicated a content
validity index (CVI) of .67 with 30 of the 45 items deemed relevant. Eight of the 15 items
determined to be non-relevant items were related to laissez-faire/non-leadership, two
related to transactional leadership and five to transformational leadership. However, as
this instrument is intended to assess a continuum of leadership and non-leadership
characteristics, all items will be retained for use in this research proposal.
Social Influence Questionnaire-GDM (SIQ)
The Social Influence Questionnaire-GDM (SIQ) was selected to measure social
influence of healthcare providers (HPs) from the GDM patient participant perspective.
This measure addresses the concept of social influence from professionals, in this case
HPs. The SIQ is a modified version of the Social Influence Questionnaire (Ohlendorf,
2014) which in turn was adapted from an original social influence scale designed to
increase mammography utilization (Champion, 1994).
The social influence measure developed by Champion (1994) is a two part 20item scale determined to have a Fleisch-Kincaid reading level of 12th grade (Champion,
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1994). Six social contacts of the participants which shall be called social influencers were
specified, two of whom are physicians and nurses. The first part of the scale measures the
participant’s perceived beliefs of each social influencer about mammography. The second
part of the scale measures the participant’s perception of the influence that each social
influencer has on the participant’s behavior (Champion, 1994). One social influence
scale score was calculated by summing the computed scored for the two factors of beliefs
and influence multiplied for each social influencer. A higher social influence score
indicated greater social influence on the patient’s health behavior modification. Internal
consistency reliability for the total social influence score was a Cronbach’s α of 0.83
(Champion, 1994). Validity was tested through factor analysis with other covariates
wherein social influence was positively correlated to mammogram screening (p=.07) with
a Goodness of Fit chi-square, p ≤.78, model chi-square, p≤ .01 (Champion, 1994).
A recent modification and utilization of this social influence scale, called the
Social Influence Questionnaire (SIQ), was adapted to assess social influence regarding
weight loss in postpartum women (Ohlendorf, 2014). The SIQ included eight social
influencers and five beliefs statements. Two of the social influencers are
physicians/nurse-midwives and hospital nurses. Testing of the SIQ resulted in a
Cronbach’s α of 0.84 (Ohlendorf, 2014). Content validity of the SIQ was conducted with
content analysis experts prior to use (Ohlendorf, 2014). Permission was received for
modification and use of the SIQ.
The SIQ is a 3-item version, newly modified for use in this study that focuses
only on healthcare providers (HPs) as sources of social influence and GDM-related health
beliefs. In contrast to the original social influence scale (Champion, 1994) and the SIQ
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(Ohlendorf, 2014), which include a variety of different social influencers including
family, friends or partners, in addition to HPs, the SIQ only includes different HPs. It has
been shortened in this publication to SIQ. The HPs that are included are three categories
that care for women diagnosed with GDM, nurses, nurse-midwives/physicians/nurse
practitioners, and Diabetic nurse-educators/Registered Dietitians. The first item asked
which HPs counseled the patient regarding GDM. The first item is categorical level
measurement that will be used for descriptive purposes only. The second and third items
inquired about the participant’s perception of the strength of the influence that each of the
three-social influencer-HP categories have on the patient’s health management behavior
and the participant’s perception of the strength of nine beliefs that the social influencerHP has that the patient can make health behavior modifications. Response options and
interval level scoring for these items are the same used in the SIQ. Response options for
the influence factor are on a 5-point Likert scale and ranges from “strongly influences” to
“no influence”. Response options for the beliefs factor are on a 5-point Likert scale and a
range from “strongly agrees” to “strongly disagrees”. Individual social influencer scores
are computed by multiplying their social influence score by their belief in patient
behavior score. Scores for each individual social influencer range from 0-225. Based on
feedback and to prevent confusion, the research analyses did not proceed with analyses
involving nurses as their role was too general to assess for professional influence in this
context. A total social influence score, the sum of all the individual social influencer’s
score, range from 0-675. This latter score was the one that used for hypothesis testing.
Content validity was conducted with content experts in a pilot study prior to use in the
main study. The CVI of the entire instrument was .90 with 28 of the 31 items deemed
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valid. Due to the overall validity of the instrument, although the three items not found to
be sufficiently relevant they were nonetheless retained as they reflected one belief
pertaining to three different HP specialties.
Quality of Information-Interaction-GDM Scale (QOII)
The Quality of Information-Interaction-Gestational Diabetes Mellitus (QOII) was
selected and modified to measure the HPI components of GDM-relevant information
provision, as well as, the interaction and delivery process by pertinent HPs. The QOII is
adapted from the Quality of Discharge Teaching Scale (QDTS)-New Mother form, which
is a modification of the original Quality of Discharge Teaching Scale (QDTS) (Weiss &
Lokken, 2009; Weiss et al., 2007). The QDTS was developed and tested in several
studies to measure the patient’s perception of the quality of discharge teaching in adult
medical-surgical patients (N=147), parents of hospitalized children (N =135) and
postpartum mothers (N =141) (Weiss et al., 2008; Weiss & Lokken, 2009; Weiss et al.,
2007). The QTDS-New Mother form for postpartum mothers is a 19-item scale
measuring the quality of hospital discharge teaching for postpartum mothers. There are
seven paired “content received and needed” items and 12 “delivery of information” items
(Weiss & Lokken, 2009). Permission was obtained from the author for the use and
modification of the QTDS-New Mother to adapt it for the purposes this study, the
counseling and delivery of GDM related information to pregnant women diagnosed with
GDM, thus named QOII-GDM and shortened to QOII for future description herein.
Although not pertinent to hospital discharge teaching, it is intended to measure content
and delivery of information for a new diagnosis requiring modification of health
behaviors for optimal self-management in the home environment.
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The QOII- is a 17-item scale modified to include six “content received” items and
11 “delivery of information-interaction” items. The “content received” domains are
related to the patients’ perceptions of the amount of informational “content received”
regarding GDM-related treatment and recommendations for self-management health
behavior modifications of healthy drinking and eating, PA, and glucose monitoring,
practice with glucose monitoring, and who and when to call with problems. These items
are subdivided into content received from two categories of HPs, usually responsible for
providing this education: a) nurse-midwife/doctor/nurse practitioner and b) diabetic
nurse-educator/Registered Dietitian. The delivery domains correspond to the interaction
and approach used by HPs for information delivery and include listening, answering
specific concerns, showing sensitivity to personal values and beliefs, teaching in
understandable manner with consistent information and at times that were good for the
patient and family, evaluating patient understanding, promoting confidence in ability to
care for self, and decreasing anxiety. One domain eliminated in the QOII-GDM version
from the original QTDS is “knowing what to do in an emergency,” as GDM is not a
condition that generally requires hospitalization. The items are scored on an 11-point
Likert scale, ranging from 0-10, indicating “none” or “not at all” to “always” or “a great
deal”. The interval level score that will be used for analyses is the total score, equal to
the sum of two subscales scores, “content received” score, the sum of the “content
received” items, and delivery score, the sum of the delivery items (Weiss et al., 2007).
Higher total scores indicate a greater amount of information received (“content received”
subscale) and the increased quality of the information-interaction (delivery subscale).
Following secondary analyses including the two “content received” and “delivery”
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subscale scores, based on previous research and per the recommendation of the author,
that the outcome variables can perform differently when the two separate subscale scores
are used instead of the total score (Weiss et al., 2008; Weiss & Lokken, 2009; Weiss, et
al., 2007), the decision was to retain the total score instead as the sub-scores did not
contribute to the analyses, presented multicollinearity concerns and added an additional
tested predictor variable which would normally require a larger sample size.
Reliability testing for total and all subscales of the QDTS resulted in a Cronbach’s
α > .80. Total content scale α = .87-.92 for postpartum mothers, parents of hospitalized
children and adult medical-surgical patients (Weiss et al., 2008; Weiss & Lokken, 2009;
Weiss et al., 2007). Validity has been established with an exploratory factor analysis
found to support a 2-factor structure (content and delivery), which explained 54.2% of
scale variance (Weiss et al., 2007). Content validity was conducted with content experts
in a pilot study prior to use in the main study. Results for the QOII found the instrument
to be valid at .95 with 35 of the 37 items relevant at .83-1.00. Two items that were not
sufficiently relevant related to contacting HP following diagnosis or counseling if needed.
These were retained as they involved two different HP specialties had the potential to
provide insight on expectations for content/delivery of information for different HP
specialties.
Diabetes Self-Efficacy Scale (DSES)
The Diabetes Self-Efficacy (DSE) scale (DSES) measures confidence levels in
beliefs related to DM and self-management health behaviors, including glucose
monitoring, healthy eating, and PA (Lorig et al., 2003; Lorig et al., 2009). The DSES was
developed for use in self-management research with DM patients (Lorig & González,
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2000; Lorig et al., 2003; Lorig et al., 2009), thus content is appropriate and specific for a
population with GDM. In addition to this, the DSES is a succinct instrument available in
English and Spanish making it a practical choice for this research. It is an eight-item
instrument available in Spanish and English that uses a 10-point Likert scale (1-10)
format indicating “not at all confident” to “totally confident”. The score is reported as the
mean of the eight item scores with a range of 0-10. The scale was modified for the study
by adding the word “gestational” prior to diabetes in two items. Focus groups including
patients and their family members, educators and HPs were involved in the design of the
DSES and the instrument has undergone standard psychometric testing for internal
consistency, test-retest reliability if indicated, item convergent and discriminate validity
as well as translation/back translation for the Spanish measures (Lorig & González, 2000;
Lorig et al., 2005). These results are reported below if provided. The DSES was tested
with samples of both English (N=186) and Spanish (N=189) speaking DMs resulting in
findings of strong reliability with internal consistency, α = .83 (English) and α = .85
(Spanish) and test-retest validity, .80 (Lorig et al., 2003; Lorig et al., 2009). A pre-test/6
week/3-month post-test study of a community-based, peer-led diabetes self-management
program resulted in increased self-efficacy for managing diabetes measured by the DSES
at 6 weeks and 3 months increasing the mean (SD) 1.6 (2.6) at 3 months over the baseline
of 6 (2.2) (p<0.0001) in a Spanish-speaking DM sample (N=109) (Lorig & González,
2000). A chronic disease self-management program was evaluated with a longitudinal
research design in Spanish (N=322) and English (N=123) speaking DMs. Increases
occurred in self-efficacy, measured by the DSES, from baseline to 4 months/1year in
Spanish-speakers (p <.0001) and at 4 months in English-speakers (p=.017) (Lorig et al.,
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2005). Baseline and change in baseline to 4 months self-efficacy was significantly
associated with improvement in eating breakfast, and aerobic exercise (p <.001 (Lorig et
al., 2005) measured with the PAS and items in the EBQ+1.
Eating Breakfast Questionnaire (SEBQ) +1
The Eating Breakfast Questionnaire (EBQ) +1 was selected to measure the
healthy behavior of healthy eating/diet. The EBQ+1 includes three items that were
developed and tested, as was the DSES, for self-management health behavior
modification research interventions in DMs (Lorig & González, 2000). Two items relate
to breakfast and a third item to vegetable portion intake, thus naming it the EBQ+1. The
EBQ+1 assesses the frequency of eating breakfast weekly, the type and number of protein
foods including the option of adding any not included on the list consumed for breakfast
that morning, and the number of portions of vegetables consumed daily. Three interval
level scores result. The response range for the first item is 0-7 while the second and third
items are open-ended values. This measure will be used in at two different times, Phase 1
and 2 and compared for differences.
The search for a healthy eating measure was quite arduous due to the exhaustive
list available, however many were found to be irrelevant, not disease specific or having
limitations for research purposes. Counseling related to DM/GDM involves carbohydrate
reduction and replacement with or increasing protein intake. A strong emphasis is placed
on the intake of adequate, but not excessive carbohydrates, low glycemic versus high
glycemic index carbohydrates, and those containing high versus low fiber. The learning
curve regarding these characteristics of carbohydrates is difficult for most patients to
achieve within a limited number of counseling sessions, thus obtaining accurate and
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reliable data in asking about these dietary patterns would be cumbersome. Research has
found that healthy eating behaviors conducive for DM/GDM include eating breakfast
following the self-evaluation of fasting blood sugar, eating frequent meals starting with
breakfast, increasing overall protein intake which increases insulin sensitivity, and
increasing fiber intake by way of increased vegetable intake (Mekary, Giovannucci,
Willett, van Dam, & Hu, 2012). Eating breakfast has also been found to decrease the risk
of DM by 30% (Mekary et al., 2012). Insulin resistance is greatest in the morning for
most women with GDM and therefore fewer carbohydrates should be eaten in the
morning (Gutierrez & Reader, 2005). There are associations between excessive dietary
fat intake and increased insulin resistance and elevated risk of GDM and DM
(Hernandez, Anderson, Charter-Logan, Friedman, & Barbour, 2013).
Several factors contributed to the selection of the EBQ+1. GDM/DM related
counseling and research evidence supports the relevance of the three items. The measure
is easy to use and score, thus increasing accuracy in completion and analysis, and is brief,
thus decreasing participant burden. Additionally, it addresses HP recommended GDM
treatment/prevention strategies of nutritional counseling and health behaviors involving
the timing and type of food intake, thus supporting the positive rather than the negative
aspects of dietary carbohydrate and high fat restriction. Multiple focus groups with
content experts, specifically diabetic nurse-educators, nutritionists, and persons with DM,
met to discuss necessary content for inclusion in DM self-management health behavior
modification peer education intervention studies and participated in the development of
the EBQ+1 item (Lorig & González, 2000). As the healthy eating recommendations are
the same for GDM as for DM, this is an appropriate measure. This measure has been used
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in research, along with the DSES, with English and Spanish speakers (Lorig & González,
2000; Lorig et al., 2005).
Development and content validity testing of the items included in the EBQ+1 was
conducted with multiple focus groups and content experts, Diabetic Educators,
nutritionists, and persons with DM and their family members (Lorig & González, 2000).
Translation, back translation, and translator consensus agreement for the Spanish
measures was undertaken (Lorig et al., 2005). Standard psychometric testing of the items
in the EBQ+1 for reliability and validity was reported as having been undertaken with
internal consistency and test-retest reliability and item convergent and discriminant
validity in English (N=123) and Spanish- (N=315/317; 109) speakers but limited
description was provided (Lorig & González, 2000; Lorig et al., 2005). Repeated
measures testing in a pre-test/6 week/3-month post-test study of a community-based,
peer-led diabetes self-management program in a Spanish-speaking DM sample (N=109)
measured by the items included in the EBQ+1 found improvement at 6 weeks in eating
breakfast, eating protein at breakfast, and number of portions of vegetables eaten daily
(p<.05) (Lorig & González, 2000). In the same study at 3 months, improvement in eating
breakfast, the mean (SD) increased .24 (2.4) over the 5.9 (2.1) baseline (p =.31), eating
protein at breakfast increased 12% over baseline 79% (p ≤ .01), and number of portions
of vegetables eaten daily increased .31 (1.3) over 1.3 (1.0) (p ≤.01) (Lorig & González,
2000). Validity testing of self-efficacy and the EBQ items was conducted in a
longitudinal study of a chronic disease self-management program with repeated measures
at pre-test, 4-months and 1 year in Spanish (N=322) and English (N=123) speaking DMs.
Increases in eating breakfast, measured by the EBQ were found at 4 months/1 year in
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Spanish-speakers (p<.001) and 4 months in English speakers (p=.006) (Lorig et al.,
2005).
Physical Activity Scale (PAS)
The Physical Activity Scale (PAS) was selected to measure the health behavior of
physical activity (PA). This measure will be used at two different times, Phase 1 and
Phase 2, and compared for within GDM group and between control and GDM group
differences. As with the previous outcome measure, a number of other instruments and
applications used to measure exercise and PA were evaluated for use in this study;
however the major impetus for selecting this measure was due to its development for and
use in prior research focused on health behavior self-management modification in chronic
illness including DMs (González et al., 1995; Lorig & González, 2000; Lorig et al., 2003;
Lorig et al., 2005; Lorig et al., 1996) and in research involving postpartum women (N
=124) (Ohlendorf, 2014). An additional benefit of the PAS is that it has been tested and
re-tested in Spanish and English-speaking populations and is thus available in Spanish
language. It is a six-item instrument addressing the total minutes of
stretching/strengthening (Item 1) and aerobic exercise (Items 2-6) weekly, resulting in
two scores. Each item receives a self-reported 5 point ordinal level scale response. These
five options range from “none” to “greater than three hours per week”. Each option
assigns a value from 0 to 180 representing “minutes spent”. One score is derived from
item 1 with a possible range of 0-180. The second score is the sum of items 2-6, with a
possible range of 0-900. The authors described this selection of an ordinal to interval
conversion approach to prevent data skewing on both ends of reporting, to correspond to
meaningful category reporting, to achieve equivalent proportions of individuals in the
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non-zero categories, to lead to scoring rules, and for correlation analyses (Lorig et al.,
1996).
Focus groups led to the development of the measure items prior to reliability and
validity testing. Test-retest reliability estimates have been reported as r = .56 for item 1
and .72 for items 2-6 in studies of English-speakers (test, N =1127, 1130; retest, n=51)
(Lorig et al., 1996), and r =.91 for item 1 and .89 for items 2-6 in Spanish-speakers (test,
N =270; retest, n=25) (González et al., 1995). Construct validity and item-convergent and
discriminant validity testing was conducted (Lorig et al., 1996). A correlation, r = .29
was found between Item 1 and Items 2-6, thus considered independent of one another.
Internal consistency was found to be .83; test-retest .86 and range of item-scale
correlations .68-.71. Item-convergent and discriminant validity testing were conducted as
part of the multi-trait scaling analyses to evaluate the correlation of self-efficacy to
perform self-management exercise to PAS. Correlations between self-efficacy exercise
scale and PAS Item 1 was .26 and Items 2-6, .37 indicating greater convergence with
aerobic exercise than with stretching/strengthening (Lorig et al., 1996).
Several longitudinal studies evaluating community-based, peer-led DM selfmanagement program with repeated measures were conducted (Lorig & González, 2000;
Lorig et al., 2003; Lorig et al., 2005). Based on pre-test/6-week/3-month post-test,
improvement in exercise (p <0.05) at 6 weeks and at 3 months with an increase in mean
(SD) of 50 (121) minutes/week over a baseline of 88 (103), p ≤ .0001) was found in a
Spanish-speaking DM sample (n=109) (Lorig & González, 2000). In a randomized
control study, Spanish-speaking participants (N=327) involved in a 6-week program
demonstrated improvements in exercise, measured by the PAS, and self-efficacy at 4
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months (n=224) and 1 year (n=271) (p≤.0001) (Lorig et al., 2003). Interventions resulted
in improvements in aerobic exercise, measured by the PAS at 4 months/ 1 year
(p<.001/p<.001) in Spanish (n=322) and 4 months (p=.005) in English (n=123) speaking
DMs (Lorig et al., 2005).
Glucose Monitoring Questionnaire (GMQ)
The Glucose Monitoring Questionnaire (GMQ) is a 4-item measure developed for
this research. The Glucose Testing Questionnaire (GTQ), a 2-item questionnaire provided
the basis for the development of the GMQ as well as one of its four items. The GTQ was
developed for and used in self-management health behaviors modification and selfefficacy research with DMs (Lorig & González, 2000; Lorig et al., 2003; Lorig et al.,
2005; Lorig et al., 2009). Other glucose monitoring measures including daily logs have
been utilized with DM/GDM, but these are not practical and feasible for outcome
measurement. Item 1 of the GTQ was not included in the GMQ because it was inquired
as to the availability of monitoring equipment which is generally provided to GDMs at
the first counselling session for the short-term duration of the pregnancy, whereas those
with long-term DM have life-long requirements for access to equipment and supplies.
Item 2 of the GTQ is the first item of the GMQ, as it is pertinent to GDM and assesses
the frequency of glucose monitoring behaviors weekly. The following items (Items 2 and
3) of the GMQ relate to GDM counseling recommendations and use the format of the
GTQ to inquire as to: Item 2) the frequency of glucose monitoring behaviors four times
daily and Item 3) a weekly recall regarding number of abnormal glucose results above the
recommendations. Items 1, 2, and 3 of the GMQ are interval level scores that range from
0 to 7, for the first two items and 0-28, for Item 3. Item 4 inquires as to the patient’s
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perception of causes of glucose elevations if occurred and results in an open-ended
response that may be used for narrative purposes only. This item is intended to prompt
participant’s thinking regarding elevations for their own self-awareness.
A general statement about reliability and validity testing using standard
psychometric studies was reported for all measures. Testing relevant to Item 1 of the
GMQ, adopted from the GTQ was conducted with English-speaking (N=62), mean (SD)
of 4.85 (2.57) and Spanish-speaking (N=142), mean (SD) 4.23 (2.73) participants (Lorig
et al., 2003; Lorig et al., 2005). A pre-test/6-week/3-month post-test study of a
community-based, peer-led diabetes self-management program in Spanish-speaking
(N=109) found improvement in frequency of glucose monitoring at 6 weeks (p <0.05)
and an increase in mean (SD) days of monitoring of .67 (2.34) over baseline 4.4 (2.7) (p ≤
.05) (Lorig & González, 2000).
The DSES and the PAS, as well as items included in the EBQ +1 and the GMQ
are all instruments that has been used in chronic illnesses self-management health
behavior modification and self-efficacy research. These have been described in the theory
development of the Integrated Theory of Health Behavior Change (ITHBC) and the
Individual and Family Self-management Theory (IFSMT) (P. Ryan, 2009; P. Ryan &
Sawin, 2009).
Participant Demographic Questionnaire (PDQ) and the HP Demographic
Questionnaire (HPDQ)
The participant demographic questionnaire (PDQ) and the HP demographic
questionnaire (HPDQ) collected patient and their maternity HP characteristics, to
evaluate the effect of concordance factors, consistent within the HPI conceptual model.

79

These two questionnaires were completed, primarily by the patient participant, and
finalized by the researcher or assistants.
The PDQ is an 11-item instrument that includes three categorical study variables
used for analysis: race/ethnicity, previous or family history of GDM/DM, and primary
language. Race/ethnicity and primary language were selected as they have been found to
correlate with health behavior modification in previous studies (Anderson, 1999; Street,
2003; Verlinde, De Laender, De Maesschalck, Deveugele, & Willems, 2012). The
additional categorical and interval level items were used for descriptive purposes only.
These include the language that the teaching was conducted in, inquiry into whether the
patient’s HP is one they preferred for care, age, completed years of education, years in
the United States, parity, pre-pregnancy and Phase 2 body mass index (BMI), and number
of HP clinic visits since screening and/or diagnosis.
The HPDQ, a 9-item questionnaire includes three categorical level items that used
for correlational analyses and six items that will be used for descriptive purposes.
Race/ethnicity, gender, and professional specialty were three variables selected for
analyses. These have been studied previously in health behavior correlational research
(Anderson, 1999; Street, 2003) as well as have been found to mediate and moderate the
effects of TFL (Bass & Riggio, 2006). The remaining items include the name of clinic
and the HP, the language used in conversation/counseling with the patient participant,
including the use of interpreter services for the interaction, years in practice, and age.
Pilot Study
A pilot study was conducted following the approval of Marquette University’s
Institutional Review Board (IRB) to establish and ensure the content validity of the three
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instruments modified for use in the study: the MLQ-5X; the SIQ-HP-GDM; and the
QOII-GDM, in both English and Spanish languages, prior to use in the research project.
As mentioned previously, the MLQ was modified for use with patients to elicit their
perception of their HP’s leadership characteristics. The SIQ was modified to eliminate all
categories of influencers except HPs and to increase the number of subcategories to
include relevant HP types as well as adapting the perceived beliefs to relate to GDM. The
QOII was modified to include item language relevant to GDM counseling and HP types.
Content validity refers to the extent to which an instrument measures what it was
developed to measure (Lynn, 1986). Content validity for the modified instruments was
used to assess the relevance and adequacy of the content area sampled (Lynn, 1986),
ensure appropriateness of use, feasibility, and language proficiency. A pilot study sample
of five content experts was determined appropriate for establishing content validity
(Lynn, 1986). A convenience sample of six patient participants were recruited as content
experts from the primary researcher’s clinical setting. Inclusion criteria were English
and/or Spanish speaking and literate, and a current or recent diagnosis of GDM within the
past 12 months. Recruitment of Spanish speakers in addition to English was intended to
gain insight and establish validity from and for use in populations more vulnerable to
GDM, such as Latina populations. Participants were approached following a prenatal or
postpartum clinic appointment. They were informed of the purpose of the pilot study and
assured that participation was voluntary. If interested, participants were given a written
description of the pilot study that included instructions about how to complete the forms
and language that stated that completion of them, implies consent. Participants were
asked to review and critique the newly modified instruments: the MLQ-5X, the SIQ-HP-

81

GDM, and the QOII-GDM by completing a content validity questionnaire. Their
suggestions for item modification were also solicited. The content validity questionnaire
was developed, based on guidelines for the validation of new or modified instruments, as
described by Lynn (1986). The foci of the content validity questionnaire were on the
clarity and importance of the instrument items and the appropriateness of content
regarding GDM counseling and leadership characteristics of their HPs. Content validity
was conducted and results of the CVI for the MLQ = .67, the SIQ = .90, and the QOII =
.95.
Protection of Human Subjects
Prior to initiating the study, the research proposal detailing procedure from
recruitment to consenting, to data collection through analyses, was sent to the
Institutional Review Board (IRB) at Marquette University. Approval was sought
subsequently from each clinic and participating hospital IRB. For clinic settings that do
not have a specific IRB committee or process, the University IRB process and approval
was reviewed, and permission secured prior to recruiting eligible participants at those
sites. The University IRB served as the IRB of record for all of the clinic sites.
Recruitment and data collection were initiated only after permission was granted to
proceed and IRB approval had been obtained.
After receiving IRB approval or administrative permission as appropriate to the
setting, a meeting was arranged with a designated contact person at each site to describe
the research project purpose and process, including voluntary consent, data collection and
handling, and the importance of maintaining confidentiality throughout all the stages of
the research. Contact information for the principal investigator (PI) was provided to the
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clinic staff and participants to answer any questions, concerns, or to report any adverse
risks or effects of recruitment, participation, and involvement.
As potential participants were identified in the various clinic settings as meeting
inclusion criteria by clinic staff, their permission to be approached to elicit interest and
permission to participate in the research study by research staff was solicited. The clinic
staff notified the research staff of the potential participant’s name and the research staff
then proceeded with recruitment at the appointment time designated for laboratory
testing. The recruitment occurred predominantly with permission in an examination room
or in the laboratory setting prior to or following specimen collection. Introductions were
made between potential participants and the PI or trained research assistants. The
recruitment process then involved providing a description of the study and provision of
consent forms. Health Insurance Portability and Accountability Act (HIPAA)
authorization for use and disclosure of Personal Health Information was obtained as part
of the consent process. No data were collected prior to recruitment and consenting.
Timing and Procedure of Participant Recruitment
Each potential participant was approached individually by the PI or trained
research assistants regarding participation in the study when identified as meeting the
inclusion criteria by clinic staff. The two times that recruitment occurred predominantly
were correlated to routine GDM screening times during routine prenatal visits based on
recommendations of the NIH Consensus Guidelines (Vandorsten et al., 2013) and
generally accepted by ACOG (2013) and the ADA (2014) and which were consistent in
across the sites. The first time, early gestational GDM testing usually occurs in the first
trimester or early second trimester prior to 14 weeks gestational weeks at the initial
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prenatal intake appointment, at which time screening for GDM is based on high risk
indicators for pre-existing DM or early GDM. These factors include obesity with Body
Mass Index (BMI) > 30, patient personal history of GDM or first degree relative family
history of DM, or other factors such as BMI > 25 coexistent with other risk factors such
as history of infant birth weight greater than nine pounds, history of unexplained
stillbirth, high-risk ethnicity (African-American, Asian-American, Hispanic/Latina,
Native American, East Indian), history of polycystic ovarian syndrome (PCOS) or
medical comorbidities, such as hypertension or heart disease. This initial screening
occurred via laboratory testing of patient blood samples for either a fasting blood sugar, a
hemoglobin A1c, or a one-hour glucose challenge test (GCT) otherwise called glucose
load test (GLT) or a glucose tolerance test (GTT) of 50 grams of carbohydrates. Elevated
results indicating early GDM (often referred to as pre-diabetes) include a fasting blood
serum level greater than 95 mg/dl, a hemoglobin A1c of greater than or equal to 5.7 or a
one-hour GLT greater than 200 mg/ dl. Results from a one-hour GLT greater than or
equal to 140 mg/ dl, but below 200 mg/ dl, lend to a follow-up diagnostic testing
recommendation of a series of four blood specimens tested for glucose levels, fasting,
and in one-hour intervals for three hours following a 100-gm carbohydrate GLT. If two
of the four results are elevated, the patient is diagnosed as having GDM. Results of a
fasting blood serum greater than 125 mg/ dl or hemoglobin A1c greater than 6.4 is
diagnostic for DM. The second time for routine screening for those pregnant women
who have not been previously screened nor determined to have high risk factors
indicating need for earlier screening occurred usually between 24- and 28-weeks
gestational age. At that time, it is recommended that all pregnant women be screened
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with a one hour 50 gm GLT and adhere to the same laboratory result recommendations
previously mentioned. With the diagnosis of GDM or DM, appropriate counseling,
treatment recommendations, and/or blood sugar monitoring should be discussed either by
the obstetrical HP and/or the Diabetic Educator/Registered Dietitian team.
Consent
All participants were informed of the study verbally and were then given a
written informed consent form (Appendix C) to read and sign. The written consent form
was given in Phase 1 and was intended to cover two phases of data collection, Phase 1
and 2. Consent included permission for the researcher or trained research assistants to
retrieve a minimal amount of information from the patient or staff to complete the PDQ
and HPDQ only. Verbal confirmation of intention and willingness to participate in Phase
2 and agreement to be contacted or to coordinate contact with the clinic staff for Phase 2
participation during a clinic appointment time was solicited during Phase 1. Prior to
Phase 2 data collection, verbal confirmation in-person was again solicited and obtained.
Assurance of the voluntary nature of consent was provided at both times of participation,
as well as permission to withdraw if at any time a participant expressed a desire to do so.
The patient would have been assured that, whether consenting to or declining to
participate, there would have been no effect or impact on the patient’s care or relationship
with the HP or clinic and also reassured that any future involvement was voluntary and
that if she does not desire to be further involved, there will be no penalty or repercussions
related to clinic care or otherwise. Appreciation will be expressed for their involvement,
and confidentiality reassured. Contact information for the PI was provided to the
participants to address any follow-up concerns, questions or adverse effects that might
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occur due to being involved in the study. There were no participants who desired to stop
the study for any reason
Data Collection Procedure
The initial period of recruitment occurred at the time the participant was identified
as high-risk for GDM, either early gestational age, or at the routine gestational age, but
prior to receiving diagnosis and counseling by any HP regarding GDM and potential
health outcomes. The timing of early or routine screening coincided as intended with the
potential participant presenting to the clinic for lab work, which takes from several
minutes to over three hours to complete. For many potential participants requiring
extensive laboratory testing time, this was determined and found to be an ideal and
appropriate time to recruit participants. The study was described to the potential
participant. If expressing interest in participating, the participant was asked to sign a
written consent form. The study data was collected in the prenatal clinic during the office
visit or laboratory testing appointment for Phase1. Following the consenting process, the
PDQ, the EBQ+1 and the PAS were given to the participant to complete. These
documents were available in English and Spanish. The coded instruments and
questionnaires were assigned a study ID number (coded). A separate document is being
kept by the PI that links the study ID number to identifying information, specifically
name, date of birth and phone number. Once the instruments were completed by the
participant, they were placed in a sealed envelope with the matching study ID number on
the outside. The participants were notified that would be contacted for a second round of
data collection, Phase 2, in the third trimester of pregnancy and asked their preferred
means of contact. Those who screened high-risk but were not diagnosed with GDM were
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assigned to a control group (non-GDMs) while those who are diagnosed with GDM will
be assigned to the study group (GDMs). This diagnosis was determined by the HP based
on the blood glucose results. Blood glucose results were obtained from clinic staff
responsible for laboratory result follow-up as well confirmation of diagnosis, who then
contacted and relayed the information to the PI for control versus study group
assignment.
Phase 2 data collection occurred at approximately 34-36 weeks gestational age.
For the GDM group, this occurred minimally, 8-10 weeks following GDM diagnosis,
counseling, and a series of repeated visits with maternity HP and/or diabetic nurseeducator/Registered Dietitian team. The participant preferred contact information was be
used to schedule Phase 2 data collection. Data collection for Phase 2 for the GDM group
occurred in-person at the prenatal clinic during the routine office visit that takes place at
that time. Contact with the participant or permission to contact the clinic staff to
determine appointment time was obtained. Control group (non-GDMs) participants were
given the option of being contacted for Phase 2 data collection by phone or completing in
the clinic at a routinely schedule prenatal appointment. The majority completed during
their routinely schedule appointment.
During Phase 2, the GDM group participants completed the HPDQ, the MLQ the
SIQ, the QOII, the DSES, the GMQ as well as repeated the EBQ+1, and the PAS (Figure
1). Appreciation was expressed and at the conclusion of this second phase, participants
received a compensation gift in the form of a gift card to area department or grocery store
in the amount of $10.00. Following completion of the participant portion of the PDQ and
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the HPDQ, the PI or trained research assistants collected the additional information from
the medical staff, thus completing the data collection.
Data Protection and Anonymity
Vigilance to data protection and maintaining confidentiality was initiated at
recruitment and throughout data collection and analysis. Consent forms and completed
data collection forms were sealed immediately in an envelope coded with a study
identification (ID) number and transferred to the PI by trained research assistants as soon
as possible. The Study ID code was linked to each participant’s contact information,
name, and date of birth using a master file, both in the form of a secured passwordprotected flash drive and a hardcopy spreadsheet. The Study ID code was placed on all
data collection forms needing completion for Phase 2. As was the case for Phase 1, once
the data forms have been completed by the participant, verified for thoroughness by the
research assistant or PI and additional data recorded, the forms were placed in a coded
envelope and transferred to the PI. All data entry occurred in a private office at the PI’s
home. The data is stored on a password-protected flash drive, along with the hard-copy
master file and all forms are kept in a locked file cabinet in a locked office in the PI’s
home at all times except during data entry. Data is retained in a de-identified format after
the completion of the study. All identifiers on hard copy and electronic files were
destroyed or erased.
Data Analyses
Data Preparation
Data was entered, and analyses conducted using Statistical Package for Social
Sciences (SPSS) 24.0. In preparing for analyses, several steps were conducted. Data was
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evaluated for missing or incomplete values as well as for distributions and outliers. Plans
were in place to replace with substitution of means of scale items if there was less than
20% of the responses missing on an individual questionnaire which had responses and if
greater to use listwise deletion, however there were no cases of data missing on any
questionnaire except for the MLQ and not greater than 20%.
Data Analyses
Due to the purpose and correlational exploratory design of this research, the
overall focus of analyses was to explore for relationships among the study variables using
correlation models. In addition to correlations models, comparative difference models of
analysis between GDM and non-GDM over two time periods during the pregnancy
addressed whether health behavior modification of healthy eating and PA occurred in
pregnancy with and without a GDM diagnosis. It is important to note that because of the
exploratory nature of the analysis and the small sample size, several considerations were
necessary. Multiple analyses were conducted with limited number of variables per
analytic model as the sample size would not support larger more complex multivariate
modeling such as structural equation modeling. The level of significance criterion was
relaxed to p≤ .10 to preserve analytic power and to provide the opportunity for
relationships to emerge as significant, that could be studied and with larger samples in the
future. The limitations of this approach are discussed in the “strengths and limitations”
section.
Descriptive and inferential statistics were used for analytic purposes to address
the aims of this research project. As an initial step, descriptive statistics, primarily
frequency and percentages, were used for categorical variables and measures of central
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tendency, such as means and standard deviations, were used for interval variables to
describe the sample demographic characteristics of the participant such as race/ethnicity,
primary language, age, history of GDM/DM as well as the HP characteristics such as
gender, race/ethnicity, age, and HP specialty.
The methods used for inferential analyses for each of the study aims included
include both univariate and multivariate analyses using multiple linear regression and
analyses of covariance (ANCOVA) to analyze paths identified in Figure 2 and listed in
Table 2. Multiple regression analyses are useful to explain the interrelationships among
multiple variables, to examine the contribution of each independent variable (IV to the
dependent outcome variable (DV) (Mertler & Vannatta, 2002; Munro, 2001). The
purpose of ANCOVA was to determine group differences while controlling for the effect
of one or more variables (Mertler & Vannatta, 2002). Repeated measures were integrated
into the ANCOVA analyses to measure group mean differences over time (Munro, 2001).
The first step following data collection and prior to analyses was to employ data
screening methods to detect potential data problems, such as data entry errors, missing
values, possible outliers, and non-normal distributions (Odom & Henson, 2002).
Depending on the type of analysis, assumptions were examined to ensure there were no
violations of linearity, normality, homogeneity of variance, homoscedasticity, and
multicollinearity (Mertler & Vannatta, 2002; Munro, 2001). Examination of residential
scatterplots, correlation coefficients among IVs, or variance inflation factor (VIF) were
conducted for multiple linear regressions (Tabachnick & Fidell, 1996; Mertler &
Vannatta, 2002). For repeated measures ANCOVAs, this can be accomplished with
boxplots or histograms, the Shapiro-Wilk test of normality, Mauchly’s test of sphericity,
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and the Levene’s test for homogeneity of variances (Mertler & Vannatta, 2002; Munro,
2001). The variables and predetermined analysis are described for each hypothesis to be
tested or question to be answered below.

91
Table 2: Research Analyses

Hypothesis (H)/
Level of
Research Question (RQ)
Measure
H1) HPI, specifically, SIQ Interval
and QOII will be positively (IV; DV)
correlated with an
improvement in HE, an
increase in PA, and
adherence to GM
recommendation behaviors
in women with GDM.

H2) Patient factors,
specifically, race and
language concordance and
a personal/family history
GDM/DM (GDMPFH)
will have a moderating
effect on the relationship
between HPI, specifically,
SIQ and QOII, and HE,
PA, and GM monitoring
behaviors in women with
GDM; the relationship will

Interval (IV)
Categorical
(Moderating
Variable)
Interval
(DV)

Method of Analyses

Gpower Sample Size Estimate

Multiple Linear Regressions:
8 separate regression models for
each of the 8 DVs: health
behaviors (3 HE, 2 PA, and 3
GM)
2 IVs: HPI (SIQ composite
score, QOII total score)

F tests – Linear multiple regression:
Fixed model, R² deviation from zero
Analysis: A priori: Compute required
sample size
Input:
Effect size f² = 0.15
α err prob = 0.1
Power (1-β err prob) = 0.8
Tested predictors = 2
Output:
Noncentrality parameter λ = 8.1000000
Critical F = 2.4097449
Numerator df = 2
Denominator df = 51
Total sample size = 54
Actual power = 0.8014124
F tests – Linear multiple regression:
Fixed model, R² deviation from zero
Analysis: A priori: Compute required
sample size
Input:
Effect size f² = 0.15
α err prob = 0.1
Power (1-β err prob) = 0.8
Tested predictors = 5
Output:
Noncentrality parameter λ=
11.2500000

Multiple Linear Regressions
In each step: Separate
regressions for each of the 8
DVs: health behaviors (3 HE, 2
PA, and 3 GM)
Step 1: on 2 IVs: HPI (SIQ
composite score, QOII total
score)
Step 2: separately on each of 3
Moderating Variables: patient
factors (race concordance,
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be stronger with race
concordance, primary
language concordance and
with a positive GDMPFH

H3) HP factors,
specifically, gender
concordance, HP specialty
and HP leadership style
(MLQ) will have a
moderating effect on the
relationship between HPI,
specifically, SIQ and QOII,
and HE, PA, and GM
behaviors in women with
GDM; the relationship will
be stronger with gender
concordance, and HP
transformational leadership
style (MLQ) but not differ
based on HP specialty.

Interval (IV)
Categorical
(Moderating
Variable)
Interval
(DV)

language concordance, and
GDMPFH)
Step 3: separately on the
interaction term between each of
the 3 Moderating Variables:
patient factors (race
concordance, language
concordance and GDMPFH) and
the 2 IVs: HPI (SIQ composite
score, QOII total score)
Multiple Linear Regressions
In each step: Separate regression
for each of the 8 DVs: health
behaviors (3 HE, 2 PA, and 3
GM)
Step 1: on 2 IVs: HPI (SIQ
composite score, QOII total
score)
Step 2: Separately on each of the
3 Moderating Variables: HP
factors (gender concordance, HP
specialty; HP leadership style
(MLQ)
Step 3: separately on the
interaction term between each of
the 3 Moderating Variables: HP
factors (gender concordance, HP
specialty; MLQ) and the 2 IVs:
HPI (SIQ composite score, QOII
total score)

Critical F =1.9325887
Numerator df =5
Denominator df = 69
Total sample size=75
Actual power =
0.8031994

F tests – Linear multiple regression:
Fixed model, R² deviation from zero
Analysis: A priori: Compute required
sample size
Input:
Effect size f² = 0.15
α err prob = 0.1
Power (1-β err prob) = 0.8
Tested predictors = 5
Output:
Noncentrality parameter λ=
11.2500000
Critical F =1.9325887
Numerator df =5
Denominator df = 69
Total sample size=75
Actual power =
0.8031994
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H4) Patient self-efficacy
will have a mediating
effect on the relationship
between HPI specifically,
SIQ and QOII) and HE,
PA, and GM behaviors in
women with GDM.

Interval
(Mediating
Variable; IV;
DV)

Multiple Linear Regressions
Primary analysis (Baron &
Kenny, 1986)
1. Regressing the Mediating
Variable: DSES on each of
the 2 IVs: HPI (SIQ
composite score and QOII
total score
2. Separately regressing the 8
DVs: health behaviors (3HE,
2 PA, and 3 GM) on 2 IVs:
HPI (SIQ composite score
and QOII total score
3. Separately regressing 8 DVs:
health behaviors (3 HE, 2
PA, and 3 GM) on 2 IVs:
HPI (SIQ composite score
and QOII total score and the
Mediating Variable: DSES
Secondary analysis: (Preacher
& Hayes, 2008)
Estimate the relative total and
indirect effects of IV: HPI (SIQ
and QOII total score) in
separate equations on 8 DVs
(health behaviors: 3 HE, 2 PA,
and 3 GM) through the
Mediating Variable: DSES
Generates bootstrap percentile
or Monte Carlo confidence
intervals for indirect effects

F tests – Linear multiple regression:
Fixed model, R² deviation from zero
Analysis: A priori: Compute required
sample size
Input:
Effect size f² = 0.15
α err prob = 0.1
Power (1-β err prob) = 0.8
Tested predictors =3
Output:
Noncentrality parameter λ=9.3000000
Critical F=2.1807273
Numerator df =3
Denominator df = 58
Total sample size= 62
Actual power =
0.8006314
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RQ1a)
Were there differences in
patient engagement in
health behavior
modification of HE and PA
as a result of time (Phase 1,
during screening and Phase
2, near the end of
pregnancy) or diagnosis of
GDM: control group: nonGDMs and study group:
GDMs?
RQ1b) Were there
differences in patient
engagement in health
behavior modification of
HE and PA as a result of
time (Phase 1, during
screening and Phase 2, near
the end of pregnancy) or
diagnosis of GDM: control
group: non-GDMs and
study group: GDMs when
adjusting for race/ethnicity,
primary language,

Categorical
(IV;
Covariates)
Interval (DV)

MEDIATE Y= health
behavior/X=HPI (SIQ
composite score and
QOII/M=DSES
Comparative Model:
One-way repeated measures
ANCOVA
Separate analyses for each of
5 DVs: health behaviors (3 HE
and 2 PA)
Two different times (Phase 1 and
2)
IV: 2 Groups: study: GDMs and
control group: Non-GDMs
Covariates: patient factors
(race/ethnicity, primary
language, personal/family
history of GDM/DM)

F tests – ANOVA: Repeated measures,
within-between interaction
Analysis: A priori: Compute required
sample size
Input:
Effect size f² = 0.25
α err prob = 0.1
Power (1-β err prob) = 0.8
Number of groups = 2
Number of measurements = 2
Correlations among rep measures = 0.5
Nonsphericity correction = 1
Output:
Noncentrality parameter λ=7.0000000
Critical F=2.9091325
Numerator df =1.0000000
Denominator df = 26.0000000
Total sample size= 28
Actual power = 0.8240978
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personal/family history of
GDM/DM)?
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Research Aim 1/Hypothesis 1
Research aim 1 was to determine if HPI was associated with patient engagement in health
behavior modification of HE, PA and GM monitoring in women with GDM. To test the
hypothesis that HPI will be positively correlated with an improvement in HE, an
increased in PA, and adherence to GM recommendation behaviors in women with GDM,
a multiple linear regression model was selected (Mertler & Vannatta, 2002). All measures
were interval level. A separate multiple linear regression equation was analyzed for each
of the eight DVs, health behaviors. Three DVs relate to HE measured by the EBQ+1.
Two related to PA, measured by the PAS. Three related to GM, measured by the GMQ.
The IVs, HPI, measured by the SIQ composite score and the QOII total score were
entered simultaneously into the analysis for each of eight DVs. A secondary analysis
followed the same steps with three IVs, including the SIQ composite score and a two
QOII-GDM “content received” and “delivery” subscale scores instead of the one QOII
total score. The decision was made to retain analyses with the QOII total score as there
were some concerns including multicollinearity issues with the subscale scores.
Research Aim 2/Hypothesis 2
Research aim 2 was is to determine if patient characteristics moderated the
relationship between HPI and patient engagement in health behavior modification of HE,
PA, and GM in women with GDM. The hypothesis states that patient factors,
specifically, race concordance, primarily language concordance and a personal/family
history GDM/DM (GDMPFH) will have a moderating effect on the relationship between
HPI, specifically, SIQ and QOII, and HE, PA, and GM behaviors in women with GDM;
the relationship will be stronger with race concordance, primarily language concordance
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and with a positive personal/family history of GDM/DM (GDMPFH). A moderating
variable is generally accepted to be a descriptive characteristic that can affect the strength
or direction of the relationship between the IV and the DV (Baron & Kenny, 1986). For
this analysis, the IV, HPI was measured by the SIQ composite score and the QOII total
score, both, interval level. The moderating variables include three patient factors (race
concordance, language concordance and GDMPFH) contained in the PDQ and are all
categorical level. The eight DV health behaviors (three relate to HE, two related to PA
and three relate to GM) measured by the EBQ+1, the PAS, and the GMQ, respectively,
are all interval level.
Using a multiple regression model, separate regressions were run on each step of
the three-step process for each of the eight DVs. In the first two steps, the eight DV
health behaviors were regressed separately on the two IVs of HPI and on the three
moderating variables, patient factors for a total of 40 regressions equations. Each of the
patient factors are categorical level dichotomous variables: race concordance
(Concordance/Discordant), primary language concordance (Concordance/Discordant),
and personal/family history of GDM/DM (Yes/No). In the third step, the eight DVs,
health behaviors were separately regressed on an interaction term between each patient
factors and each of the two IVs of HPI to determine if there is a moderating effect, for a
total of 48 additional regressions. In this latter step, if the regression results were
significant, the moderating hypothesis would be supported. A secondary analysis using
the same steps above included all the same variables listed however, using three IVs, the
SIQ score and two QOII “content received” and “delivery” subscales instead of the QOIIGDM total score. Interactions were tested on simple slopes with the use of Preacher’s
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website (Preacher, Curran, & Bauer, 2006). The decision was made to retain analyses
with the QOII total score only as there were some concerns including multicollinearity
issues with the subscale scores.
Research Aim 3/Hypothesis 3
Research aim three was to determine if healthcare provider characteristics
moderate the relationship between HPI and patient engagement in health behavior
modification of HE, PA, and GM in women with GDM. The hypothesis states that HP
factors will have a moderating effect on the relationship between HPI and HE, PA, and
GM behaviors in women with GDM; the relationship will be stronger with gender
concordance and HP transformational leadership style (MLQ) but not differ based on HP
specialty. The IV, HPI, measured by the SIQ composite score and the QOII total score,
were both at interval level. The moderating variables include three HP factors (gender
concordance, HP specialty) measured by the HPQ and the leadership characteristic
measured by the MLQ, all categorical levels. The eight DV health behaviors (three relate
to HE, two relate to PA, and three relate to GM) are measured by the EBQ+1, the PAS,
and the GMQ, respectively and all are interval levels.
Using a multiple regression model, separate regressions were run in each step of
the three-step process for each of the eight DVs. In the first two steps, calculating main
effects, each of the eight DVs, health behaviors were regressed separately on the two IVs
of HPI and on each of the three moderating variables, HP factors for a total of 48
regressions. Each of the HP factors are categorical dichotomous variables: gender
concordance (Yes/No), HP specialty (nurse-midwife/physician) and leadership
characteristic (transformational/transactional). In the third step, calculating an interaction
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effect, the eight DV health behaviors were separately regressed on an interaction term
between each of the four HP factors and each of the IVs of HPI to determine if there is a
moderating effect for an additional 48 regressions. If in this latter step, the regression
results were significant, the moderating hypothesis would be supported. A secondary
analysis using the same steps includes all the same variables but with three IVs, the SIQ
score and two QOII “content received” and “delivery” subscales instead of the QOII
score. To explore interaction patterns, simple slope tests were conducted with the use of
Preacher’s website (Preacher, Curran, & Bauer, 2006). The decision was made to retain
analyses with the QOII total score only as there were some concerns including
multicollinearity issues with the subscale scores.
Research Aim 4/Hypothesis 4
In addition to the exploration of the moderating effects of patient and HP factors
on the relationship between HPI and health behavior modification, it was important to
explore the mediating effect of patient self-efficacy on that same relationship as well. The
fourth research aim was to determine if self-efficacy mediated the relationship between
HPI and patient engagement in health behavior modification of HE, PA, and GM in
women with GDM. This addressed whether the degree of self-efficacy (either higher or
lower) affects the relationship between HPI and health behavior modification differently.
In general, a mediating variable reflects a transformative process within a
participant that intervenes between the IV and the DVs and is said to account for the
relation between the IV and the DVs (Baron & Kenny, 1986). To test the hypothesis that
there will be a mediating effect of patient self-efficacy on the relationship between HPI
and HE, PA, and GM behaviors in women with GDM, it was necessary to evaluate the
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level of measurement and address several conditions to conduct multiple linear
regressions. All the levels of measurement were interval for this analysis. Assumptions
when doing multiple regressions with mediating variables are that there is no
measurement error in the mediator, although this is virtually impossible as mediators are
often, as in this case, an internal psychological variable, likely to be measured with error
(Baron & Kenny, 1986). Another assumption is that the DVs do not cause the mediator
(Baron & Kenny, 1986). Conditions that must be met are that variations in HPI
significantly account for variations in self-efficacy, variations in self-efficacy
significantly account for variations in health behavior modifications and when variations
in HPI on self-efficacy and variation in self-efficacy on health behavior modifications are
controlled, a previously significant relation between HPI and health behavior
modification is no longer significant (Baron & Kenny, 1986).
This multiple regression model involved a three-step process testing separate
coefficients for each regression equation. The first step involved regressing the mediating
variable, self-efficacy, measured by DSES on the IVs, HPI, measured by the SIQ and the
QOII total score, entered separately. For self-efficacy to function as a mediator, HPI
must be shown to correlate with self-efficacy. The second step involves eight separate
regressions equations for each of the eight DV health behaviors, three HE, two PA, and
three GM, measured by the EBQ+1, the PAS, and the GMQ on HPI. A prerequisite to
mediation by self-efficacy was that HPI must affect the health behaviors. The third step
involves regressing each of the eight DV health behaviors on the combined IVs, HPI and
the mediating variable, self-efficacy, wherein self-efficacy must affect the health
behaviors (Baron & Kenny, 1986). A secondary analysis was conducted using the same
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steps and include all the same variables but with three IVs, the SIQ score, and two QOII
“content received” and “delivery” subscales instead of the QOII-GDM total score. The
decision was made to retain analyses with the QOII total score only as there were some
concerns including multicollinearity issues with the subscale scores as well as increased
risk for error with an added variable.
A further analysis was conducted to estimate the relative total and indirect effects
of the IVs: HPI (SIQ and QOII total score) in separate equations on 8 DVs (health
behaviors: 3 HE, 2 PA, and 3 GM) through the mediating variable: self-efficacy (DSES).
This analysis generated bootstrap percentile or Monte Carlo confidence intervals for
indirect effects using the equation: MEDIATE Y= health behavior/X=HPI (SIQ-HPGDM composite score and QOII-GDM)/M=DSES (Preacher & Hayes, 2008).
Research Aim 5/Research Questions 1a/1b
The fifth aim was to determine if there were differences in the pattern of patient
engagement in HE and PA during pregnancy for women with and without a GDM
diagnosis.
To address this aim, the research question asks, “were there differences in patient
engagement in health behavior modification of HE and PA over time (Phase 1, during
screening and Phase 2, near the end of pregnancy) or diagnosis of GDM (control group:
non-GDMs and GDMs)?” A mixed design, repeated measures ANCOVA addressed this
two-part question inquiring into the between two groups and within each group
differences at two times in the pregnancy. ANCOVA combines analysis of variance
(ANOVA) with regression to measure differences among group means (Munro, 2001).
Following pre-analysis assumption testing, this analysis input included the IV, two
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groups, the control group (non-GDMs) and the GDM group, five DV health behaviors
(three HE and two PA), measured by the EBQ+1 and the PAS, all interval level, and
three covariates, patient factors (race/ethnicity, primary language, personal/family history
of GDM/DM), measured by the PDQ, all categorical level. Separate equations were run
for each of the five DVs, and include the IV and the three covariates, for mean
differences between the GDM and non-GDM groups over time (Phase 1 and Phase 1).
The third health behavior outcome, glucose monitoring was only measured in Phase 2 as
it is not relevant to Phase 1 and thus was not be included in this analysis.
Methodological Rigor
To strive for methodological rigor, it was imperative to carefully design and
describe a research protocol and policies that addressed the many elements of a research
project with integrity, legitimacy, soundness, validity and feasibility. To confirm
methodological rigor, it was imperative to evaluate the appropriateness of the research
design and selection of method in answering the research question, address internal and
external validity threats, and provide an overall assessment of the strengths and
limitations of the research design and methods, instruments, and analyses.
The research design was appropriate for research inquiries involving cognitive,
behavioral and social factors of participants and HPs and the outcomes of health behavior
modification. The correlational design has been used in similar research inquiries
involving one or multiple concepts of social influence, self-efficacy, and health behavior
modification. It was designed as an initial exploration into the concept of HPI, testing of
a recently developed conceptual model, and the association of HPI with patient health
behavior modification, thus addressing an identified gap in the healthcare literature and
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legitimizing the need for the inquiry. The design provided a solid approach to initiating
the understanding of how HPs influence patient health behavior modification and thus
how to increase this process toward overall improved health status. Quantitative
methodology supported this research designed to describe associations between HPI and
health behavior modification as well as exploring additional potential patient and HP
factors that modifying that relationship. A non-experimental correlational design is
appropriate for the exploration of associations, prior to implementation of any future
intervention studies. However, this design also carried with it, potential threats to internal
and external validity.
Strengths and Limitations of the Research Design, Methods, and Measures
Several measures were taken to increase the strength and reduce threats to
external and internal validity. External validity relates to the how well the research design
reflects the research question whereby research findings can be generalized to the
populations and settings (Hulley, 2007; Polit & Beck, 2008). Internal validity is related to
how well the implementation of the study reflects the research plan and whether the
results are attributable to the IVs or other unrelated factors (Polit & Beck, 2008).
Design
This correlational exploratory research design was appropriate to conduct initial
validity testing of the newly developed HPI conceptual model. It was a first step in a
process to collect data and information to contribute to the understanding of the process
wherein HPs influence patient health behavior modification, describe more fully the HP
as social influence situated within the ITHBC model, and provide guidance for the
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eventual development of future exploratory and intervention studies. The sample,
measures and analyses are described separately following the discussion of the design.
Using a control group provided strength to the design, as it allowed for the
comparison between those who were diagnosed versus those who were not diagnosed
with GDM. It considered that health behavior modification might occur because of
pregnancy alone. There are several possible design limitations. The first was the use of
quantitative methods as the sole methodology. Although this method is pertinent to postpositivist philosophy, the use of qualitative methods could enrich the values-component
included in this paradigm. Following initial exploration of the relationships among
variables in this quantitative study, future studies should include a more robust mixed
methods approach to increase the depth and richness of data that leads to a better
understanding of the association between the concept of HPI and health behavior
modification. Another possible limitation impacting the results and reflecting a threat to
internal validity come from a threat of maturation, the effect that the naturally occurring
process of time has on participants and outcomes (Polit & Beck, 2008). There is some
concern that time, or time-related factors present a threat to validity. The longer a
participant is enrolled in the study, such as in the case of early pregnancy versus midpregnancy diagnosis of GDM, the more it could impact health behavior modification. In
addition, greater time could have allowed influences for behavior modification, apart
from HPI. However, it is important to remark that time, including the duration and
frequency of contact with the HP, is contributory to the relationship and included in the
process and conceptual model of HPI, although not directly tested in this study.
Sample
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There are several strengths related to the sample. Participants were recruited
based on predetermined inclusion and exclusion criteria. They were recruited from
various healthcare clinical settings and institutions, with various types and specialties of
HPs and includes both English and Spanish-speakers. This was intended to provide for a
clinically and demographically diverse participant sample, to represent the target
population well (Hulley, 2007), and to explore diverse HP-patient relationships with
different HP specialties. The intentions with these sample considerations were to increase
accuracy of estimations, decrease bias and homogeneity, and thus add to the design
strength. A limitation related to sample selection includes the use of convenience
sampling. This could also contribute to the opposite effect listed previously, wherein the
sample was not representative of the population demographics.
Adequacy of sample size estimation is an important criterion for internal validity.
Power analysis was used to determine a samples size a priori. An acceptable power
criterion of .80 was selected. A moderate effect size was predetermined, which is one of
the most important elements of the power analysis and may contribute more to the
clinical and practical significance of the results than could be achieved by the statistical
significance. Additionally, adding to the precision of the estimate was the decision to
recruit and collect and review data until it is determined that the sample size estimate was
achieved for analyses purposes, even if data collection resulted in greater than the sample
size calculation (Hulley, 2007), albeit overall recognizably small in relation to the
number of variables to be explored.
A limitation that could result in an increased risk of type 1 error related to the
sample size estimation is the relaxing of the selected significance level to p<.10 as well as
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a family wise error rate resulting from conducting multiple linear regressions for several
hypotheses. Statistical significance alone is insufficient as a criterion for behavioral
research and was selected based on the feasibility of recruiting participants in a timely
manner, albeit a lower level which inherently may limit the findings (Thompson, 2002).
This decision was based on the relatively infrequent occurrence of GDM among
pregnancy women and this study serving as an initial exploration and testing of the HPI
conceptual model.

Data Collection
Measures to ensure validity included standardized and consistent training of
research assistants in recruitment criteria and procedures, consenting, and procedures for
data collection and ensuring quality and completeness of data based on the understanding
that the results of the analyses are only as good as the reported data (Hulley, 2007;
Mertler & Vannatta, 2002). The decision to thoroughly train research assistants in
recruitment as well as in consistent face-to-face data collection methods while providing
continuous access to the PI occurred and contributed to design strength on several levels
as well as decreasing random measurement or systemic error. These include an increase
in the accuracy, thoroughness, and usefulness of the data responses for analyses both by
decreasing potential response bias in the event the PI is the exclusive recruiter and data
collector but also by increasing the ability to review forms following completion, return
immediately for missing data or to assist with instruction or clarification (Hulley, 2007).
These measures simultaneously decreased the threat to measurement error, prevented
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missing data, increased adherence to maintaining confidentiality, and provided for
assurance to participants and subsequently retention and participation in Phase 2 of the
study. Missing data and retention did not present as concerns. There was an overall lost to
follow-up in both the control and the study group of 7%. Involving clinic staff in
identifying potential participants was beneficial as it increased staff interested and their
willingness to recommend participants. Likewise, it did appear to increase the trust of the
participants and increase their willingness to participate, while preventing attrition and
loss to follow-up, which often present as threats in longitudinal studies. Additional
strengths relate to the timing of data collection which eliminated any inconvenience
related to financial or transportation burden was facilitating recruitment and participation
at times the participant participated in routine receiving prenatal care. Burdens and
possible limitations related to data collection involving multiple clinic settings did require
an increased need for organization, training, and persistence on the part of the PI for
adequate and appropriate participant recruitment and reimbursement however it also
increased the diversity of the sample. An additional limitation is possible due to the
option of a different data collection method, via phone, for Phase 2 for the control group
participants. This was a seldom selected option.
Measures
To increase precision and accuracy of findings and to reduce measurement
systematic error, several factors to strengthen the design were considered. Each
instrument was scrutinized prior to selection for relevance to content, fit with study
purposes, prior use in similar research projects, level of measurement, and strong
reliability and validity. The outcome and mediating variables have all been used jointly in
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previous self-management health behavior modification research with DMs. All the
variables are measured with interval level of measurement except the moderating
variables. Reliability and validity have been reported for the instruments overall and
many have been tested and used with similar and diverse populations, except for those
modified for this research. However, the three instruments that were modified underwent
a pilot study testing for content validity prior to implementation in the study to determine
relevance, clarity and comprehensiveness by content experts. Content validity was
evaluated by both English and Spanish speakers to gain insight and establish validity for
the study population. All the instruments are available in English and Spanish, including
those that were translated and back translated by certified medical interpreters for the
purposes of this study. Competent translation reduces random measurement and systemic
error that occurs with response variation and results in accurate results when item
confusion or lack of clarity in wording or content is addressed (Hulley, 2007).
Most of the instruments impose little participant burden as they were brief and
easy to understand. Instrument options that were disregarded included multiple day food
diaries or logs that would have been relevant but bear the risk of reporting errors or recall
regarding portion sizes, types of foods, forgotten foods or beverages which could be
significant, and thus deemed unsuitable. In addition to potential inaccuracies, they are
cumbersome for the participant and time-consuming for analyses for the researcher.
Those types of instruments might be better used in the clinic setting for counseling
purposes rather than research purposes for longitudinal behavior modification
comparisons.
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Several possible limitations are measure-related. Most of the instruments are
completed by the participants, and all the health behavior modification outcomes
measures are self-reported. While there are limitations to using self-report measures, they
can also be the useful and provide an insight to the self-perception of a participant’s
behaviors, which is an overall facet to this research (P. Ryan, 2009). Habitual responding
might also occur wherein the participant may get into a pattern of responding without
considering the questions, especially when they are somewhat repetitive. One instrument,
the MLQ did lacks brevity, although it is shorter that previous versions, and has been
used reliably with large samples, in multiple languages and cultures and with populations
having literacy levels below its designated level. Regarding instrument modifications,
the MLQ, it had never been used in the clinical setting for patient evaluation of HP
characteristics. As a result, it may not be the most appropriate instrument for this
purpose. However, a review of the literature fails to result in any other option for this
specific purpose of patient evaluation of HP influence. Future replication and uses with
this modified instrument will be necessary to establish reliability and validity.
Analyses
There are several strengths of the selected analyses. One is the use of repeated
measures ANCOVA which removes added sources of variance before comparing group
means, thus decreasing error, increasing power, and requiring a smaller sample (Munro,
2001). Multivariate analysis in final regression pathways adds strength to the analyses.
Multiple variables increase the amount of variance accounted for in the DV, which will
increase the accuracy of a prediction (Munro, 2001). Multiple regression is described as
most flexible and appropriate technique to analyze both categorical and continuous
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variables, as well as numerous independent and dependent variables simultaneously
(Munro, 2001). This allows for a more holistic and comprehensive understanding, and
possible identification of interconnected relationships between variables. The exploration
into the relationships between variables may result in findings that reflect the complexity
of the human mind or a set of behaviors that often do not exist in isolation but rather may
affect or be affected by several variables that even with the increased potential for errors
might not have been considered prior to analyses (Mertler & Vannatta, 2002). Secondary
analyses are planned to test several of the hypotheses using additional IVs, which may
provide relevant information for future research.
Due to the limited availability of participants and feasibility for this study, the
sample size was small overall. One of the major limitations of analyses with a smaller
sample is the need to run multiple linear regression models for several of the hypotheses,
one for each of the moderating variables and for each of the DVs for each research
hypotheses instead of an alternative, for example, structural equation modeling. These
multiple analyses of the same sample data increase the risk of Type 1 error, with
possibility for a robust family size error, thus finding a significant effect in one or more
of the multiple analyses that can be in fact a spurious finding. In this exploratory study,
no correction for multiple comparisons is included. Another limitation involves
categorical levels of measurement when conducting multiple regression models. As much
as was possible, instruments with higher level interval measurement were selected for
analyses purposes as well as to increase precision, accuracy and resultant generalizability
of inferences (Hulley, 2007). Another possible limitation is that the p value criterion is
relaxed to p<.10. However, the rationale for this choice has been described previously
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and additionally, this is intended to allow for possible associations to emerge for future
more in-depth analyses with larger samples.
Summary
Identifying gaps in the healthcare research literature regarding the process of how
HPs influence patient self-management of health behavior modification in women
diagnosed with GDM resulted in formulating a research purpose and proposal to begin
addressing this health promotion concern. The research purpose, five aims and related
hypotheses or question were all described. The predictor and outcome variables were
delineated as well as the instruments used to measure the variables and their levels of
measurement. The instruments were described in detail, including the rationale for the
selection of these instruments and reported reliability and validity. Modifications made to
the original instruments for use in this study were pilot tested to establish content validity
to determine if the modified content was appropriate for the study population. The plan
and process for implementing the research project including estimating the sample size,
recruitment of the sample, protection of the participants and data, seeking IRB approval,
participant consenting, and procedure for data collection were detailed. Data analyses,
including the selection of the appropriate test, adherence to methodological rigor and
minimizing error or bias were described. The research design and methodology were
thoroughly planned to address the study aims with the intention of understanding the
process and components of how HPs influence patient health behavior modification in
women diagnosed with GDM.
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Chapter 4: Results
The majority of the results of this research study is presented in a manuscript
titled “Healthcare Provider Influence on Health Behavior Modification in Gestational
Diabetics (“Appendix E). The manuscript includes the details of the descriptive statistics
and characteristics for the research study participants as well as the psychometric
properties of the study instruments used. Additionally, a description and discussion of the
analyses of four research aims including Hypotheses 1-3 and an additional research
question are reported, clinical practice implications, future research recommendations,
and a conclusion. One hypothesis and two research questions not reported in the
manuscript are presented in this chapter.
Hypothesis 4 and Research Questions
1) Hypothesis 4 states that patient self-efficacy will have a mediating effect on the
relationship between HPI specifically, SIQ and QOII and healthy eating, physical activity
and glucose monitoring behaviors in women with GDM.
2) The research questions were: a) Are there differences in patient engagement in
health behavior modification of healthy eating and physical activity as a result of time
(Phase 1, during screening and Phase 2, between 34-36 weeks gestational age) or
diagnosis of GDM (control group: non-GDMs and study group: GDMs) and b) are there
differences in patient engagement in health behavior modification of healthy eating and
physical activity as a result of time (Phase 1, during screening and Phase 2, between 3436 weeks gestational age) or diagnosis of GDM (control group: non-GDMs and study
group: GDMs)when adjusting for three covariates: race/ethnicity, primarily language and
personal/family history of GDM/DM?
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Data Analyses
Following data collection and prior to analyses, data cleaning was conducted to
detect and resolve data problems, such as data entry errors, missing values, possible
outliers, and non-normal distributions (Odom & Henson, 2002). Correlation analyses
were computed using Pearson’s r for interval level data, point biserial for categorical to
interval level and chi-square for categorical to categorical level data.
To address Hypothesis 4, regression analyses were conducted separately for two
healthcare provider types: the maternity healthcare provider (HP) and the diabetic nurseeducator (DE). Separately, each of the eight health behavior outcomes: three healthy
eating (HE1, HE2, and HE3), two physical activity (PA1 and PA2 and three glucose
monitoring (GM1, GM2, and GM3) were regressed onto the HPI measures, SIQ and
QOII for the HP. Second, self-efficacy (DSES) score was regressed onto the same HPI
measures. The eight health behavior outcomes were regressed onto DSES score and
lastly, the eight health behavior outcome scores were regressed onto the HPI measures
and DSES score. This process was repeated for the HPI measures for the DE.
Paired t-tests were used to measure the within group differences at two different
times, Phase 1 to Phase 2 for control (non-GDM) and the study (GDM) group. One-way
repeated measure analysis of variance (ANOVAs) compared the control and the study
groups outcome change scores for the three HE and two PA outcomes at Phase 1 and
Phase 2 for group differences. Analysis of covariance (ANCOVAs) analyzed the variance
of group differences from three covariates: (race/ethnicity, referred to as race, primary
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language, referred to as language, and personal/family history of GDM/DM, referred to
as GDMPFH) in the outcome scores for the same five outcomes.
Prior to regressions and ANCOVA analyses, violations of the assumptions of
linearity, normality, homogeneity of variance, homoscedasticity, and multicollinearity via
scatterplots, histograms, correlation coefficients, Variance Inflation Factor, KolmogorovSmirov test of normality, F tests for independent and covariate interactions, Box’s and
Levene’s tests were examined. (Tabachnick & Fidell, 1996; Munro, 2001; Mertler &
Vannatta, 2002).
Instrument Description and Psychometrics
Instrument description and psychometric test results for all measures except the
DSES are described in the manuscript in Appendix E.
The Diabetes Self-Efficacy Scale (DSES), modified to add “gestational” is an 8item instrument which is scored from 0-10 and results in one mean score. Self-efficacy
has been studied often in patients with DM (Lorig & González, 2000; Lorig, Ritter, &
Jacquez, 2005; Lorig, Ritter, Villa, & Armas, 2009). The DSES measures confidence
levels in beliefs related to DM and self-management health behaviors, including healthy
eating, physical activity and glucose monitoring. Prior reliability testing found internal
consistency, α = .83 (Lorig et al., 2009), similar to this study’s results, α =.86. The interitem mean correlations = .44 with the actual range from 2.13-10 with a mean (SD) of
7.9(1.56).
Results
Descriptive Statistics
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The description of the total sample is presented in Table 1. The total sample
recruited (n=210) for this study were divided into a control group (n=126) and a study
group (n=84). At Phase 2, 93% from each group, 117 of 126 (control group) and 78 of 84
(study group), completed the study. Statistically significant differences between the Phase
1, control (n=126) and study group (n=84) participants included age, primary language,
GDM screening, early versus routine (all p ≤ .01), personal history of GDM (p ≤ .01),
and personal/family history of GDM/DM (GDMPFH) (p ≤ .05). Early screening for
GDM based on risk factors versus routine screening at approximately 24 weeks GA
occurred 75.4% in the control versus 51.2% in the study groups. The control group
reported a 12.7% personal history of GDM and a 63.5% GDMPFH versus a 28.6%
personal history of GDM and a 77.4% GDMPFH in the study group.
Correlations
Correlations for all the study variables were analyzed to determine associations
and to assess for multicollinearity concerns among the variables. Table 2 reports
correlation results between study variables. Significant correlations were found between
∆HE1 and ∆HE2 (r = .38) and glucose monitoring days/weekly (GM1) and 4 times/daily
(GM2), (r = .63), both p ≤ .001 and GM1 and abnormal glucose results/weekly (GM3) (r
= .25) and ∆PA1 and GM2 (r = .27), both p ≤ .05.
Among the HPI conceptual model measures, both professional influence scores
(SIQHP and SIQDE) were significantly associated (p ≤ .001), both quality of information
and interaction (QOII) scores (QOIIHP and QOIIDE) were significantly associated (p ≤
.001) and each professional influence score for the HP and DE were associated with its
related quality of information and interaction score (SIQHP: QOIIHP and SIQDE:
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QOIIDE) (p ≤.001). Point serial and chi-square correlations were used for the following
analyses. Race and language concordance were negatively correlated with QOIIHP,
QOIIDE, and only the former with self-efficacy. Transformational leadership style was
associated with glucose monitoring daily, race and language concordance and SIQHP and
SIQDE.

Hypothesis 4: Self-efficacy as a mediator of HPI and health behavior
outcomes
As previously described (Appendix E), models including HPI measures for the
HP, with SIQHP and QOIIHP as independent predictors and the DE, with QOIIDE as an
independent predictor were predictive of one healthy eating outcome, breakfast
frequency/weekly (HE1). HPI measures for the HP further explained 10% of the total
variance, F (1,77) =4.153, p = .02 with QOIIHP as the only independent predictor (ß=.31,
p=.01) for self-efficacy. Similarly, HPI measures for the DE explained 8% of the total
variance, F (1,77) = 3.162, p = .05 with QOIIDE as the only independent predictor
(ß=.33, p=.02) for self-efficacy. Self-efficacy was found to be a significant positive
independent predictor for eating protein for breakfast (HE2) (ß = .22, p ≤ .05) and a
significant negative predictor for increased abnormal glucose results (GM3) (ß = -.22, p ≤
.05) but was not a mediator for HPI measures on HE1, nor predictive of any other
outcomes.
Research Questions: Comparison of non-GDM and GDM health behavior
change
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Tables 3 and 4 presents the descriptive frequencies and results of paired t-tests for
outcome changes for the control (non-GDM) and the study (GDM) group. Over time
(Phase 1 to 2) significant increases in HE1 was found for both groups, control (p =.003)
and study (p =.03). While approximately 56-58% in each group made no changes, 2329% increased and 12.8-15.4% decreased their breakfast frequency in both groups.
Significant increases in HE2 occurred in the control group (p <.001) with 23.1 % more
and 3.4% less eating protein for breakfast and in the study group 15.4 % more 9 % less
eating protein and 74-76% in both groups not changing their behavior either way. In the
study group, significant increases were evident for HE3, 51.3% increased vegetable
portions and PA1, 50% increased stretching/strengthening exercise duration (p<.001)
Table 5 presents the one-way repeated ANOVA results for within and between
group differences over time in healthy eating and physical activity. Over time, there were
significant improvements in HE1, HE2, HE3 (p≤ .001) and PA1 (p=.02) for the total
group. Between group significant differences over time were HE2 (p =.06) with more
improvements in the control and in HE3 (p <.003) and PA1 (p <.01) more improvements
in the study groups. Significant between group differences were found in vegetable
portions/daily HE3 (p≤ .01) improvement in the study group and aerobic exercise
duration (PA2) (p≤ .1) improvement in the control group.
Table 6 present the ANCOVA results for within and between group differences
over time in healthy eating and physical activity while controlling for race (white),
language (English-speaking), and personal/family history of GDM/DM (GDMPFH)
(positive history). Kolmogorov-Smirov testing for ANCOVA covariates were significant
(p ≤ .001).
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The increase in breakfast frequency (HE1) over time was accounted for by white
race (p=.04) and for vegetables portions/daily (HE3) by positive GDMPFH (p=.06). The
difference over time between groups for eating protein for breakfast (HE2), vegetables
portions/daily (HE3) and for stretching and strengthening exercise (PA1) were all
accounted for by white race, English language and positive GDMPFH. For HE2: race
(p=.06), language (p=.06) and GDMPFH (p=.04); for HE3, race (p=.003), language
(p=.004) and GDMPFH (p=.01); and for PA1: race and language (p= .01) and GDMPFH
(p=.02).
The difference between the groups in HE1 were explained by white race (p=.003),
English language (=.07) and positive GDMPFH (p=.02). The difference between the
groups in HE2 were explained by white race (p=.06). The difference between the groups
in HE3 were explained by white race and English language (p≤ .001). All the significant
effect sizes reported from the ANCOVA analyses were small ranging from 2-9%.
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Chapter 5: Discussion

Discussion, Implications, and Conclusions
The manuscript titled “Healthcare Provider Influence on Health Behavior
Modification in Gestational Diabetics” (Appendix E) includes a discussion of the study
results as well as limitations, implications for practice and a conclusion.
This chapter includes additional discussion regarding the findings related to the
comparison of a control: non-GDM and a study: GDM group, as well as additional
discussion of threats to validity, limitations and strengths, and implications for vulnerable
populations and nursing education, research, and policy.
Discussion of Findings
In consideration of the hypotheses and findings reported here and, in the
manuscript, (Appendix E), HPI measures (patients’ perception of their healthcare
providers’ influence, quality of information and interaction in teaching encounters),
leadership style, and patient-healthcare provider concordance factors influence GDM
patients’ engagement in health behavior modifications of healthy eating, physical activity
and glucose monitoring outcomes. Self-efficacy was not a mediator but an independent
predictor of one healthy eating and one glucose monitoring outcomes, findings consistent
with previous studies (Lorig & González, 2000; Lorig, Ritter, & Jacquez, 2005; Lorig,
Ritter, Villa, & Armas, 2009). Although social influence was not predictive of selfefficacy, quality of information and interaction from HPs and DEs was. Self-efficacy
appears to play a role in influencing and has a place in the HPI conceptual model.
Significant improvements in three healthy eating (HE1, HE2, HE3) and one
physical activity (PA1) outcomes occurred in the group over time providing evidence that
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that pregnant women make positive changes whether or not they have GDM and receive
counseling. While both groups increased breakfast frequency (HE1), an important dietary
modification for GDM, the control group as well increased consumption of protein for
breakfast (HE2) more than the study group and the study group increased vegetable
portions/daily and stretching and strengthening exercise minutes/weekly (PA1) resulting
in between group differences over time.
Emphasis should be placed on counseling GDM patients of the benefits of eating
fewer carbohydrates at the first meal in the morning due to increased insulin resistance
and instead adding or increasing protein which increases insulin sensitivity.(Gutierrez &
Reader, 2005, Mekary, Giobannucci, Willett, van Dam, & Hu, 2012) It is important to
consider whether the control group, although at high risk for GDM was able to maintain
stable glucose results, in part related to this change. The study group did however
increase their vegetable portions/daily significantly whereas the control group did not.
While in pregnancy, vegetables would benefit both groups with increased vitamin and
mineral content to counter the loss to fetal development needs and the benefits of
increased fiber to counter gastrointestinal slowing in pregnancy, they are also the optimal
choice for acquiring this carbohydrate sourced nutrient without increasing the risk for
higher glucose results from other less optimal and higher glycemic index carbohydratefiber sources, such as grains (Mekary, et al, 2012).
The benefits of stretching/strengthening exercises, found to be increased in the
study group, should be consistently a focus of GDM counseling. Strengthening exercises
potentially increase muscle mass which increased insulin sensitivity and decreases need
by increasing the absorption of glucose for energy (ADA, 2017), thus supporting more

121

stable glucose levels and, in the study group, 77% of participants reported achieving
recommended normal levels of ≤ 2 abnormal results/weekly. The are other pregnancyrelated benefits of stretching and strengthening, such as treating advancing gestational
age aches and discomforts that both groups would have benefitted from. Although
aerobic exercise change was not found to be significant, 44-48% of participants in both
groups did increase their duration weekly, a commendable change in pregnancy when
considering the increasing physical discomforts and fatigue that can occur as the
gestational age increases which may have thus led to 29-33% decreasing aerobic exercise
duration in both groups. There is some evidence that GDM counseling may be was
effective in influencing the study group engagement in more healthy eating and physical
activity behavior conducive to achieving glycemic control.
In considering variables accounting for differences in outcomes, all three
covariates: white race, English language, and positive GDMPFH played small significant
effects on change over time and between the control and the study groups. Englishspeaking, white women, and those with a previous experience or exposure to GDM or
DM and the study group improved breakfast frequency, vegetable portion intake and
increased stretching and strengthening exercises, more than those in the control group.
Although the effects were small, a focus on understanding how women of different races,
languages and health history modify their behaviors more or less than others and may
respond to professional influence differently is an area worthy of further exploration. In
the context of influencing health behavior modification, patient and HP characteristics
should remain an area of focus and may help to redirect counseling content, delivery, and
interaction with HPs and how these contribute to HPI.
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The increase in breakfast frequency (HE1) over time was accounted for by race
(p=.04) and for vegetables portions/daily (HE3) by GDMPFH (p=.06). The difference
over time between groups for eating protein for breakfast (HE2), vegetable portions/daily
(HE3) and for stretching and strengthening exercise (PA1) were all accounted for by race,
language and GDMPFH. For HE2: race (p=.06), language (p=.06) and GDMPFH
(p=.04); for HE3, race (p=.003), language (p=.004) and GDMPFH (p=.01); and for PA1:
race and language (p= .01) and GDMPFH (p=.02).
Threats to Internal and External Validity
Threats to validity of results were considered. There were time variations
between Phase 1 and Phase 2 depending on whether involvement in the control or study
group began at early versus routine screening time. This time variation may have affected
the ability and amount of behavior change that could occur an thus affect the between
group difference results.
During the data collection process, feedback was received from one Asian
participant that providing perceptions related to someone in a position of power, such as
HPs, (referring to completion of the MLQ) especially if it contained any negative content,
or was not culturally appropriate; however she understood the confidential nature of the
responses and did not feel this would change her answers but felt it was important to
bring light to this issue for the researchers in case other participants were impeded in
responding accurately. As this study is based on patient perceptions of their HPs
influence, interaction, and leadership style, objective measures would arguably diminish
the intention, purpose and value of including the patient view.
Limitations and Strengths

123

Limitations regarding instruments were considered. Although the QOII and the
DSES address glucose monitoring, the SIQ did not specifically inquire as to HP influence
and beliefs of patient ability and barriers for engagement in glucose monitoring for GDM
control and prevention of DM.
Strengths incorporated into the research design include counseling regarding
and use of anonymous reporting, use of trained research assistants (RAs) to collect data,
and the longitudinal nature of the design using the change score for five of the health
behaviors as the outcome measure decreased concern for inflating responses. Outcome
measure surveys are easy to complete with very few questions, which decrease
participant burden. Additional strengths included the certified medical translators
completed two-way forward-backward translation for Spanish language forms. Not only
did this increase the accuracy but also allowed for the recruitment and inclusion of a
more diverse sample which represents a vulnerable population at higher risk for GDM
and DM. All revised and translated forms were able to be pilot testing for content validity
prior to their use in this study.
Unanticipated benefits included the opportunity for multiple participants to
express their positive and negative feedback, although unsolicited, by verbalizing to
researcher or RAs or written expressions of gratitude or frustrations regarding counseling
experiences or content, pertinence to their individual needs and healthcare system
concerns in regard to approaching management for GDM. One participant requested to be
contacted and participate in public presentations where the research results might be
presented as well as reported her personal motivation to become a DE because of what
she described as missing from her counseling experience.
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Implications for Vulnerable Populations
Ethnic minority populations have the greatest prevalence and are at greatest risk
for GDM/DM and, if current trends continue, the latter is projected to affect 50% of
minority versus 33% of all U.S. children born after 2000 (DeSisto, Kim, & Sharma,
2014; Fujimoto, Samoa, & Wotring, 2013; Guariguata, Linnenkamp, Beagley, Whiting,
& Cho, 2014; Narayan, Boyle, Thompson, Sorensen, & Williamson, 2003). Barriers that
pose increased risks to developing GDM/DM and the inability to modify diet/eating and
increase physical activity health behaviors recommended for the prevention and treatment
of GDM/DM are the lack of awareness prevention knowledge and awareness as well as
decreased access to quality healthy and sufficient foods and safe communities (Gucciardi,
Vahabi, Norris, Del Monte, & Farnum, 2014; Hasan-Ghomi, Ejtahed, Mirmiran,
Hosseini-Esfahani, Sarbazi, Azizi, et al., 2015; Laraia, Siega-Riz, Gundersen, 2010;
López, & Seligman, 2012). Recognizing the increased prevalence and seriousness of DM,
the diagnosis, prevention and formal DM education became a major focus of the Healthy
People 2020 objectives on (DHHS, 2013). Extending this objective to include formal
education with GDM management during pregnancy could address the more remote goal
for prevention, delay of onset or earlier treatment of DM in females. Multiple approaches
are necessary that are tailored to the specific target population group and its environment.
Healthcare providers should assess the knowledge, awareness, and vulnerabilities of their
individual patients in relation to GDM/DM treatment knowledge and their community
and environmental resources to determine actions that can help to improve knowledge
and eliminate health disparities within these and other vulnerable populations (Gonzalez,
2012). Screening for food insecurity, finding means to access quality foods, increasing
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awareness of cultural differences in staple foods, attitudes to physical activity, and access
to safe areas, while eliciting family support when often there are few or few willing to
help can be difficult (Laraia, Siega-Riz, Gundersen, 2010; López, & Seligman, 2012).
A specific focus on GDM/DM involves not only providing correct, consistent,
culturally and linguistically appropriate counseling but also trialing different strategies to
interact, communicate, and even solicit information that can lead to more confidence and
subsequently more influencing potential. In collaboration with patients and families,
finding out what is available, appetizing, adequate, and quality resources that would
additionally meet optimal health eating recommendations is important. HPs who take
responsibility to be as educated and informed regarding their resources on every level of
their patients can increase their potential to best influence health behavior modification
and improve outcomes.
Education Implications
While the counseling and education of patients specific to the treatment and
prevention of health problems and diseases is imperative, the initial education and
training of HPs on how to counsel, interview, motivate, and interact with patients is
equally important. In addition to encouraging self-reflective clinical practice and
stimulating individual or group change to approaching patient health behavior
modification, these research findings can be used to contribute to strategies and models of
learning in education programs for all, including new and experienced, clinical,
academic, and research focused HPs. Professional influence from HPs can positively
impact all areas of practice which can stimulate a trickle-down effect of improved health
outcomes at the least and the potential of many more benefits. Understanding how
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perceptions of influence, information, interaction, leadership styles, and concordance
factors affect the overall influencing capacity and potential of a HP can be not only
individually transformative but also organizationally and nationally. Using different
leadership skills can potentially affect both short and long-term outcomes. While
transactional skills may focus on behavior modification for obvious proximal benefits,
transformational skills involve exploring individual’s values, goals, experiences, and
vision, and uses these to impact longer term behavior change.
Policy Implications
To address the rapidly increasing rise in GDM and the number of potential
deleterious effects to the mother and fetus, a bill was passed in 2012 mandating screening
for GDM in order to lead to earlier diagnosis and treatment with the objective to reverse
or prevent these complications. While screening is critical to identify those at risk, the
follow-up diagnostic testing and management of GDM is even more vital. First line
treatment considerations for GDM include optimal eating/drinking, physical activity and
glucose monitoring. Health behavior modification minimally requires access to
appropriate counseling and support from trained, culturally sensitive, and language
concordant HPs and DEs via medical interpreters, if indicated, as well as, access to
appropriate foods and safe places for physical activity. Treating GDM appropriately is
one early and direct pathway to DM prevention, delay and treatment (Ruchat & Mottola,
2013). These considerations as well as the national objective calling for formal DM
counseling (DHHS, 2013) are beginning steps to awareness for future policy changes.
Legislative initiatives and policy modifications are essential and must
continuously evolve to address changing health care access, coverage and access to
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appropriate foods, resolve food resource and scarcity concerns, ensure safe places for
physical activity, and access to glucose monitoring supplies for those with GDM/DM
(Gonzalez, 2012). A current focus could include government assistant programs, such as
the Supplemental Nutrition Program for Women Infants and Children Program (WIC)
which currently addresses food scarcity concerns and already focuses on anemia as one
area of eating related malnutrition. Expanding the scope of nutrition awareness and
resources for GDM treatment is a potential objective for this program. Providing diligent
and accurate education and awareness regarding dietary and healthy eating GDM
recommendations from this program is a first step. Additionally, reviewing foods that are
approved, recommended and available for those with GDM, such as increased promotion
of proteins and vegetables/vegetable juices and fewer but higher fiber carbohydrates,
decreased fruit juices and other high carbohydrate nutrient poor processed foods/drinks
could be effective. This is only one of many potential areas to focus efforts for change.
Research Implications and Future Directions
Addressing a gap in the research literature by conducting this pilot study has
provided an initial understanding of the process of HPI and an additional layer of
comprehension regarding patient-centered healthcare communication and counseling. In
addition, it has stimulated the emergence of many new questions and served to guide
education efforts for HPs in addressing GDM in order to prevent DM. Replicating testing
of the current and additional testing of new components of the HPI conceptual model is
highly recommended in order to lend a more comprehensive understanding and trajectory
into utilizing this patient-centered model to improve influencing HBM, potentially
benefitting other major acute or chronic illnesses such as hypertension, obesity, and
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cardiovascular diseases. A specific direction using this model in the context of
prevention/treatment of DM is measuring continued health behavior modification with a
more distal focus in the postpartum period, such as at the 6-week routine and annually
when glucose tolerance screening is recommended. A greater understanding how HP use
of leadership styles is associated with short and long-term health behavior modification
outcomes could lead to new approaches for health promotion and disease prevention. An
awareness of how transformational leadership skills consider, inspire, motivate and
transform individual patient’s decision-making/goal setting and behavior modification
should be sought after. This process of social/professional influence should be compared
to the use of specific protocol reinforced recommendations for health outcome
achievement in terms of satisfaction, quality of life and other variables.
Additional considerations for future research include the following: 1) adding
research variables from the HPI conceptual model such as time, number and duration of
visits by HP/DE, previously established personal or family relationship and interaction
with HP prior to this pregnancy, and additional concordance factors, such as personal
similarity and HP communication/patient learning styles; 2) further inquiry into how
quality of information and interaction but not social influence was associated with selfefficacy, while both predicted different outcomes, 3) other factors of HPI that could
increase self-efficacy and further exploration of its role as a mediator and moderator in
outcome behavior modification; 4) deepening the inquiry into the leadership style of DEs
may provide additional information and guidance for their improved influencing.; and 5)
inclusion of other sources of social facilitation-support and influence to augment the
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professional influence via family, community, peer, media or technological sources is
another area of future research.
Finally, more comprehensive outcome measures for healthy eating, physical
activity, and glucose monitoring behaviors and modifications to the SIQ would increase
the strength of this design. Minor changes include modifying the HE2, protein for
breakfast measure to include the number of protein portions at breakfast daily or weekly
or overall daily portions. Another direction would be the development and use of an
application that would assemble, analyze and report out what is entered into them
including timing of meals, amount, type and nutrient-content of foods, such as protein,
carbohydrates, fats, total calories in and used, BMI, physical activity tracker for time
spent in exercise, and glucose results would provide invaluable information, but of course
is sensitive to accurate input. The modification of the SIQ measure would include glucose
monitoring items with a focus on inclusion of transformative leadership language
throughout the instrument.
Summary
This chapter provides additional discussion regarding results for research findings
not previously discussed in the manuscript, “Healthcare Provider Influence on Health
Behavior Modification in Gestational Diabetics (Appendix E). It adds policy and
educational implications and additional future research recommendations for
consideration.
Conclusion
This pilot study’s exploratory findings provide initial glimpses into the
association between professional influence variables on health behavior modification.

130

Patients’ perception of their healthcare providers’ influence, the quality of information
and interaction in teaching encounters, their leadership style, their specialty, and patienthealthcare provider concordance factors provide initial insight and awareness of what and
how influence works for improving GDM patients’ engagement in health behavior
modifications. Healthcare provider self-reflection on practice, communication, interaction
and leadership style could motivate the desire for professional transformation and play a
role in influencing increased patient engagement in health behaviors. Every healthcare
provider and every patient have the potential to become or do more. While some factors
such as race, language, personal or family history, and concordance factors may increase
or decrease this influencing potential, an awareness of these relationships can guide
personal or organizations strategies for growth and improvement. There are numerous
future directions for professional influence research.

Results Tables and Figures

Table 1: Total Sample Demographics and Descriptors
Range Mean (SD)
Variable
Control P1
Control P2
Study P1
(n=126)
(n=117)
(n=84)
Gender
Female 100% Female 100% Female 100%
Age****
Race/Ethnicity
White
Black
Asian
Latina
Other
Primary
Language****
English

18-39;
29.35(5.1)

18-39;
29.41(5.13)

18-41;
31.98(5.44)

Study P2
(n=78)
Female
100%
18-41;
32.06(5.14)

50.8%
12.7%
3.2%
31.7%
1.6%

48.7%
12.8%
3.4%
34.2%
0.9%

42.9%
15.5%
13.1%
27.4%
1.2%

44.9%
14.4%
11.5%
28.2%
1.3%

69.8%

67.5%

60.7%

61.5%
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Spanish
Other
Years in US
Education
Insurance
Medicaid
Private
Nulliparity
Yes
Intended pregnancy
Yes
Desired HP
Yes
GDM screening****
Early
Routine
GDMPFH**
GDMPH***
FH DM 1st degree
FHDM
1st degree
Grandparent
Other

28.6%
1.6%
0.1-39;
23.59(11.04)
3-25;
13.96(4.31)

30.8%
1.7%
0.1-39;
23.21(11.29)
3-25;
13.79(4.3)

23.8%
15.5%
0.3-41;
21.95(11.86)
3-23;
14.66(4.46)

24.4%
14.1%
0.3-41;
22.3(12.05)
3-23;
14.75(4.48)

54%
46%

55.6%
44.4%

46.4%
53.6%

43.6%
56.4%

27%

27.4%

33.3%

33.3%

63.5%

64.1%

71.4%

71.8%

97.6%

97.4%

97.6%

98.7%

75.4%
24.6%
63.5%
12.7%
36.5%
57.9%
62.2%
31.1%
6.8%

73.5%
26.5%
63.2%
12%
36.8%
58.1%
62.3%
30.4%
7.2%

51.2%
48.8%
77.4%
28.6%
47.6%
70.2%
67.8%
28.8%
3.4%

48.7%
51.3%
75.6%
25.6%
47.4%
70.5%
67.3%
29.1%
3.6%

(Notes: Chi-square difference in P1 control and study groups: [*p ≤.1, **p ≤.05, ***p≤.01, ****p≤.001; DM: Diabetes Mellitus;
GDM: Gestational Diabetes Mellitus; GDMPFH: personal/family history of GDM/DM.; HP: Healthcare Provider
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Table 2 Correlation Matrix
Variable
∆HE1
(1)
∆HE2
(2)
∆HE3
(3)
∆PA1
(4)
∆PA2
(5)
GM1
(6)
GM2
(7)
GM3
(8)
SIQHP
(9)
SIQDE
(10)
QOIIHP
(11)
QOIIDE
(12)
DSES
(13)
RC
(14)
LC
(15)
GC
(16)
GDMPFH
(17)
HP Spec
(18)
MLQ
(19)

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

(9)

(10)

(11)

(12)

(13)

(14)

(15)

(16)

(17)

(18)

(19)

.38****

.15

.02

.14

-.06

-.03

.05

.05

.06

.2*

.27**

.17

-.24**

.005

.07

.04

-.25

-.23**

-.01

.07

-.001

-.08

-.04

.1

-.06

-.06

.1

.08

.22**

-.11

.04

.09

.2*

.06

.02

.04

.09

-.08

-.05

-.02

.07

.06

.12

.05

-.05

.09

.02

.09

.21*

.06

-.04

.21*

-.01

.28**

-.04

-.1

-.17

-.13

-.15

.07

-.07

.06

.14

.11

-.09

-.003

-.04

.18

-.17

.04

.01

-.002

.01

.17

-.11

-.14

.13

-.08

-.13

-.16

.63****

.25**

-.14

.09

-.09

-.01

-.13

.14

.11

-.15

-.05

.07

.19*

.05

-.17

.07

-.04

-.06

.07

.01

.05

-.06

-.02

-.02

.05

-.08

.01

-.03

-.03

-.22**

-.17

-.06

-.25**

.11

-.09

-.12

.59****

.38****

.27**

.06

.02

-.05

.11

.09

-.01

.26**

.45****

.55****

.06

.06

-.06

.04

-.07

.2*

.79****

.31***

-.19*

-.27**

-.02
.
.15

.06

.14

.01

.26**

-.2*

-.3***

.11

-.08

-.02

.1

-.32***

-.02

.14

.05

.11

-.02

.46****

.1

-.13

.14

.21*

.02

.07

.1

.27**

-.18

.53****

.03

-.04

.06
.06

(Notes: Significant findings bolded [*p ≤.1, **p ≤.05, ***p≤.01, ****p≤.001,), ∆HE1: Healthy Eating 1 Change Score, ∆HE2: Healthy Eating 2 Change Score, ∆HE3: Healthy Eating 3 Change Score,
∆PA1: Physical Activity 1 Change Score; ∆PA2: Physical Activity 2 Change Score. RC: race concordance. LC: language concordance, GC: gender concordance, GDMPFH: personal/family history of GDM/DM. HP SPec:
Healthcare provider specialty, MLQ: Leadership style, DSES: Self-efficacy
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Table 3: Outcome Changes Over Time
(Phase 1 to Phase 2)

HE1
No change
Increase
Decrease
HE2
No change
Increase
Decrease
HE3
No change
Increase
Decrease
PA1
No change
Increase
Decrease
PA2
No change
Increase
Decrease
GM1
(7 days/week)
GM2
4 times/day)
GM3
(≤ 2 abnormal
results week)

Control (N=117)
N (%)

Study (N=78)
N (%)

65 (55.6)
34 (29.1)
18 (15.4)

45 (57.7)
23 (23.1)
10 (12.8)

86 (73.5)
27 (23.1)
4 (3.4)

59 (75.6)
12 (15.4)
7 (9)

44 (37.6)
41 (35)
32 (27.4)

22 (28.2)
40 (51.3)
16 (20.5)

53 (45.3)
34 (29.1)
30 (25.6)

31 (39.7)
39 (50)
6 (8)

26 (22.2)
56 (47.9)
34 (29.1)

18 (23.2)
34 (43.6)
26 (33.3)
61 (78.2)
41 (52.6)
60 (76.9)

Notes: HE1: Healthy Eating 1, HE2: Healthy Eating, HE3: Healthy Eating 3, PA1: Physical Activity 1,
PA2: Physical Activity 2; GM1: Glucose monitoring 1, GM2: Glucose monitoring 2, GM3: Glucose Monitoring 3
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Table 4: Paired t-tests
DV
Control P1P2(n=117)
Study P1P2(n=78)
P2-P1 Diff ∆

HE1
Control
P1
P2
Diff (P2-P1)
Study
P1
P2
Diff (P2-P1)
HE2
Control
P1
P2
Diff (P2-P1)
Study
P1
P2
Diff (P2-P1
HE3
Control
P1
P2
Diff (P2-P1)
Study
P1
P2
Diff (P2-P1)
PA1
Control
P1
P2
Diff (P2-P1)
Study
P1
P2
Diff (P2-P1)
PA2
Control
P1
P2
Diff (P2-P1)
Study
P1
P2
Diff (P2-P1)

Range

-5-+7

-7-+6

-1-+1

-1-+1

-3-+3

-3.5-+4.5

-180-+165

M(SD)
M(SD) W/I Grp
Diff P2-P2

Std Error Mean
(Diff)

Within group
Mean diff
Sig(p)
t (df)
Control (116)
Study (77)

5.39(2.22)
5.91(1.95)
.52(1.87)

.21
.18
.17

3.01 (.003)

5.43(2.23)
5.94(1.78)
.51(2.03)

.25
.2
.23

2.23 (.03)

.72 (.45)
.91(.28)
.2(.48)

.04
.03
.04

4.45 (.000)

.82(.39)
.88(.32)
.06(.49)

.04
.04
.06

1.15 (.25)

2.08(1.16)
2.13(1.14)
.05(.89)

.11
.11
.08

.63 (.53)

2.3(1.51)
2.78(1.34)
.48(1.12)

.17
.15
.13

3.79 (.000)

31.92(52.13)
31.41(47.68)
-.51(55.22)

4.9
4.41
5.11

-.1 (.92)

25.58(44.98)
44.62(53.24)
19.04(47.91)

5.09
6.03
5.43

3.51 (.001)

98.46(95.26)
106.54(89.42)
8.08(103.52)

8.81
8.28
9.57

.84 (.4)

124.42(134.95)
125(119.01)
.58(119.45)

15.28
13.48
13.53

.04 (.97)

-165-+180

-450-+255

-420-+360

Notes: HE1: Healthy Eating 1, HE2: Healthy Eating 2, HE3: Healthy Eating 3, PA1: Physical Activity 1, PA2: Physical Activity
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Table 5: One-way repeated measures ANOVA within and between groups
Within Group (1,191) ANOVA
Between group
F, p, partial ɳ2 within/
*group F between group diff
F = .016, p =.9, ɳ2 =.00
F=13.317, p ≤.001, ɳ2 = .07
HE1
2
*Grp F = .000, p =.99, ɳ =.00
F = .802, p =.37, ɳ2 = .004
F=13.592, p ≤.001, ɳ2 =.07
HE2
2
*Grp F= 3.51, p =.06, ɳ =.02
F = 13.61, p ≤.001, ɳ2 =.07
F = 6.443, p = .01, ɳ2 = .03
HE3
2
*Grp F=8.837 p =.003, ɳ =.04
F = .309, p=.58, ɳ2 =.002
F=.5845, p =.02, ɳ2 = .03
PA1
2
* Grp F= 6.51, p ≤.01, ɳ = .03
F=.289, p =.59 partial ɳ2 =.001
F=2.699, p = .1, ɳ2=.01
PA2
2
*Grp F=.217, p = .64, ɳ =.001
Notes: HE1: Healthy Eating 1, HE2: Healthy Eating 2, HE3: Healthy Eating, PA1: Physical Activity 1; PA2: Physical Activity 2.
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Table 6: One-way repeated measures ANCOVA
Within Group
Covariate/Group Interaction effect
(1,192); BMI
F, p, partial ɳ2

HE1

HE2

HE3

PA1

PA2

*Race F=4.494, p=.04, ɳ2 = .02
*Grp F= .001, p=.98, ɳ2 =.00
*Lang F=.808, p= .37, ɳ2 =.004
*Grp F = .000, p=.99, ɳ2 = .00
* GDM F = 1.869, p=.17, ɳ2 =.01
*Grp F = .037, p=.85, ɳ2 =. 00
*Race F=2.276, p=.133, ɳ2 = .01
*Grp F=3.56, p=. 06, ɳ2 =.02
*Lang F=.015, p= .9, ɳ2 = .00
*Grp F = 3.485, p=.06, ɳ2 = .02
* GDM F =2.258, p=.14, ɳ2 =.01
*Grp F =4.242, p=.04, ɳ2 =.02
*Race F=.729, p=.39, ɳ2 =. 004
*Grp F=8.801, p=. 003, ɳ2 = .04
*Lang F= .022, p=.88, ɳ2 =.000
*Grp F = 8.729, p=.004, ɳ2 = .04
*GDM F = 3.698, p=.06, ɳ2 =.02
*Grp F = 7.383., p<.01, ɳ2 =.04
*Race F=1.806 p=.18, ɳ2 = .01
*Grp F=6.569, p=.01, ɳ2 =.03
*Lang F= .585, p=.45, ɳ2 = .03
*Grp F = 6.935, p=.01, ɳ2 = .04
* GDM F = 1.01, p=.32, ɳ2 =.01
*Grp F = 5.754., p=.02, ɳ2 =.03
*Race F=.784, p=.38, ɳ2 =.004
*Grp F=.221, p .64, ɳ2 = .001
*Lang F= .616, p= .43, ɳ2 =.003
*Grp F = .331, p=.57, ɳ2 = .002
*GDM F=2.965, p=.09, ɳ2 =.02
*Grp F = .057, p=.81, ɳ2 =.00

Between Group
Covariate interactions (1, 191)
F, p, partial ɳ2
Race F = 9.105, p = .003, ɳ2 = .05
Lang F = 3.316, p=.07, ɳ2 = .02
GDM F =5.212, p=.02, ɳ2 = .03

Race F= 3.602, p =.06, ɳ2 = .02
Lang F = 1.752, p =.19, ɳ2 = .01
GDM F = .198, p=.66, ɳ2 = .001

Race F= 19.517, p≤.001, ɳ2 = .09
Lang F =14.87, p≤.001, ɳ2 = .07
GDM F =.672, p=.41, ɳ2 = .003

Race F= .185, p= .67, ɳ2 = .001
Lang F =.415, p=.52, ɳ2 = .002
GDM F = .661, p=.42, ɳ2 = .003

Race F=1.585, p=.21, ɳ2 = .01
Lang F =1.201, p=.27, ɳ2 = .01
GDM F =.002, p=.97, ɳ2 = .00

HE1: Healthy Eating 1, HE2: Healthy Eating 2, HE3: Healthy Eating, PA1: Physical ctivity 1;
PA2: Physical Activity 2, p<0.1

Notes:
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APPENDICES
Appendix A
Table of Abbreviation

Table 1: Abbreviations
BMI: Body Mass Index
DSES: Diabetes Self-Efficacy Scale
EBQ+1: Eating Breakfast Questionnaire +1
GC: Gender Concordance
GDMPFH: Personal/Family History of Gestational Diabetes Mellitus/ Diabetes
Mellitus
GM1: Glucose Monitoring Question 1: Glucose Monitoring days/week
GM2: Glucose Monitoring Question 2: Glucose Monitoring 4 times/day
GM3: Glucose Monitoring Question 3: Abnormal blood glucose results/weekly
GMQ: Glucose Monitoring Questionnaire
∆HE1: Healthy Eating 1 Change Score: Frequency of Eating Breakfast/Weekly
∆HE2: Healthy Eating 2 Change Score: Eating Protein for Breakfast
∆HE3: Healthy Eating 3 Change Score: Vegetable Portions/Daily
HP specialty: Healthcare Provider Specialty
LC: Language Concordance
MLQ: Multifactor Leadership Questionnaire- Healthcare Provider Leadership Type
P1: Phase 1
P2: Phase 2
PAS: Physical Activity Scale
∆PA1: Physical Activity Change Score 1: Stretch/Strengthen Exercise Minutes/Weekly
∆PA2: Physical Activity Change Score 2: Aerobic Exercise Minutes/Weekly
QOII: Quality of Information and Interaction GDM
QOIIDE: Quality of Information and Interaction GDM-Diabetes Nurse- Educator Total
Score
QOIIHP: Quality of Information and Interaction GDM-Healthcare Provider Total
Score
RC: Race Concordance
SIQ: Social Influence Questionnaire-GDM
SIQDE: Social Influence Questionnaire-GDM-Diabetic Nurse-Educator
SIQHP: Social Influence Questionnaire-GDM-Healthcare Provider
TAL: Transactional Leadership
TFL: Transformational Leadership
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Integrative Review and Development of a Model of Healthcare Provider Influence
Denise K. FRYZELKA, MS, CNM
Marianne E. WEISS, DNSc, RN

Abstract
Background: Effective communication impacts several patient and healthcare measures,
including patient satisfaction, health status, and treatment adherence. Influence,
frequently associated with communication, is used ubiquitously and primarily to describe
an action or effect between persons, however the concept of healthcare provider influence
has not been explicitly described in nursing or health sciences literature
Aim: To understand the process of healthcare provider influence on patient health
behavior modification.
Design: Integrative review of the healthcare literature
Data Sources: PubMed and CINAHL 1992-2013
Review Methods: The research questions and recommendations by Whittemore and
Knafl (2005) guided the methods used for retrieval and analysis of relevant publications
and synthesis of the literature.
Results: Synthesis of the relevant publications (n=8) resulted in the development of a
model and definition of healthcare provider influence. Healthcare provider influence is
defined as a process wherein a purposeful interpersonal interactive, collaborative, and
transformative relationship develops between a patient and healthcare provider working
together toward a specific focus of health behavior modification. Components include
social, communicative, emotive, cognitive, concordant, and logistic factors. Conditions
include a healthcare need, mental capacity for decision-making, and potential for
interaction. Outcomes include health behavior modifications and cognitive and emotive
enhancement. Relevance to populations wherein values and beliefs vary significantly
from the interpersonal collaborative perspective that underpins this healthcare provider
influence model may not be possible.
Conclusion: A definition and model of Healthcare Provider Influence can be utilized to
understand and research the influence providers can exert on health behavior
modification.

Keywords: influence, healthcare, provider, professional, clinician, integrative literature
review.
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SUMMARY STATEMENT

Why is this review needed?
•

•
•

Extensive research has explored patient-centered communication by healthcare
providers and its relationship to patient outcomes, including patient satisfaction,
preventive health practices, adherence to treatment plans, and improved patient
health.
Patient-centered communication is foundational to healthcare provider influence,
but it is only part of the process.
Understanding the healthcare provider role in influencing patients can provide a
new perspective or approach for modifying health behaviors, improving health
outcomes, and decreasing costs associated with poor health behaviors.

What are the key findings?
•
•

•

An integrative review of the literature unearthed very few references to healthcare
provider influence and found it to be a form of social influence. There was no
description, definition, or model to explain the process.
HPI is the name given to a concept that is used to describe the process of how and
what HPs do that contribute to patients envisioning, desiring, and activating steps
to make modifications in their thinking, desires, motivation, goals for health
behavior modification.
Healthcare provider influence is a process wherein a purposeful interpersonal
interactive, collaborative, and transformative relationship develops between a
patient and a healthcare provider working together toward a specific focus of
health behavior modification.

How should the findings be used to influence policy/practice/research/education?
•
•

The definition and conceptual model of healthcare provider influence should
facilitate the complex process of influence that can affect transformative health
behavior changes in a patient through interaction and collaboration.
Healthcare policy, practice and research should incorporate the concept of
healthcare provider influence which places the onus of responsibility on the
healthcare provider to stimulate patient health behavior changes in a manner that
emphasizes patient self-advocacy.
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INTRODUCTION
Healthcare literature is replete with communication research that describes effective
patterns and characteristics of patient-provider relationships, barriers to and factors to improve
communication among individuals, groups and systems within the health care professions, and
how communication impacts health behaviors and outcomes. Multiple variables affect patients
and their modification of health behaviors and health outcomes. However, a noticeable gap in the
literature revealed lack of a comprehensive description regarding the intricate process or essential
components of the relationship between healthcare providers (HPs) and patients that are
necessary to influence patient adaptation and modification of health behaviors and ultimately
health outcomes. This comprehension of how patients prioritize and modify health behaviors in
interaction and collaboration with their HP, what HPs do or do not do, and how HPs do or do not
influence these changes is important for HP educational preparation and for planned
implementation of health promotion strategies. HP-patient communication is ubiquitous to all
areas of healthcare. The term “healthcare provider” (HP) will be hereafter used to include all
terms for or categories of trained health professionals that designate provision of care to a patient,
including but not limited to providers, professionals, healthcare professionals, healthcare
providers, advanced practice nurses or advanced nurse practitioners, nurses, clinicians,
physicians, doctors, and allied healthcare providers.
REVIEW
Aim
The aim of this integrative review was to gain a greater understanding of the
interpersonal process of influence and the role that HPs have on patients’ decisions and goals, and
in facilitating, initiating, and supporting implementation of health behavior modifications in order
to address chronic or acute healthcare concerns, problems, or diagnoses and improve health
outcomes. Understanding this influence from the perspective of the patients and how this
influence drives or assists in increasing knowledge and motivation for health behavior change is
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imperative.
Two specific questions provided the direction for this review: (1), “What is known in the
health care research literature about the influence of HPs on the patients’ adaptation and
modification of health behaviors related to treating or preventing acute and chronic illness and
diseases? and (2), “What are the most influential elements that HPs contribute to patient
understanding, motivation, adaptation and modification of health behaviors related to acute and
chronic health problems?”
Design
The integrative review of the healthcare literature was undertaken to understand the published
literature related to the concept of influence specific to HPs. The search methods, analyses, and
synthesis for this review were guided by the recommendations of Whittemore and Knafl (2005).
Search Methods
Searches were conducted utilizing PubMed and Cumulative Index of Nursing and Allied
Health Literature (CINAHL) electronic databases to provide a comprehensive perspective from
nursing, socio-psychology, medicine, and allied health care professions research. To include an
international perspective and current relevant research findings, criteria included national and
international research and scholarly publications, in English from 1992-2013. The search term
“influence” was linked with “healthcare”, “health care”, “provider”, “professional”, and
“clinician” in seven different search combinations to retrieve the largest number of references
possible for review.
Due to the scarcity of publications and to expound the complex concept of healthcare
provider influence, hereafter named HPI, it was necessary to further explore patient-centered
communication (PCC), one of its main tenets. Several principal research publications regarding
PCC, from the copious supply available, were retrieved as essential references for describing HPI.
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Search Outcome
The final number of publications referencing “influence” obtained and reviewed after
elimination of duplicates totaled 26. After a review of these publications for relevance, however,
the total number included in the analysis was reduced to eight. The search strategy, terms, and
total retrieved for each combination are presented (Table 1). Additional theory and PCC
references were also included in the final analysis.
Quality Appraisal
After relevance was determined, ancestral searching was conducted, and publication
reference lists were scrutinized for additional relevant references. References were retained if
they were retrieved from peer-reviewed publications or scholarly commentaries and included a
description or reference to HPI, theoretical or experimental, even if related to a specific disease or
population.
Data Abstraction
The publications were analyzed for type of research, population, research query or
theoretical basis, relation to HP or patient, health behaviors, outcomes, as well as descriptors,
definition, process or characteristics of influence. A matrix was used to organize the references
and findings (Table 1) to facilitate synthesis.
Synthesis
Requiring an iterative and reflective process, all references were reviewed for conditions,
components or descriptors, and outcomes that were then classified and named. Several
classifications serve as categories of components as well as conditions or outcomes of the process
of influence. For example, cognitive knowledge and awareness serve as both a category of
transformation as well as, when enhanced, also functions as an outcome, and physical, also
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functions as both a category of condition as well as an outcome (Figure 1). A synthesis of the data
ensued, and a conceptual model was developed to clarify and describe the characteristics and
components of HPI.
RESULTS
Throughout the literature, the term ‘influence’ has been utilized as an action or result
between factors or individuals or as a description of an individual or a system, including
references to the influence that HPs have on patients. It has not been well described or analyzed
as a concept, which embodies a process of impacting or affecting a change or modification. It has
however been used frequently as a verb in association with other terms such as when discussing
or describing outcomes or behaviors. Surrogate terms for influence include affect, effect, and
impact. Due to the lack of description and definition of HP influence, the process selected to
clarify HPI was the development of a conceptual model from the integrative synthesis of the
literature.
Influence cannot occur without communication, one of its main components. It could not
therefore be well isolated from the patient-provider and effective communication (EC) literature.
When EC is described, it is almost always in relation to the EC results, its effects, or influences.
Therefore, multiple references related to aspects and emerging trends in the healthcare
communication research literature are included as they provided vital foundational elements for
the development of the HPI model.
Development of the HPI Definition and Conceptual Model
After synthesizing the results from the integrated review of the healthcare literature, the
necessary components for describing HPI became apparent and within the context of health care,
a description, definition, and conceptual model of HPI were developed (see Figure 1). HPI is the
name given to a concept that is used to describe the process of how and what HPs do that
contribute to patients envisioning, desiring, and activating steps to make modifications in their
thinking, desires, motivation, goals for health behavior modification. HPI is defined as a process
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wherein a purposeful interpersonal interactive, collaborative, and transformative relationship
develops between a patient and a HP working together toward a specific focus of health behavior
modification. The conditions, components and outcomes of the concept are described.
Conditions
For HPI to occur, there are necessary conditions that must be in place. These are patientrelated and categorized as mental-physical and resources. Mental-physical includes an existent or
elevated risk for an impending health problem or need, the mental and physical capacity for
decision-making and health behavior modification, and finally, an awareness of how to access
and initiate a relationship. Access may include navigation of the infrastructure established by
healthcare policy, insurance, and organizations and there must be an opportunity for interaction.
Resources include time and means, such as finances, insurance, and transportation to access or
seek care whether in a physical or virtual space (Jucks et al., 2012). Some patients lack the
ability to interact or process and understand basic health information they need to make decisions
due to cognitive, mental or speech disorders (Travaline et al., 2005, Tarkan, 2008), creating
barriers to HPI. Events of illness, pain or stress, prolonged wait or access times, time constraints,
physical space or ambiance as well as lack of income or resources, such as, insurance,
transportation or technology may also impede or influence the HP-patient interaction and
adherence to recommendations (Sheppard et al., 2004, Travaline et al., 2005, Verlinde et al.,
2012).
Components
Fundamental to HPI is a relationship that is interpersonal between a patient and HP
within a healthcare context and purposeful due to the designated roles of each. The central and
essential dimension upon which the concept of HPI is based is social-communication. The HPI
model describes a process that evolves because of this relationship that includes three primary
components: interaction, collaboration, and transformation. Four additional categories are
described under the primary components they most strongly support, although there is
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unquestionably a relationship across components. The categories are logistics and concordance,
linked to interaction, and cognitive and emotive, linked to transformation.
Social-Communication
Pivotal to HPI and all its components and categories is social-communication, and more
specifically, PCC. Effective interpersonal communication (EC) is described as a dynamic and
ongoing process between patients and providers leading to understanding of each other’s
perspectives, cooperation, and coordination (Stewart, 1995, Epstein & Street, 2007). EC becomes
PCC when the patient is viewed and approached as a whole person with a unique personal history
and having individual needs from a bio-psycho-social or holistic perspective (Charlton et al.,
2008, Hartog, 2009, Verlinde et al., 2012). PCC skills and care are based in human respect,
central to culturally competent care, used in verbal, non-verbal and virtual communication, and
involve patient-value guided clinical decisions (DiMatteo, 1995, National Research Council,
2001, Verlinde et al., 2012). Examples of PCC skills include; (a) understanding patient’s
perspective of illness, causes, treatment options, and ability to adhere to recommended treatment;
(b) active and careful listening; (c) asking non-judgmental questions about concerns and
expectations for treatment; (d) empathetic understanding; (e) providing clear and thorough
information, explanations, and recommendations; (f) not avoiding discussion of sensitive topics:
and (g) engaging in negotiation by involving and working with patient to problem-solve and set
realistic and achievable health lifestyle goals for behavior change as well as coaching and
empowerment (Koster et al., 2005). Both EC and PCC have been described as important
components for clinical management of chronic diseases, patient compliance and adherence to
treatment recommendation, self-management, influence on patient health behavior modification,
alteration of patient perception of health-damaging effects and as well as reduction in preventable
adverse events (Jerant et al., 2005, Durant et al., 2009, Jensen et al., 2010). An analysis of seven
studies of nurse practitioners’ communication styles demonstrated that use of PCC influences
patient outcomes, such as increased understanding of problem, adherence to treatment, pain
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control, symptom resolution, overall health status and satisfaction as well as diagnostic
expediency and accuracy by the HPs (Charlton et al., 2008). Multiple research efforts have
demonstrated that the overall quality and consistency in communication as well as specific
characteristics of the HP-patient interaction utilizing PCC positively impacts these same
outcomes (Street, 2002, Duberstein et al., 2007, Jensen et al., 2010). When communication is not
effective or PC, the opposite outcomes have been demonstrated (DiMatteo, 1995, Koster et al.,
2005, Durant et al., 2009).
PCC training models teach HPs the process of EC with patients as well as behaviors to
avoid in order to improve the HP-patient interaction. One such model, AGENDA, stands for
Agenda and health Goal setting; Expressing concerns, questions, and negotiations; Navigating
health literacy issues; Disclosing detailed information; and Active types of listening (Arnold et
al., 2012). Patient communication training has improved interaction and increased patient health
knowledge, organization, and positive attitudes during visits (Talen et al., 2011).
Non-verbal communication behaviors, such as eye gaze, tone of voice, and proximity of
the patient and HP to each other affect outcomes, such as patient satisfaction (Mast, 2007). In
written HP-patient communication interactions, such as email, the importance of awareness,
anticipation, and continuous vigilance to elements of PCC by the HP were deemed to be
necessary to identify discrepancies in patient self-reports of knowledge and understanding of
medical conditions that indicated lack of full comprehension (Jucks et al., 2012).
When “influence” is used in the health communication literature, PCC is frequently
referenced. Not only the HP’s communication style but also the HP’s personal qualities have been
identified as sources of potential influence (Verlinde et al., 2012). HPI is considered a form of
social influence wherein a social process occurs between the HP, the social influencer and the
patient, the influenced. “Social influence is the attempt of one or more individuals to alter, modify
or change the attitudes, reactions or behaviors of another individual or group (Gabel, 2012). The
Integrated Theory of Health Behavior Change (ITHBC) classifies professional influence, a type

162
of social influence, under social facilitation, and describes a knowledgeable person in a position
of perceived authority who sways the thinking and motivation of another, leading to engagement
in behavior (Ryan, 2009). In a study based on ITBHC, social influence was associated with
postpartum weight self-regulation, but the influencers included family, friends, and/or providers
(Ryan et al., 2011).
Interactive
HPI is a process, which may occur within a single patient encounter but is more
successful if it is continuous, evolving, and builds on previous steps or events. It is an
interpersonal interactive process, thus involving and between at least two persons or individuals,
in this case, a patient and a HP, and denoting an intended productive action and a positive
outcome. It is not a unidirectional HP to patient instruction, characterized by passive receptivity
on the part of the patient that is more representative of an oppressive relationship between the
individuals wherein the HP is significantly more dominant and controlling or demanding. The
process does not have to be person to person within the same space but there must be an
interaction. This means that HPI can occur in virtual as well as physically shared space settings
(Jucks et al., 2012). While the work of the process may be predominantly social-communicative,
the external portrayal of that action may be presented as behavior or behavior modification
outcome.
Logistics
Time and physical and virtual environment have an impact on patient behaviors and
perspectives. Measures of influence in published research frequently focused on logistical aspects
of time, such as time spent in interaction or counseling, length of the HP-patient relationship, and
timing of interaction correlating to increased patient disclosure and seeking of health care
(Morrison, 1996, Scholle & Kelleher, 2003, Orford et al., 2006). Increased time spent or
continuity of care over time in the HP-patient relationship increased trust, access to and quality of
health care, more preventive services, higher patient satisfaction and improved patient’s
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perception of the quality of interactions between themselves and their HP (Sheppard et al., 2004,
Wallace et al., 2009, Verlinde et al., 2012). HPs who interacted and spent adequate time inside
and outside of the exam room were perceived by patients to be more competent (Shay et al.,
2012).
Concordance
Concordant factors refer to the similarity of characteristics that the HP and the patient
share such as race, culture, age, gender, socioeconomic status, language, literacy, religion, and
personality (Cooper-Patrick et al., 1999, Travaline et al., 2005). HP-patient concordance in
demographics, language, culture, values and beliefs, experiences, and patient characteristics are
important sources of potential influence and have been shown to impact patient expectations,
health behaviors and status (Anderson, 1999, DeVoe et al., 2009, Verlinde et al., 2012).
Discordance can negatively affect a patient’s perceptions of the relationship and interaction with
their HP, the content of the consultation, and healthcare delivery (Bertakis, 2009, Verlinde et al.,
2012). Less time and explanation regarding treatment and diagnoses and less patient participation
were reported when socioeconomic discordant factors, such as low income, limited education or
health literacy were present (Verlinde et al., 2012). Discordance in culture and native language, as
well as failure to provide or correct these via interpretive services, for example, have been found
to correlate with increases in health care use and costs, hospitalizations, misdiagnoses, infection
transmission rates, sicker patients, missed appointments, as well as, decreases in patient trust,
satisfaction, willingness to follow advice, compliance with medical or treatment
recommendations, continuation of care, health status, preventative behaviors, and provider
satisfaction (Smith & Pietrzyk, 2012).
Significant practice style behavior and foci differences, such as emphasis on preventive
services and psychosocial counseling, and higher satisfaction ratings and empathy were found in
female compared to male HPs with increased rates for both found for female HPs, even after
adjustments for patient characteristics, physician practice style, gender discordant factors and
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other variables such as age, ethnicity, and personal experience were examined (Bylund &
Makoul, 2002, Bertakis, 2009). These differences and discordant variables can alter the structure
of the communication and affect goals, skills, perceptions, emotions and overall influence the HPpatient interaction (Street, 2002, Markova & Broome, 2007, Bertakis, 2009).
Corrections to or modification of discordant factors or use of collaborative PCC in
discordant relationship interactions positively influenced patient perception of communication
quality, increased emotive factors such as faith and trust, and other outcome measures (Anderson,
1999, Schoenthaler et al., 2012, Verlinde et al., 2012). Provision of language access services for
improved language concordance increased EC, trust, access to and quality of health care, more
preventive services, higher patient satisfaction and improved patient’s perception of the quality of
interactions between themselves and their HP (Gregg & Saha, 2007; Wallace et al., 2009).
Collaborative
The process of HPI is also collaborative, with a patient and HP working together on a
mutual understanding of information, agenda setting, goal congruence and decision-making.
Collaboration requires interaction via EC between a patient and HP within a relationship that is
therapeutic, balanced, and reciprocal with shared power and responsibility and equal participation
(Mead & Bower, 2000, Talen et al., 2011, Verlinde et al., 2012). Sharing information,
appreciating the other’s strengths and differences, establishing mutually agreed upon priorities
and goals, and sharing decision-making are all aspects of collaboration and found to be essential
for improved health status (Cegala et al., 2000, Street & Millay, 2001, Bylund et al., 2010).
The primary purpose of collaboration is decision-making. Patients have different
perspectives, priorities, needs, preferences and approaches to decision-making. HPs have been
described as influential in both autonomous and shared decisions with patients. They are
encouraged to be cognizant of their own professional influence in this process (Rempel et al.,
2004). Awareness of communication differences, understanding the different values and beliefs
that guide decisions, and providing active support and assistance rather than pressure are
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influential in optimizing PC decision making (Anderson, 1999, Rempel et al., 2004). Tailoring
information, eliciting perspectives, asking questions, determining outcomes, ensuring
collaboration and assessing other HP-patient characteristics are also imperative to this process
(Tinetti & Basch, 2013, Verlinde et al., 2012).
When shared decision-making was emphasized, self-reports of greater adherence to
treatment recommendations and improved health outcomes in patients with chronic diseases
resulted (Stewart, 1995, Stewart et al., 2000). Shared decision making with HPs is the preference
of more than 70% of patients, although this is not consistent across all patient populations as
certain subsets prefer HP-delegated decision-making (Chewning et al., 2012).
Transformative
The process of HPI is also transformative. Cognitive and emotive transformation can
begin as soon as HP-patient interaction is initiated and continues as the relationship evolves. It
can occur with HP provision of health information, skills, and recommendations that lead to
increased patient knowledge, awareness, motivation, desire, trust, respect, rapport and
confidence, if received and acted upon for health behavior modification.
Power and leadership are required for this transformative component of HPI, a type of
social influence (Gabel, 2012). The Transformational Leadership Model developed by Gabel
(2012), social psychologist, provides a strong foundation upon which HPI is constructed. It
describes a relationship between power and leadership, the types of power that play a potential
role, and the appropriate exertion of power and leadership that is necessary to foster PC goals
(Gabel, 2012). Expert power is that which comes from the HP as the “health problem expert” in
the relationship and referent power is that which is derived from being respected or trusted,
increasing as the relationship builds (Raven, 2008, Gabel, 2012). “Leadership involves working
in socially appropriate ways to influence others in subordinate or follower positions to achieve
principle-driven goals or objectives that these individuals may not have wanted to reach, may not
have thought of reaching, or may not have had the courage or motivation to attempt on their own”
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(Gabel, 2001) whereas, power is described as the strategies used by leaders to influence those in
subordinate or follower positions to achieve important goals (Gabel, 2012). HPI adopts these two
concepts, placing the onus of responsibility on HPs as experts and leaders to potentiate patient
health behavior modification.
The idea of power and leadership may appear to be in contrast with negotiation, sharing
information, “power sharing” and reciprocity, essential components of PC communication (PCC),
however a power differential does not negate these components but rather reinforces them via
referent power, resulting in empowerment. Empowerment of patients promotes patient
engagement in decision-making and consequently improves health outcomes (Stoddart & Bugge,
2012, Verlinde et al., 2012).
Cognitive
The cognitive component should continuously evolve as awareness, understanding, and
knowledge about one’s health problem or needs, and involvement in treatment choice is
enhanced. Cognitive transformation requires HP use of PCC during interaction and collaboration
to modify information, strategies, or recommendations to address alterations in patient goals,
values, lifestyle factors, motivation, intention and desire for decision-making. In many of the
references specific to HPs, influence was described or measured as a transformative component.
Inquiries, discussion, and provision of information by HPs via teaching and demonstration
increases knowledge, understanding, and adoption of healthy practices (Morrison, 1996, Rempel
et al., 2004, Orford et al., 2006, Farmer et al., 2007, Binns et al., 2009). In a study of predictors of
breast self-examination (BSE), personal HP-to-patient teaching and HP inquiries about BSE
practices were described as provider influence, categorized as enabling and reinforcing factors,
and were associated with the proficiency and frequency of patient BSE practice (Morrison, 1996).
Similarly, when the HP discussed colorectal cancer screening, odds of patient screening
significantly increased (Farmer et al., 2007). Delivery of new or different information than
previously received from HPs led to nervousness and subsequently negatively influenced
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pursuing previously determined procedures (Gilliam et al., 2008). Discussion of treatment
availability and provision of timely referrals for health problems by HPs was categorized as an
external influence measure (Orford, et al., 2006). Counseling influenced the patient’s perception
of HP’s role or status as expert, as well as the HP’s awareness of own professional and personal
values and beliefs and assessment of patient’s personal values and beliefs (Anderson, 1999,
Rempel et al., 2004). Decreased patient understanding of information was related to decreased
questioning about a medical condition, treatment plans, or advice and options, and subsequently
less adherence and compliance to treatment recommendations (Arnold et al., 2012).
Emotive
The emotive component includes rapport building with increasing mutual respect, trust,
caring, confidence, support, and encouragement. Patient perception of the relationship with their
HP, the HP’s competence, and faith and trust in their HP were found to be influenced by a
number of provider, patient, and visit factors (Shay et al., 2012). Poor HP perceptions and past
unfortunate patient experiences can adversely impact trust in HPs and contribute to decreased
adherence to treatment recommendations for some patients (Ciechanowski et al., 2001, Sheppard
et al., 2004). Conversely, HP use of PCC skills, such as understanding patient’s and own values,
preferences and emotions while listening and discussing diagnosis and treatment options,
allowing control and choice, and expressing concerns stimulated increased trust and positively
predicted increased patient perception of HP competence and subsequent adherence to certain
protective health behaviors (Epstein & Street, 2007, Sheppard et al., 2004, Verlinde, et al., 2012,
Wallace et al., 2009,). Empathy, truthfulness, and hopefulness in HP-patient communication are
more effective when compared to purely information-based medical consults (Hartog, 2009;
Travaline et al., 2005). Influence has been described as faith and trust in the HP (Anderson, 1999,
Rempel et al., 2004).
Outcomes
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Patient-related outcomes of HPI can be categorized as cognitive, psychological,
behavioral, and physical. Cognitively and psychologically, positive outcomes include an
increased awareness, understanding, and knowledge of a personal health problem or need, a
heightened perception of self and ability for change, increased desire, intention, and resolution for
behavior modification, improved personal health outcomes, and increased satisfaction.
Behaviorally and physically, positive outcomes include behavior modification activation, distal
and proximal health goal(s) achievement, and improved health status and outcomes. The process
of HPI is intended to stimulate patient activation (PA), a concept in the health literature that
describes patient’s acquiring the understanding, knowledge, skills, beliefs, and confidence and
then assuming a primary role in the care process by adapting health behaviors that result in better
outcomes and satisfaction with care experiences (Hibbard et al., 2004, Hibbard & Greene, 2013).
Related Models
Two models contain similar constructs to those included in the HPI. Health Behavior
Framework (HBF) (Bastani et al., 2010) identifies two categories: (1) physician and health care
system factors, under which HP characteristics, health care settings and environment are listed
and (2) individual factors: knowledge, communication with provider, health beliefs, social norms
and support, past health behaviors, barriers and supports, cultural factors and beliefs. In this
patient-centric model, the HBF does not address the HP leadership and expert role or HP
communication, only that of the individual patient and HP characteristics. The second model, the
Ecological Model of Communication (Street, 2002) describes the social and reciprocal nature and
PCC aspects for decision- making and how HP and patient characteristic concordance is
influential but lacks other components of influence, health behavior modification outcomes, and
the leadership and expert role of the HP.
DISCUSSION
Components of communication, such as different styles, demographic and language
concordance, and milieu have been previously described as influencers of health care outcomes
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but neither a definition nor a model describing the process of HPI on patient health behavior
modification and outcomes has previously been fully described in healthcare research.
HPI Model
A diagrammatic representation of the HP concepts (Figure 1) depicts the components
intentionally situated to demonstrate their relationship to one another. Social-communication is
centrally located, placed under and extends across the three components (interaction,
collaboration, and transformation) as it represents the primary process for the work of these
components. The concordance and logistics factors are located under interaction as these
primarily relate to space, time, and positive or negative aspects of the interaction. Emotive and
cognitive are located under transformation as these are the transformation foci that result from
interaction and collaboration. The left to right ordering of interaction, collaboration, and
transformation is intended to denote a primarily left to right direction of action although a spiral
would illustrate the circular nature of this process ideally.
The HPI model will likely have utility and applicability to a variety of populations, health
behaviors, problems, and diseases as health behavior modification is first and foremost an
individual issue and this model emphasizes an individual rather than a collective approach,
focusing on individual HP-patient characteristics and relationship. The conditions within this
model however may not be conducive for use in settings, communities, cultures, or countries in
which social or cultural values do not support interaction and collaboration between HP and
patient or in which reciprocity in the relationship, mutual respect and trust are not valued.
There are several limitations to this integrative review of the literature and analysis. The
HPI model is newly developed and has not yet been utilized or tested in practice or research.
Limiting the literature review to PubMed and CINAHL and utilizing quotations around search
terms to extract references with conceptual descriptions of influence rather than an action may
have limited exposure to other relevant descriptions of the concept HPI or another closely termed
concept, although no references reviewed suggested otherwise. There is a wide range of years
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selected for publications but restricting to English language may have limited finding
international research or descriptions about HPI.
CONCLUSION
The development of the HPI model derived from a synthesis of relevant literature serves
to fill a gap regarding the multifaceted process of HPI by providing an expansive and methodical
depiction of the role the HP plays in the interaction with patients in transforming the patient’s
adoption or modification of health behaviors. This model extends the conceptualization of PCC,
an essential and well-researched component, to include multiple other variables that collectively
correlate to distal or short term as well as proximal or long-term health improvement and
outcomes. Clarifying how influence has been described and measured along with this current
conceptualization contributes to knowledge development and understanding by HPs about how
their demeanor, actions, understanding, communication and interaction with patients contribute to
health status.
HPI model research could contribute to the definition, description and measurement of
the social facilitation construct in Ryan’s Integrated Theory of Health Behavior Change (2009),
which serves as an ideal theoretical framework to support the HPI model. Using the HPI model in
conjunction with TFL model concepts (Gabel, 2012) provides the framework for the development
of new or modifications of existing PCC education and training models and interventions for HPs
that have the potential to optimize their interactions during healthcare consultations to assist in
achieving optimal patient health outcomes.
The new HPI model provides a foundation for the development of future knowledge,
research, interventions, and tailored instruments to measure the influence of nurses and other
health care providers across a broad spectrum of patient populations and practice settings, on
health behaviors with the long-range goals of improved health care status, decreased healthcare
costs, and reduction in the myriad of burdens that accompany health problems. Individual health
status and outcomes is a common empirical measure used to grade the overall wealth and well-
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being of a community or a country. An influential HP is critical to achieving these outcomes.
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Table 1: Search Strategy and Summary of Articles on Healthcare Provider Influence
Database: CINAHL and PubMed, Years 1992-2013
Combined search terms and results: “influence” linked with each of the following:
healthcare provider (1); health care provider (2); healthcare professional (0); health care professional (0); provider (18); professional (21);
and clinician (3).
Cumulative Results: Total 42- duplications (13) = 29 - Dissertations (3, unable to obtain) = 26 - irrelevant (18) = Final (8).
Study

Search Term

Aim

Method

Sample

Influence Measure/
Descriptor
*Discussion/Information
sharing (genetic counseling)
*HP behavior
*Pt perception of HP as
expert authority and behavior

Anderson,
1999
(USA)

“provider
influence”
and
“health care
provider
influence”

Document
values and
beliefs that
influence a pt’s
decision to
accept or
decline prenatal
genetic
diagnosis

Qualitative
Interviews

N=24
Advanced
maternal
age women
(>35 years)
and male
spouses

Bins et al.,
2009
(USA)

“clinician
influence”

Quantitative
Surveys

N=463
adults of
diverse
households
with
smokers

*Discussion/Information
sharing (query / counseling
about smoking)

Farmer et
al., 2007
(USA)

“provider
influence”

Understand
clinician
influence on
parental
smoking bans in
homes of
children living
with a smoker
Predictors of
colorectal
cancer (CRC)
screening

Quantitative
Repeated
crosssectional
surveys

> 50 years
(women /
men equal)
1: n=498
2: n=482

*Discussion/Information
sharing (CRC) with HP

Major findings
*HPs professional and personal
biases, values and morals affect
medical knowledge presentation
and clinical decisions.
*listened/heard/understood by
HP: “knowing the pt.”
and faith/trust in HP help pts
make informed and autonomous
decisions about screening and
diagnostic tests
*Perception of harm was
strongly associated with having
bans
*Recall of child’s doctor query
about smoking status were less
likely to have a home smoking
ban - possible inadequate/too
short counseling = less concern
1 (of 2) strongest determinants
of obtaining CRC screening: HP
influence- discussion
significantly increased screening
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Gilliam et
al., 2008
(USA)

“provider
influence”

Barriers to
postpartum
sterilization

Qualitative
Interviews

Morrison,
1996
(USA)

“provider
influence”

Predictors of
breast selfexamination
(BSE)

Quantitative
Survey

Orford et al.,
2006
(England)

“professional
influence”

Understand
why pts seek
professional
treatment for
drinking
problems

Qualitative
Interviews

Rempel et
al., 2004
(USA)

“professional
influence”

Describe parent
decision
making after
antenatal
diagnosis of
congenital heart
disease

Qualitative
Interviews

N=34
Low
income
minority
women
postpartum
with
unfulfilled
sterilization
requests
N=204
Low
income
women
(ages 4086)

*Discussion/Information
sharing with HP
*interactions with HP

1 (of 5) last-minute themes for
not undergoing postpartum
sterilization.
HPI: new/different information
than given previously nervous
and “leery”; convincing to opt
for reversible options.
Negative interactions- neglected
/ treated poorly.

*Discussion/Information
sharing (personal 1:1 pt.-HP)
BSE demo/instruction)

1 (of 10) variables found to
predict BSE behavior in this
population: HP influenceinfluential teaching, exposure to
clinician messages – timing and
frequency

N=98,
Male and
female
(> 16
years),
primary
problem
with
alcohol
Mothers
(N=19) and
fathers
(N=15) of
babies
diagnosed
congenital
heart
disease
antenatally

*Discussion/Information
sharing (query about
drinking-nature of problemtreatment availability
drinking /referral)
*Timing-referral/relationship
with HP

External Influence seeking
professional help for drinking
problems: pressure / referral –
from HPs

*Discussion/Information
sharing (post-diagnosis
options)
*HP behavior, understanding
of pt. perspective, timing, and
support
*Pt perception of HP role and
input from expert

Parent perception of HP role and
expert authority varied.
Some sought HP opinion if
greater deliberation about
decision
Some offended by information –
even if option not decision based
Recommendations for HPs:
Aware of parents’ perspective,
cognizant of own professional
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Scholle et
al., 2003
(USA)

“provider
influence”

Preferences/
factors for
depression
advice among
high- risk
women.

Notes: Healthcare provider (HP); patient (pt.)

Quantitative
Survey

N=147
women
(18-44
years) on
Medicaid

*Time-length/continuity of
HP-pt. relationship

influence and provide active
support
Greater HP-pt. familiarity
influences women’s disclosure /
solicitation of depression advice
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Figure 1: Healthcare Provider Influence Diagram
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April 14, 2015
Ms. Denise Fryzelka Nursing
Dear Ms. Fryzelka:
Your protocol number HR-2942, titled, “Healthcare Provider Influence on Health Behavior
Modifications in Gestational Diabetics” was expedited on April 14, 2015, by a member of the
Marquette University Institutional Review Board.
Your IRB approved informed consent form and Authorization to Use and Disclose Protected
Health Information in Research is enclosed with this letter. Use the stamped copies of this form
when recruiting research participants. Each research participant should receive a copy of the
stamped consent form for their records.
Subjects who go through the consent process are considered enrolled participants and are counted
toward the total number of subjects, even if they have no further participation in the study. Please
keep this in mind when conducting your research. This study is currently approved for 66
subjects.
If you need to increase the number of subjects, add research personnel, or make any other
changes to your protocol you must submit an IRB Protocol Amendment Form, which can be
found on the Office of Research Compliance web site:
http://www.marquette.edu/researchcompliance/research/irbforms.shtml. All changes must be
reviewed and approved by the IRB before being initiated, except when necessary to eliminate
apparent immediate hazards to the human subjects. Any public advertising of this project requires
prior IRB approval. If there are any adverse events, please notify the Marquette University IRB
immediately.
Your approval is valid until April 13, 2016. Prior to this date, you will be contacted regarding
continuing IRB review.
An IRB Final Report Form must be submitted once this research project is complete. The form
should be submitted in a timely fashion and must be received no later than the protocol expiration
date.
Contact the IRB office if you have any further questions. Thank you for your cooperation and
best wishes for a successful project.
Sincerely,

Benjamin Kennedy
Research Compliance Officer-Human Subjects & Radiation Safety
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cc: Dr. Marianne Weiss Enclosures (1)
BK/tk
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December 7, 2015
Ms. Denise Fryzelka Nursing
Dear Ms. Fryzelka:
The amendment you submitted for your protocol number HR-2942, titled, “Healthcare
Provider Influence on Health Behavior Modifications in Gestational Diabetics,” received
expedited approval on December 7, 2015, from a member of the Marquette University
Institutional Review Board.
This amendment:
•
•
•
•
•

Adds Christine Kern Steffan to research personnel;
Adds a control group;
Increases sample size to 200;
Modifies data collection instruments; and
Adds a $10 incentive to GDM participants.
Your protocol is valid until April 13, 2016. Prior to this date, you will be
contacted regarding continuing IRB review. Any public advertising of this project
requires prior IRB approval. If there are any changes in your protocol or adverse
events, please notify the IRB immediately.
Contact the IRB office if you have any further questions. Thank you for your
cooperation and best wishes for a successful project.
Sincerely,

Jessica Rice
IRB Manager
Office of Research Compliance
Enclosures (2) JR/tk
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April 7, 2016
Ms. Denise Fryzelka Nursing
Dear Ms. Fryzelka:
Your protocol number HR-2942, titled “Healthcare Provider Influence on Health Behavior
Modifications in Gestational Diabetics” received expedited continuing approval on April 7,
2016, from a member of the Marquette University Institutional Review Board.
You are approved to recruit a total of 200 subjects, of which you have already recruited 7.
You are also approved to add Stephanie Conley, Julie Hillard, Kandra Barb, Keeley Johnson
Crosby and Alexandra Ramirez to your research personnel.
Any changes to your protocol must be requested in writing by submitting an IRB Protocol
Amendment Form. All changes must be reviewed and approved by the IRB before being initiated,
except when necessary to eliminate apparent immediate hazards to the human subjects. Any
public advertising of this project requires prior IRB approval. If there are any adverse events,
please notify the Marquette University IRB immediately.
Your approval is valid until April 17, 2017. Prior to this date, you will be contacted regarding
continuing IRB review.
An IRB Final Report Form must be submitted once this research project is complete. The form
should be submitted in a timely fashion and must be received no later than the protocol expiration
date.
Contact the IRB office if you have any further questions. Thank you for your cooperation and
best wishes for a successful project.
Sincerely,

Jessica Rice
IRB Manager
Office of Research Compliance
cc: Ms. Sherri Lex, Graduate School Dr. Marianne Weiss, Adviser
JR/tk
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March 21, 2017
Ms. Denise Fryzelka College of Nursing
Dear Ms. Fryzelka:
The amendment you submitted for your protocol number HR-2942, titled, “Healthcare
Provider Influence on Health Behavior Modifications in Gestational Diabetics,” received
expedited approval on March 20, 2017, from a member of the Marquette University
Institutional Review Board.
This amendment approves the following:
• addition of Associate Physicians of Madison, WI as a recruitment site
Your protocol is valid until April 17, 2017. Prior to this date, you will be contacted
regarding continuing IRB review. Any public advertising of this project requires prior
IRB approval. If there are any changes in your protocol or adverse events, please notify
the IRB immediately.
Contact the IRB office if you have any further questions. Thank you for your cooperation
and best wishes for a successful project.
Sincerely,

Jessica Rice, MPH, CIP
IRB Manager
Office of Research Compliance
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March 30, 2017
Ms. Denise Fryzelka College of Nursing
Dear Ms. Fryselka:
Your protocol number HR-2942, titled “Healthcare Provider Influence on Health
Behavior Modifications in Gestational Diabetics” received expedited continuing
approval on March 30, 2017, from a member of the Marquette University Institutional
Review Board.
You are approved to recruit a total of 200 subjects, of which you have already recruited
162.
Any changes to your protocol must be requested in writing by submitting an IRB
Protocol Amendment Form. All changes must be reviewed and approved by the IRB
before being initiated, except when necessary to eliminate apparent immediate hazards to
the human subjects. Any public advertising of this project requires prior IRB approval. If
there are any adverse events, please notify the Marquette University IRB immediately.
Your approval is valid until April 17, 2018. Prior to this date, you will be contacted
regarding continuing IRB review. Please note that it is the PI’s responsibility to be aware
of the study’s expiration date and submit continuing review materials as needed.
Continuing review materials submitted less than two weeks before the expiration date
may lead to a lapse in study approval.
An IRB Final Report Form must be submitted once this research project is complete. The
form should be submitted in a timely fashion and must be received no later than the
protocol expiration date.
Contact the IRB office if you have any further questions. Thank you for your cooperation
and best wishes for a successful project.
Sincerely,
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Jessica Rice, MPH, CIP
IRB Manager
Office of Research Compliance

April 6, 2018
Ms. Denise Fryzelka College of Nursing
Dear Ms. Fryselka:
Your protocol number HR-2942, titled “Healthcare Provider Influence on Health Behavior
Modifications in Gestational Diabetics” received expedited continuing approval on April 5,
2018, from a member of the Marquette University Institutional Review Board.
You are approved to recruit a total of 200 subjects, of which you have already recruited 162.
Any changes to your protocol must be requested in writing by submitting an IRB Protocol
Amendment Form. All changes must be reviewed and approved by the IRB before being
initiated, except when necessary to eliminate apparent immediate hazards to the human
subjects. Any public advertising of this project requires prior IRB approval. If there are any
adverse events, please notify the Marquette University IRB immediately.
Your approval is valid until April 17, 2019. Prior to this date, you will be contacted
regarding continuing IRB review. Please note that it is the PI’s responsibility to be aware of
the study’s expiration date and submit continuing review materials as needed. Continuing
review materials submitted less than two weeks before the expiration date may lead to a lapse
in study approval.
An IRB Final Report Form must be submitted once this research project is complete. The
form should be submitted in a timely fashion and must be received no later than the protocol
expiration date.
Contact the IRB office if you have any further questions. Thank you for your cooperation and
best wishes for a successful project.
Sincerely,

Benjamin Kennedy
Compliance Officer – Human Subjects and Radiation Safety Office of Research Compliance
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Are you interested in participating in research to gain further
knowledge regarding Gestational Diabetes Mellitus?
DO YOU QUALIFY?
If you are 18 years or older, pregnant, speak and write English or Spanish, and have been
told that you will be tested for Gestational Diabetes Mellitus because you are at higher
risk or have an elevated blood sugar result from your one-hour glucose test, you may
qualify.

WHY IS IT IMPORTANT?
Acquiring more knowledge about how to better treat Gestational Diabetes Mellitus
during pregnancy is important to help prevent complications in pregnancy and following
pregnancy for mothers and babies and reduce the risks of Diabetes Mellitus later in life.

BENEFITS:
Participating in this research study allows you to help us learn more about how healthcare
providers can help women with Gestational Diabetes Mellitus engage in healthy
behaviors, in order to treat themselves to reduce the complications for themselves and
their babies during pregnancy and prevent Diabetes Mellitus in the future.

TIME COMMITMENT:
It will only take 5 minutes to complete questionnaires for Phase 1. It will take an
additional 2‐‐3 minutes to complete questionnaires for Phase 2 if you do not have
Gestational Diabetes Mellitus and approximately 25 minutes to complete
questionnaires if you do have Gestational Diabetes Mellitus.
It will not require any additional laboratory testing or extra visits.
You can complete it during a clinic visit before or after you see your healthcare provider.
If you are interested, please contact ***
Conducted by Denise Fryzelka, PhD student, Marquette University
If you have any questions about this research project, you can contact Denise Fryzelka by phone at
816‐716‐ 9901 or by email at dfryzelkacnm@hotmail.com.
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¿Ud. interesa participar en la investigación para adquirir más conocimientos
sobre Diabetes Mellitus Gestacional?
¿CALIFICA USTED?
Si Ud. tiene 18 años o más, está embarazada, habla y escribir inglés o español y le han
dicho que le harán la prueba para Diabetes gestacional porque Ud. Corre un mayor riesgo
o ya tiene un resultado de azúcar en la sangre elevada en su prueba de glucosa de una
hora, usted puede calificar.

¿POR QUÉ ES IMPORTANTE?
Adquirir más conocimientos sobre cómo tratar mejor la Diabetes gestacional durante el
embarazo es importante para ayudar a prevenir complicaciones en el presente embarazo y
el siguiente embarazo para las madres y los bebés y reducir los riesgos diabetes más
adelante en vida.

BENEFICIOS:
Participar en este estudio de investigación permite que nos ayuden a aprender más sobre
cómo los prestadores de servicios pueden ayudar a las mujeres con Diabetes gestacional
involucrarse en comportamientos saludables, para tratar ellos mismos para reducir las
complicaciones para ellas y sus bebés durante el embarazo y prevenir la Diabetes más
adelante en la vida.

CUANTO TIEMPO TOMA:
Solo tardará 5 minutos para completar cuestionarios de fase 1. Tomará unos 2 a 3
minutos más para completar la segunda fase si Ud. no tiene diabetes gestacional y 25
minutos completar la segunda fase si Ud. tiene diabetes gestacional.
No requerirá visitas adicionales o pruebas de laboratorio adicionales.
Usted puede completar durante una visita a la clínica antes o después de ver su proveedor
de atención médica. Si usted está interesado, póngase en contacto con:
Realizado por Denise Fryzelka, CNM, PhDc, estudiante de doctorado, Universidad de
Marquette. Si usted tiene alguna pregunta acerca de este proyecto de investigación,
puede comunicarse con Denise Fryzelka por teléfono al 816‐716‐9901 o por correo
electrónico a dfryzelkacnm@hotmail.com.

195

MARQUETTE UNIVERSITY
AGREEMENT OF CONSENT FOR RESEARCH PARTICIPANTS
HEALTHCARE PROVIDER INFLUENCE ON HEALTH BEHAVIOR
MODIFICATIONS IN GESTATIONAL DIABETICS
Denise K. Fryzelka, CNM, MS
College of Nursing
You have been invited to participate in this research study. Before you agree to
participate, it is important that you read and understand the following information.
Participation is completely voluntary. Please ask questions about anything you do not
understand before deciding whether or not to participate.
PURPOSE: The purpose of this research study is ask questions about eating and physical
activity practices you engage in and who and how pregnant women with gestational
diabetes are influenced to make changes in their diet and physical activity levels. You
will be one of a minimum of 66 participants in this research study.
PROCEDURES: You will be asked to complete a set of questionnaires. Following your
laboratory testing, if you are diagnosed with gestational diabetes you will be invited to
participate in a second phase, wherein you will be asked to complete another set of
questionnaire and surveys when you return for one of your prenatal visits at
approximately 34-36 weeks gestational age. After completion of the questionnaires, your
participation in the study is fulfilled
DURATION: Your participation may take approximately 5 minutes to complete
questionnaires for the first phase today and 25 minutes for the second phase to complete
questionnaires.
RISKS: There are no risks associated with participation in this study or at least none
greater than you would experience in everyday life.
BENEFITS: The benefits associated with participation in this study include assisting
research efforts in understanding how healthcare providers can improve their care and
counseling for pregnant women with gestational diabetes. Additionally, your
participation may provide you with a better understanding and an increased awareness of
the educational components that are involved in caring for and treating gestational
diabetes and how these may prevent or decrease future risks for developing Diabetes
Mellitus.
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2/2

CONFIDENTIALITY: All information you reveal in this study will be kept
confidential. All your data will be assigned an arbitrary code number rather than using
your name or other personal information that could identify you as an individual. When
the results of the study are published, you will not be identified by name at any time and
results will be reported grouped together with others. The data will be destroyed by
shredding paper documents and deleting electronic files three years after the completion
of the study. All data in hard copy or electronic copy will be stored in a locked and secure
location and all computer files will be password protected.
VOLUNTARY NATURE OF PARTICIPATION: Participating in this study is
completely voluntary and you may withdraw from the study and stop participating at any
time without penalty or loss of benefits.
COMPENSATION: Due to the additional length of time to complete the questionnaires
in Phase 2 of the study if you do have gestational diabetes; you will be compensated with
a $10.00 gift card to a local department or grocery store (e.g. Target, Walmart,
Woodmans, or other) following completion of Phase 2.
CONTACT INFORMATION: If you have any questions about this research project,
you can contact Denise Fryzelka by phone at 816-716-9901 or by email at
dfryzelkacnm@hotmail.com. If you have questions or concerns about your rights as a
research participant, you can contact Marquette University’s Office of Research
Compliance at (414) 288-7570 or orc@mu.edu.
I HAVE HAD THE OPPORTUNITY TO READ THIS CONSENT FORM, ASK
QUESTIONS ABOUT THE RESEARCH PROJECT AND AM PREPARED TO
PARTICIPATE IN THIS PROJECT.
_________________________________________
(Printed Name of Participant)
_________________________________________
(Signature of Participant)
________________________
Date
__________________________________________
(Printed Name of Individual Obtaining Consent)
__________________________________________
(Signature of Individual Obtaining Consent)
________________________
Date
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MARQUETTE UNIVERSITY
AGREEMENT OF CONSENT FOR RESEARCH PARTICIPANTS
HEALTHCARE PROVIDER INFLUENCE ON HEALTH BEHAVIOR
MODIFICATIONS IN GESTATIONAL DIABETICS
Denise K. Fryzelka, CNM, MS
College of Nursing
You have been invited to participate in this research study. Before you agree to
participate, it is important that you read and understand the following information.
Participation is completely voluntary. Please ask questions about anything you do not
understand before deciding whether or not to participate.
PURPOSE: The purpose of this research study is ask questions about eating and physical
activity practices you engage in and who and how pregnant women with gestational
diabetes are influenced to make changes in their diet and physical activity levels. You
will be one of a minimum of 200 participants in this research study.
PROCEDURES: You will be asked to complete a set of questionnaires. Following your
laboratory testing, you will be invited to participate in a second phase, wherein you will
be asked to complete another set of questionnaire and surveys when you return for one of
your prenatal visits at approximately 34-36 weeks gestational age. The number of
questionnaires will depend on whether you are diagnosed with gestational diabetes or not.
After completion of the questionnaires, your participation in the study is fulfilled
DURATION: Your participation may take approximately 5 minutes to complete
questionnaires for Phase 1 today. It will take approximately 2-3 minutes to complete
Phase 2 if you do not have gestational diabetes and 25 minutes for Phase 2 if you do have
gestational diabetes.
RISKS: There are no risks associated with participation in this study or at least none
greater than you would experience in everyday life.
BENEFITS: The benefits associated with participation in this study include assisting
research efforts in understanding how healthcare providers can improve their care and
counseling for pregnant women with gestational diabetes. Additionally, you participation
may provide you with a better understanding and an increased awareness of the
educational components that are involved in caring for and treating gestational diabetes
and how these may prevent or decrease future risks for developing Diabetes Mellitus.
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CONFIDENTIALITY: All information you reveal in this study will be kept
confidential. All your data will be assigned an arbitrary code number rather than using
your name or other personal information that could identify you as an individual. When
the results of the study are published, you will not be identified by name at any time and
results will be reported grouped together with others. The data will be destroyed by
shredding paper documents and deleting electronic files three years after the completion
of the study. All data in hard copy or electronic copy will be stored in a locked and secure
location and all computer files will be password protected.
VOLUNTARY NATURE OF PARTICIPATION: Participating in this study is
completely voluntary and you may withdraw from the study and stop participating at any
time without penalty or loss of benefits.
COMPENSATION: Due to the additional length of time to complete the questionnaires
in Phase 2 of the study if you do have gestational diabetes; you will be compensated with
a $10.00 gift card to a local department or grocery store (e.g. Target, Walmart,
Woodmans, or other) following completion of Phase 2.
CONTACT INFORMATION: If you have any questions about this research project,
you can contact Denise Fryzelka by phone at 816-716-9901 or by email at
dfryzelkacnm@hotmail.com. If you have questions or concerns about your rights as a
research participant, you can contact Marquette University’s Office of Research
Compliance at (414) 288-7570 or orc@mu.edu.
I HAVE HAD THE OPPORTUNITY TO READ THIS CONSENT FORM, ASK
QUESTIONS ABOUT THE RESEARCH PROJECT AND AM PREPARED TO
PARTICIPATE IN THIS PROJECT.
___________________________________________________________________
(Printed Name of Participant)
___________________________________________________________________
(Signature of Participant)
____________________________
Date
___________________________________________________________________
(Printed Name of Individual Obtaining Consent)
__________________________________________________________________
(Signature of Individual Obtaining Consent)
____________________________
Date
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UNIVERSIDAD MARQUETTE
ACUERDO DE CONSENTIMIENTO PARA LOS PARTICIPANTES DE LA
INVESTIGACIÓN
INFLUENCIA DEL PROVEEDOR DE LA SALUD EN LAS MODIFICACIONES DEL
COMPORTAMIENTO EN DIABÉTICAS GESTACIONALES
Denise K. Fryzelka, CNM, MS
Facultad de Enfermería
Ud. ha sido invitada a participar en este estudio de investigación. Antes de que Ud.
acceda a participar, es importante que Ud. lea y entienda la siguiente información. Su
participación es completamente voluntaria. Por favor pregunte si no entiende algo antes
de decidir participar.
PROPOSITO: El propósito de este estudio de investigación es el de preguntar con
respecto a prácticas de alimentación y actividad física que Ud. hace y quién y cómo las
mujeres embarazadas con diabetes gestacional son influenciadas a hacer cambios en su
dieta y niveles de actividad física. Ud. será una de un mínimo de 66 participantes en este
estudio de investigación.
PROCEDIMIENTOS: Le pedirán completar una seria de cuestionarios. Después de la
prueba de laboratorio, y si se le diagnostica diabetes gestacional le invitarán a que
participe en un segunda fase en la cual se le pedirá que complete otra serie de
cuestionarios y encuestas cuando usted venga para una de sus visitas prenatales entre las
semanas 34-36 aproximadamente. Después de la terminación de los cuestionarios, su
participación en el estudio se ha completado.
DURACION: Su participación puede tomar aproximadamente 5 minutos para completar
los cuestionarios de la primera fase. Tomará unos 2 a 3 minutos más para completar la
segunda fase si Ud. no tiene diabetes gestacional y 25 minutos completar la segunda fase
si Ud. tiene diabetes gestacional.
RIESGOS: No hay riesgos asociados a la participación en este estudio o por lo menos
ninguno mayor al que usted experimentaría en la vida diaria.
BENEFICIOS: Las ventajas asociaron a la participación en este estudio incluyen ayudar a
los esfuerzos de investigación entendiendo como los proveedores de salud pueden
mejorar los cuidados de salud al aconsejar embarazadas con diabetes gestacional.
Además, su participación puede darle a usted una comprensión mejor y mayor
conocimiento de los componentes educacionales que implican cuidar y tratar la diabetes
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gestacional y de cómo estos previenen o disminuyen los riesgos futuros para desarrollar
la Diabetes Mellitus.

CONFIDENCIALIDAD: Toda la información que usted revela en este estudio será
mantenida confidencial. Todos sus datos serán asignados un número de código en vez de
utilizar su nombre u otra información personal que pudiera identificarla individualmente.
Cuando los resultados del estudio se publiquen, usted no va a ser nunca identificada por
nombre y sus resultados se reportaran agrupados con otros. Los datos serán destruidos y
todo papel será pulverizado tres años después de haber completado el estudio y los
archivos electrónicos serán destruidos.. Todos los datos en computadores serán
protegidos con contraseñas y los computadores estarán en un lugar seguro y bajo llave.
NATURALEZA VOLUNTARIA DE LA PARTICIPACION: El participar en este
estudio es completamente voluntario y Ud. puede retirarse del estudio y parar de
participar en cualquier momento sin ningún tipo de multa o pérdida de beneficios.
COMPENSATION: Si le diagnostican diabetes gestacional y participa en la
Segunda fase del estudio, se le compensará con una tarjeta de regalo por $10.00 de un
almacén local de departamento o de la tienda de comestibles (e.g. Target, Walmart,
Woodmans entre otras.
INFORMACION DE CONTACTO: si usted tiene alguna pregunta acerca de este
proyecto de investigació n, puede comunicarse con Denise Fryzelka por telé fono al
816‐716‐9901 o por correo electró nico a dfryzelkacnm@hotmail.com. Si Ud. tiene
preguntas con respecto a sus derechos como participante Ud. Puede contactar la
oficina de Cumplimiento de Investigació n de la Universidad Marquette al (414) 2887570 o orc@mu.edu.
HE TENIDO LA OPORTUNIDAD DE LEER ESTA FORMA DE
CONSENTIMIENTO, HE HECHO PREGUNTAS ACERCA DEL PROYECTO DE
INVESTIGACIÓN Y ESTOY PREPARADA PARA PARTICIPAR EN ESTE
PROYECTO.
______________________________________________
(Nombre en imprenta de la participante)
______________________________________________
(Firma de la Participante)
______________________
Fecha
_______________________________________________
(Nombre en imprenta del individuo que obtiene el permiso)
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_______________________________________________
(Firma del individuo que obtiene el permiso)
______________________
Fecha

Appendix D:
Study Forms and Instruments
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Phase 1 HPI Research Study
You have been selected and invited to participate in this research study while you are
completing laboratory testing for Gestational Diabetes Mellitus (GDM).
Consent: Participation is completely voluntary. Completion of this form indicates your
willingness to participate in this study. Confidentiality will be maintained, as no personal
information regarding you will be reported on these forms.
Purpose: Your participation in this study will support research intended to increase the
knowledge and lend a greater understanding about GDM in pregnancy.
Procedure: You are asked to answer the questions below. If you qualify for the second
part of the research project and you agree to participate, you will be asked to complete
additional questionnaires at approximately 34-36 weeks of pregnancy before or following
a prenatal appointment. After completion of those questionnaires, your participation in the
study is fulfilled. Please place your name and contact information on the outside of the
envelope only in order to allow us to contact you regarding the date of an appointment at
which to complete the forms. Thank you for participating in this important research.
Study Participant #_____________
Date _________________________
Participant Demographic Questionnaire (PDQ)
•
Age _____________________________________
•
Completed years of education_________________
•
What is your Race/Ethnicity ______________________?
•
Have you ever had Gestational Diabetes Mellitus: Yes_____ No______?
•
Do you have a family history of Diabetes Mellitus: Yes_____ No______?
o
If yes, who had Diabetes Mellitus? __________________________________
•
How long have you lived in the United States? ____________________
•
What is your primary language? ________________________________
•
Are you seeing the type of Healthcare provider you desired to see for your
prenatal care? Y_____ N______
To be completed by researcher
•
Early GA GDM screening: Yes _____ if yes, indication _____________ No______
OR routine GDM screening Yes __________
•
Parity_________
•
Pre-pregnancy BMI: _________
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Eating Breakfast Questionnaire + 1 (EBQ+1)
1.
How many times last week (past 7 days) did you eat breakfast when you got
up? (within 2 hours of getting up) _________________times last week?
2.
This morning, did you eat any of the following foods for breakfast? (please
check all that apply)
o
Milk (1/2 cup) / nut “milk” (for example, almond milk, coconut milk)
o
eggs
o
cheese / cottage cheese
o
meat, poultry, or fish
o
yogurt
o
beans
o
nuts/nut butters (for example, almond butter / peanut butter)
If you ate anything else, please write here: ______________________________
3.

How many portions of vegetables do you eat every day? ___________
Physical Activity Scale (PAS)

During the past week, even if it was not a typical week for you, how much total time (for the
entire week) did you spend on each of the following? (Please circle only one number for each
question)
How much time total
during the past week (past
7 days) …

None

1. Stretching or
strengthening exercises
(range of motion, using
weights, etc.)

0

Less than
30
minutes/
week
1

30-60
minutes/
week

1-3
hours/
week

2

3

More
than
3 hours/
week
4

2. Walk for exercise

0

1

2

3

4

3. Swimming or aquatic
exercise
4. Bicycling (including
stationary exercise bikes)

0

1

2

3

4

0

1

2

3

4

5. Other aerobic exercise
equipment (Stairmaster,
rowing, skiing machine,
etc.)
6. Other aerobic exercise
Specify________________
_

0

1

2

3

4

0

1

2

3

4
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Phase 2 HPI Research Study
You have been selected and invited to participate in the second phase of this research
study due to your experience with Gestational Diabetes Mellitus (GDM).
Consent: Participation is completely voluntary. Completion of these questionnaires
indicates your willingness to participate in this study. Confidentiality will be maintained,
as no personal information regarding you will be reported on these forms. A few pieces
of information regarding your biometrics will be collected from your medical record
related to factors effecting GDM after which no more information will be accessed from
your medical records.
Purpose: Your participation in this study will support research intended to increase the
knowledge and lend a greater understanding about GDM in pregnancy.
Procedure: You are asked to complete the questionnaires below. After completion of those
questionnaires, your participation in the study is fulfilled. Thank you for participating in
this important research.
Study Participant #_____________
Date _________________________
Healthcare Provider Demographic Questionnaire (HPDQ)
•
•
•
•
•
•

Where do you receive your prenatal care: clinic name?
___________________________________________
What is the name of your healthcare provider or group?
____________________________________________
What is the gender of your healthcare provider?
______________________________________
What is the race/ethnicity of your healthcare provider?
___________________________________________
What language does your healthcare provider use with you at your visits?
__________________________________________________________
Does your healthcare provider use an interpreter?
Yes ________________
No______________

To be completed by researcher
• Phase 2 BMI: __________
• Professional discipline: MD/DO: OB or FP, CNM, NP, PA
• HP Age ____________
HP Years in practice_________
• Was the teaching / counseling conducted in patient primary language?
Y_____ N_____
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Social Influence Questionnaire (SIQ)
Please tell me how who gave you counseling regarding Gestational Diabetes Mellitus
(GDM).
(Can mark more than one)
1.
Nurse/Nurse Practitioner
2.
Midwife
3.
Doctor
4.
Diabetic Nurse-Educator/Registered Dietitian
5.
Other (Provider Type/Specialty) ______________________________
Please tell me how much influence each healthcare provider or group of healthcare
providers has / have on decisions you make about your health management, such as food
and drink intake and physical activity by circling one number from 1 to 5 that best describes
how you feel. For example, circling number 4 means you feel more like the description of number
5 (“strongly influences”) than number 1 (“no influence”) but not completely.
1
“no influence”
My ___________ has/or ____________decisions I make about
my health management such as food/drink intake and
physical activity…
Nurse/Nurse Practitioner
Midwife or Doctor
Diabetic Educator/Registered Dietitian
Other (Provider type or specialty)
__________________________

5
“strongly influences”
1 meaning “no influence
and 5 meaning “strongly
influences”
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5

Social Influence Questionnaire – Healthcare Provider (SIQHP)
Please rate how strongly you think each healthcare provider agrees with the following
statement on a scale of 1-5 by circling one number from 1 to 5 that best describes how you feel.
For example, circling number 4 means you feel more like the description of number 5 (“strongly
agrees”) than number 1 (“strongly disagrees”) but not completely.
1
“strongly disagrees”

My perinatal healthcare provider (Midwife or Doctor)
________that …
I can treat my Gestational Diabetes if I change what I eat and
drink now
I can treat my Gestational Diabetes if I become more physically
active now
I could develop Diabetes Mellitus later in life if I do not change
what I eat and drink now

5
“strongly agrees”
1 meaning “strongly
disagrees” and 5 meaning
“strongly agrees”
1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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I could develop Diabetes Mellitus later in life if I do not become
more physically active now
I am able to change what I eat and drink
I am able to become more physically active
If I begin to change what I eat and drink, I could prevent
Diabetes Mellitus later in life
If I become more physically active, I could prevent Diabetes
Mellitus later in life
Lot of things get in the way of me changing what I eat and drink
and/or becoming more physically active

1

2

3

4

5

1
1
1

2
2
2

3
3
3

4
4
4

5
5
5

1

2

3

4

5

1

2

3

4

5

Social Influence Questionnaire – Diabetic Educator (SIQDE)
Please rate how strongly you think each healthcare provider agrees with the following
statement on a scale of 1-5 by circling one number from 1 to 5 that best describes how you feel.
For example, circling number 4 means you feel more like the description of number 5 (“strongly
agrees”) than number 1 (“strongly disagrees”) but not completely.
1
“ strongly disagrees”

The Diabetic Educator/Registered Dietitian ______ that …
I can treat my Gestational Diabetes if I change what I eat and
drink now
I can treat my Gestational Diabetes if I become more physically
active now
I could develop Diabetes Mellitus later in life if I do not change
what I eat and drink now
I could develop Diabetes Mellitus later in life if I do not become
more physically active now
I am able to change what I eat and drink
I am able to become more physically active
If I begin to change what I eat and drink, I could prevent
Diabetes Mellitus later in life
If I become more physically active, I could prevent Diabetes
Mellitus later in life
Lot of things get in the way of me changing what I eat and drink
and/or becoming more physically active

5
“strongly agrees”
1 meaning “strongly
disagree” and 5 meaning
“strongly agree”
1
2
3
4
5
1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1
1
1

2
2
2

3
3
3

4
4
4

5
5
5

1

2

3

4

5

1

2

3

4

5
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Quality of Information-Interaction-Gestational Diabetes Mellitus (QOII)
Please circle your answer by selecting one number from 0 to 10. The words below the numbers indicate
what the 0 or the 10 mean. Pick a number between 0 and 10 that best describes how you feel. For example,
circling number 7 means you feel more like the description of number 10 than number 0 but not
completely.
1a. How much information did you need
from your healthcare provider (nurse,
midwife, or doctor) about treating
Gestational Diabetes Mellitus after you
were told about your diagnosis?
1b. How much information did you receive
from your healthcare provider (nurse,
midwife, or doctor) about treating
Gestational Diabetes Mellitus after you
were told about your diagnosis?
2a. How much information did you need
from your healthcare provider (nurse,
midwife, or doctor) about what changes to
make in what you eat and drink?
2b. How much information did you receive
from your healthcare provider (nurse,
midwife, or doctor) about what changes to
make in what you eat and drink?
2c. How much information did you need
from the Diabetic Educator/Registered
Dietitian about what changes to make in
what you eat and drink?
2d. How much information did you receive
from the Diabetic Educator/Registered

0

1

2

3

4

5

6

7

None

0

1

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

9

10

8

9

10

8

9

10

A great deal
2

3

4

5

6

7

None
0 1
None

8

A great deal

None
0

10

A great deal

None
0

9

A great deal

None

0

8

8

9

10

A great deal
2

3

4

5

6

7

8 9 10
A great deal
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Dietitian about what changes to make in
what you eat and drink?
3a. How much information did you need
from your healthcare provider (nurse,
midwife, or doctor) about increasing
physical activity?
3b. How much information did you receive
from your healthcare provider (nurse,
midwife, or doctor) about increasing
physical activity?
3c. How much information did you need
from the Diabetic Educator/Registered
Dietitian about increasing physical activity?
3d. How much information did you receive
from the Diabetic Educator/Registered
Dietitian about increasing physical activity?
4a. How much information did you need
from the Diabetic Educator about how to
take and record your blood sugars?
4b. How much information did you receive
from the Diabetic Educator about how to
take and record your blood sugars?
5a. How much practice did you need with
checking your blood sugars before leaving
your counseling appointment with the
Diabetic Educator?
5b. How much practice did you have with
checking your blood sugars before leaving
your counseling appointment with the
Diabetic Educator?
6a. How much information did you need
from your healthcare provider (nurse,
midwife, or doctor) about who and when to

0 1
None

2

3

4

5

6

7

8 9 10
A great deal

0 1
None

2

3

4

5

6

7

8 9 10
A great deal

0 1
None

2

3

4

5

6

7

8 9 10
A great deal

0 1
None

2

3

4

5

6

7

8 9 10
A great deal

0 1
None

2

3

4

5

6

7

8 9 10
A great deal

0 1
None

2

3

4

5

6

7

8 9 10
A great deal

0 1
None

2

3

4

5

6

7

8 9 10
A great deal

0 1
None

2

3

4

5

6

7

8 9 10
A great deal

0 1
None

2

3

4

5

6

7

8 9 10
A great deal
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call if you have problems at home after you
received your diagnosis?
6b. How much information did you receive
from your healthcare provider (nurse,
midwife, or doctor) about who and when to
call if you have problems at home after you
received your diagnosis?
6c. How much information did you need
from the Diabetic Educator/Registered
Dietitian about who and when to call if you
have problems at home after your
counseling appointment?
6d. How much information did you receive
from the Diabetic Educator/Registered
Dietitian about who and when to call if you
have problems at home after your
counseling appointment?
7a. How much did the information
provided by your healthcare provider
(nurse, midwife, or doctor) answer your
specific concerns and questions?
7b. How much did the information
provided by the Diabetic
Educator/Registered Dietitian answer your
specific concerns and questions?
8a. How much did your healthcare provider
(nurse, midwife, or doctor) listen to your
concerns?
8b. How much did the Diabetic
Educator/Registered Dietitian listen to
your concerns?

0 1
None

2

3

4

5

6

7

8 9 10
A great deal

0 1
None

2

3

4

5

6

7

8 9 10
A great deal

0 1
None

2

3

4

5

6

7

8 9 10
A great deal

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal

0 1 2
Not at all

3

4

5

6

7

8 9 10
Extremely

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal
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9a. Was your healthcare provider (nurse,
midwife, or doctor) sensitive to your
personal beliefs and values?
9b. Was the Diabetic Educator/Registered
Dietitian sensitive to your personal beliefs
and values?
10a. Did you like the way your healthcare
provider (nurse, midwife, or doctor)
taught you about how to take care of your
Gestational Diabetes Mellitus?
10b. Did you like the way the Diabetic
Educator/Registered Dietitian taught you
about how to take care of your Gestational
Diabetes Mellitus?
11a. Was the information your healthcare
provider (nurse, midwife or doctor)
provided about caring for Gestational
Diabetes Mellitus presented to you in a
way you could understand?
11b. Was the information the Diabetic
Educator/Registered Dietitian provided
about caring for Gestational Diabetes
Mellitus presented to you in a way you
could understand?
12a. Did your healthcare provider (nurse,
midwife, or doctor) check to make sure
you understood the information and
instructions?
12b. Did the Diabetic Educator/Registered
Dietitian check to make sure you
understood the information and
instructions?

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal

0 1 2
Not at all

3

4

5

6

7

8

9 10
Always

0 1 2
Not at all

3

4

5

6

7

8

9 10
Always

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal
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13. Did you receive consistent (the same)
information from your healthcare provider
(nurses, midwives, doctors) and Diabetic
Educator/Registered Dietitian?
14. Was the information about caring for
your Gestational Diabetes Mellitus given to
you at times that were good for you?
15. Was the information you received from
the Diabetic Educator/Registered Dietitian
given at times when your family
member(s) or others could attend?
16a. Did your healthcare provider (nurse,
midwife, or doctor) help you to feel
confident in your ability to care for
Gestational Diabetes Mellitus?
16b. Did the Diabetic Educator/Registered
Dietitian help you to feel confident in your
ability to care for Gestational Diabetes
Mellitus?
17a. Did the information your healthcare
provider (nurse, midwife, or doctor)
provided about Gestational Diabetes
Mellitus decrease your anxiety about
taking care of yourself?
17b. Did the information your Diabetic
Educator/Registered Dietitian provided
you about Gestational Diabetes Mellitus
decrease your anxiety about taking care
of yourself?

0 1 2
Not at all

3

4

5

6

7

8

9 10
Always

0 1 2
Not at all

3

4

5

6

7

8

9 10
Always

0 1 2
Not at all

3

4

5

6

7

8

9 10
Always

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal

0 1 2
Not at all

3

4

5

6

7

8 9 10
A great deal
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Multifactor Leadership Questionnaire 5-X (Sample*)
Healthcare provider name or group___________________________________
This questionnaire is to describe the leadership style of the Healthcare Provider
individual or Group mentioned above as you perceive it.
Please answer all items on this answer sheet. If an item is irrelevant, or if you are
unsure or do not know the answer, leave the answer blank.
Please answer this questionnaire anonymously.
Judge how frequently each statement fits the Healthcare provider
(Midwife/Doctor/Nurse Practitioner) you are describing. Use the following rating
scale:
Not at all

Once in a while

Sometimes

Fairly often Frequently, if not

always
0
1
2
3
My healthcare provider (s) (midwife /doctor/nurse practitioner) …
1. Provides me with assistance
when showing my efforts in
making changes for my health
2. Delays responding to urgent
questions
3. Treats me as an individual rather
than just another patient
4. Makes clear what one can
expect to receive when goals are
achieved
5. Increases my willingness to try
harder

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

© Altered by permission of publisher, Mind Garden, Inc. © Mind and Garden, Approved
changes 2014
*Due to copyright protection, “Can only list 5 sample items from the instrument for inclusion
in proposal, thesis or dissertation.
The entire instrument may not be included or reproduced at any time in any other published
material".
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For use by Denise Fryzelka only. Received from Mind Garden, Inc. on February 4, 2015

www.mindgarden.com
To whom it may concern,
This letter is to grant permission for the above named person to use the following
copyright material;
Instrument: Multifactor Leadership Questionnaire Authors: Bruce Avolio and Bernard
Bass Copyright: 1995 by Bruce Avolio and Bernard Bass for his/her thesis research.
Five sample items from this instrument may be reproduced for inclusion in a proposal,
thesis, or dissertation.
The entire instrument may not be included or reproduced at any time in any other
published material.
Sincerely,
Robert Most Mind Garden, Inc. www.mindgarden.com

© 1995 Bruce Avolio and Bernard Bass. All Rights Reserved. Published by Mind
Garden, Inc., www.mindgarden.com
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Diabetes Self-Efficacy Scale-Gestational Diabetes Mellitus (DSES)
We would like to know how confident you are in doing certain activities.
For each of the following questions, please choose the number scale 1-10 below that
corresponds to your confidence that you can do the tasks regularly at the present time.
Not at all
Totally
1
2 3 4 5 6 7 8 9
10
confident
confident
Using the scale of 1-10 above, please score the questions below:
1. How confident do you feel that you can eat your meals every 4 to 5 hours every day,
including breakfast every day? _____________
2. How confident do you feel that you can follow your diet when you have to prepare or
share food with other people who do not have gestational diabetes? __________
3. How confident do you feel that you can choose the appropriate foods to eat when you
are hungry (for example, snacks)? _____________
4. How confident do you feel that you can exercise 15 to 30 minutes, 4 to 5 times a week?
5. How confident do you feel that you can do something to prevent your blood sugar level
from dropping when you exercise? _______________
6. How confident do you feel that you know what to do when your blood sugar level goes
higher or lower than it should be? _________________
7. How confident do you feel that you can judge when the changes in your illness mean
you should visit the doctor? __________________
8. How confident do you feel that you can control your gestational diabetes so that it does
not interfere with the things you want to do? ______________
EBS+1 and PAS – Repeated in Phase 2
Glucose Monitoring Questionnaire (GMQ)
On how many days in the last week did you test your blood sugar levels?
(If you were sick in the last week, think of the most recent 7 days when you were NOT
sick)
1. On how many days in the last week (past 7 days) did you test your blood sugar
levels? ___________________
2. On how many days in the last week (past 7 days) did you test your blood sugar
levels 4 times per day? _______________
3. How many times during the last week (past 7 days) were your blood sugar
results higher than what is recommended? _______________
4. What do you know think caused the higher blood sugar elevations?
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
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ABSTRACT
Objective: To explore associations between healthcare provider professional influence of
maternity healthcare providers and diabetic nurse-educators on gestational diabetes
mellitus (GDM) patient engagement in modification of eight healthy eating, physical
activity, and glucose monitoring behaviors.
Methods: In an exploratory study that utilized a longitudinal correlational design,
participants (N=78) completed questionnaires at initial high-risk GDM screening and 3436 weeks gestational age.
Results: Professional influence and quality of information and patient interaction during
teaching encounters by maternity healthcare providers and diabetic nurse-educators
contributed to increased breakfast frequency/weekly (p=.09). Maternity healthcare
providers leadership style, specialty, and provider-patient concordance variables were
associated with modification of other health behaviors.
Conclusion: Patients’ perception of their healthcare providers’ influence, quality of
information and interaction in teaching encounters and leadership style, and patienthealthcare provider concordance factors influence GDM patients’ engagement in health
behavior modifications.
Practice Implications: Self-reflection about professional influence, quality of teaching,
and leadership style could improve provider capacity to influence health behavior
modification in GDM patients. Attention to provider-patient concordance can also be an
influencing factor in health behavior change.
Keywords: Healthcare provider influence, Health behavior modification, Gestational
diabetes mellitus, Healthy eating, Physical activity, Glucose monitoring

•
•
•
•
•

Highlights
Maternity and diabetic nurse-educator healthcare providers are professional influencers
Professional influence, information and interaction were associated with healthy eating
Interpersonal power dynamics of race and gender affect health behavior change
Professional influence from nurse-midwives predicted increased physical activity
Providers using transformational leadership influenced physical activity

218

1. Introduction
1.1. Background
Gestational diabetes mellitus (GDM), diagnosed in pregnancy, has an
estimated prevalence rate of 9.2%-19.9%, in the US and globally with steadily rising
incidence rates up to 25% [1-4]. Rates of reoccurrence of GDM in subsequent
pregnancies range from 30-84%, and up to 74% for developing Diabetes Mellitus (DM)
[5-7]. Risks for GDM include a complex and inter-related pattern of demographic
characteristics (such as advanced maternal age, higher parity, non-white race, lower
economic status, acculturation to the U.S), health history (previous history, prepregnancy obesity, increased intra-pregnancy weight gain, family history of DM), and
health behaviors (unhealthy eating habits, lack of physical activity) [8-10]. Improperly
managed or uncontrolled GDM can result in significant pregnancy and long-term
maternal-child complications, including malformations, pre-eclampsia, preterm delivery,
macrosomia, maternal and fetal birth injury, childhood/adult obesity, maternal/neonatal
hypoglycemia, increased labor inductions or operative deliveries, increased miscarriage,
stillbirth and infant mortality rates [11-13].
Evidence-based practice for managing GDM and preventing future GDM and DM
includes recommendations for early high-risk and routine screening in pregnancy,
postpartum, and lifelong. Treatment modalities include support by reiterative education
and counseling by healthcare providers on initiation and continuation of health behavior
modifications to healthy eating, physical activity, and glucose monitoring [14-16]. The
goal is to prevent complications by establishing and maintaining good glucose control
throughout the pregnancy and beyond [4,14,17].
GDM patient-identified barriers to self-management in pregnancy include
communication problems with healthcare providers, specifically, language discordance,
lack of discussion time in patient visits, not being heard about needs and inability to
control sugars, and inadequate verbal or written information [18]. Other discordance
factors of race, culture, attitude, age, and gender are also potential barriers to healthcare
provider-patient communication [19-21].
Multiple sources of social influence have been found to be associated with health
behaviors [23-25]. As a credible authority, healthcare providers can influence patients to
engage in health behavior modification and provide informational support and
recommendations for action. Insufficient GDM/DM knowledge in patient understanding
around a lifelong risk, and belief that diabetes is transient and will go away after
childbirth, can impede attentiveness to diet and other lifestyle modification
recommendations [13,18,22]. While a lack of social support and influence from
healthcare providers contribute to barriers for women engaging in GDM self-care,
alternately their influence can potentiate the modification and maintenance of relevant
health behaviors throughout pregnancy and well beyond the postpartum period [19].
The Integrated Theory of Health Behavior Change (ITHBC) [26] includes
constructs for engagement in health behaviors, one of which is social facilitation
comprised of social support and social influence. One source of social influence is
professional influence from healthcare providers. An integrated conceptual framework
based on the ITHBC and Transformational Leadership theory [27,28] was developed to
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name, describe and define the process of “healthcare provider influence” (HPI) as a
purposeful interpersonal interactive, collaborative, and transformative relationship that
develops between a patient and a healthcare provider working toward a specific focus of
health behavior modification [29]. Leadership is characterized as responsive to the
follower’s needs in aligning goals and objectives, and, through empowerment stimulates,
inspires and moves followers to meet and exceed performance expectations and strive for
higher levels of potential [27,28]. Having advanced knowledge of health, disease
pathology, and prevention/treatment measures to improve health status and outcomes, the
healthcare provider is their source of expert power. This power can be transferred to a
patient-centered source of power (called referent power) through professional influence.
Influence occurs by using transformational leadership skills and increasing the patient’s
knowledge, internal motivation, and self-efficacy leading to the ability to engage in
healthy behavior modification and improve health outcomes [30,31].
Fig. 1 presents the theoretical constructs and components of the ITHBC and
Leadership theory as represented by HPI concepts and their empirical measures. The
ITHBC is situated on the conceptual level with constructs of social influence, specifically
professional influence, knowledge and beliefs, and proximal outcomes, along with
Transformational Leadership theory, the referent power process for HPI. On the
theoretical levels, HPI represents the healthcare provider as the professional influencer,
and includes logistics, concordance, emotive, cognitive, and social/communication
components as well as behavioral outcomes. On the empirical level, measures of the
theory and framework concepts are linked to study questionnaires (Section 2.4).

2. Methods
2.1. Purpose/Aims
The purpose of the study was to explore possible mechanisms underlying health
provider influence (HPI) on health behavior modification during pregnancy in GDM
patients. As GDM patients are cared for by two healthcare provider types whose roles in
care and counseling are distinct yet complementary, the influence from both maternity
healthcare providers (HPs) and diabetic nurse-educators (DEs) was the focus in this
study. GDM-related care and counseling provided by HPs focuses on prenatal maternalfetal surveillance, review of glucose results, and a review/reiteration of recommendations
provided by DEs. Care and counseling from the DE focuses on specific recommendations
for healthy eating, including nutrient intake/restriction, portions, timing and frequency of
eating, physical activity, including benefits, frequency, and duration of exercise, and
glucose monitoring, including demonstration, timing, frequency, desired result ranges,
and follow-up.
Specific aims were to determine if 1) HPI, measured as professional influence and
the quality of interaction and information from HPs and DEs are associated with health
behavior modifications, specifically, healthy eating (HE), physical activity (PA), and
glucose monitoring (GM), and 2) patient characteristics (race and language concordance
and personal/family history of GDM/DM) and HP characteristics (gender concordance,
HP specialty and leadership style) moderate this relationship.
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2.2. Design
This longitudinal correlational design measured patient and HP factors associated
with change in health behaviors of women with GDM from screening, routinely at 24-28
weeks gestational age or the initial prenatal visit if high-risk (Phase 1) and subsequently,
at 34-36 weeks gestational age (Phase 2).
2.3. Sample
A priori, the sample size estimate of 75 was based on two tested, one mediating,
and ten total predictor variables for multiple linear regression analyses to achieve a
desired power of 0.80, a moderate effect size ƒ ² of 0.15, and a significance level of
p<0.10 (Gpower) [32] for this exploratory study.
The patient sample was recruited using flyers distributed at seven different
obstetric, nurse-midwife, and family practices, in an academic medical center and
federally qualified health clinic settings in a U.S. Midwestern city. Maternity care was
managed by two HP specialties: nurse-midwives and physicians. Inclusion criteria were
pregnant women, screened for high-risk GDM status, ≥ 18 years who were English or
Spanish speakers with literacy levels sufficient to comprehend and complete surveys.
2.4. Ethical considerations
Clinical site and university IRB approval was obtained. Interested patients
were contacted, a detailed description of the study provided, and informed consent
obtained by the principal investigator or trained research assistants.
2.5. Data Collection Instruments
Study instruments were available in English and Spanish; instruments not
previously available in Spanish were forward and backward translated by certified
medical translators. These questionnaires were completed by patients at their prenatal
care appointments in Phases 1 and 2. A participant demographic questionnaire,
completed in Phase 1, collected information for sample description (patient age, years of
education, years in the U.S., personal/family history of GDM/DM, insurance, and
intendedness of pregnancy) as well as items for determining race and language
concordance with provider. Parity and body mass index were obtained from the patient’s
health record. A healthcare provider questionnaire completed in Phase 2, included the
clinic site, HP specialty, age, years in practice, race/ethnicity, gender, language, use of
interpreter, and GDM management. The following dichotomous variables were
constructed for concordance between patient and HP response: race, language, and
gender, coded as 0= discordant, 1= concordant.
Two questionnaires, the Social Influence Questionnaire-GDM (SIQ) and the
Quality of Information-Interaction-GDM (QOII) measure social/communication and
emotive/cognitive components of HPI. The Multifactor Leadership Questionnaire (MLQ)
measures HP leadership characteristics. These three scales were modified for use with
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GDM patients, following author permission, licensed if required, and pilot tested with
content experts. The content validity index for SIQ = .90, QOII = .95, and MLQ = .67.
All three instruments reflect patients’ perceptions.
The SIQ measures patients’ perceptions of their HPs influence on their health
behaviors computed separately for HPs (SIQHP) and DEs (SIQDE). The scale consists of
provider-belief items paired with a degree of influence item. Both are rated on a 1-5
scale; the paired items are multiplied, and the resulting scores added together for a total
range of 9-225. Higher scores indicating greater provider influence on and belief in the
patient’s ability to modify their behaviors. Prior reliability and validity testing from
mammography and postpartum weight loss research resulted in Cronbach’s α = .83-.84
and a Goodness of Fit chi-square, p ≤ .78, model chi-square, p ≤ .01 [33,34]. In this
study, Cronbach’s α for SIQHP = .86 and SIQDE, α = .87.
The QOII was modified from the Quality of Discharge Teaching Scale [35] to
include GDM-behavior modification content. It measures the quality of informational
content received by the patient and the interactional skills of providers in teaching
encounters, as reported by patients. A total QOII score, calculated separately for HPs
(QOIIHP) and DEs (QOIIDE) is reported as the mean of items, each scored on a 0-10
scale, with higher scores indicating higher quality teaching. The original scale, tested in
medical-surgical adult patients, parents of hospitalized children, and postpartum mothers,
had reliability estimates of Cronbach’s α = .87- .92 [35-37]. In this study, the Cronbach’s
α for the QOIIHP = .95 and QOIIDE = .93.
The MLQ, modified from the Multifactor Leadership Questionnaire-5X for eight
minor stem changes but not domain or content, measures nine leadership characteristics
to determine dominant leadership style: transformational, transactional, or laissez-faire
non-leadership. In this study, patients were asked to complete the scale by rating their
healthcare provider. As laissez-faire non-leadership style did not emerge as a dominant
style, HP leadership style, was coded as a dichotomous variable: 0= transactional, 1=
transformational. The MLQ has been used widely in many large, and varied study
samples, with reliability estimates exceeding α of .80, convergent, divergent and
construct validity testing supporting the nine-factor scales and leadership composite
scores, and indices of goodness of fit = .93 in confirmatory factor analysis [27,28, 38,39].
In this study, the Cronbach’s α = 0.85.
The Eating Breakfast Questionnaire (EBQ +1) records the following healthy
eating (HE) behaviors in three separate scores: breakfast frequency/weekly (HE1), eating
protein for breakfast (HE2), and daily portions of vegetables (HE3) [40-42]. Correlations
between Phases 1 and 2 were r =.51, .04, and .70 respectively. Similarly, the Physical
Activity Scale (PAS) records the following physical activity (PA) behaviors in two
separate scores: total minutes weekly of stretching/strengthening (PA1) and aerobic
exercise (PA2). Previous test-retest results for the two scores were, r = .56 and .72 in
English and r =.91 and .89 in Spanish-speaking adults [40-43]. In this study, correlations
between Phases 1 and 2 were r =.54 (PA1) and .56 (PA2). The Glucose Monitoring
Questionnaire (GMQ) extracting 1-item from the Glucose Testing questionnaire [40, 41,
43] documents the frequency of glucose monitoring days/weekly (GM1), 4 times/daily
(GM2), and the number of abnormal glucose results/weekly (GM3). In this study, interitem correlation of GM1 and GM2 was r = .63. EBQ+1 and PAS were collected in
Phases 1 and 2 and the GMQ was collected in Phase 2 only.
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2.6. Data Analyses
Demographic data were analyzed using descriptive statistics (Table 1). Paired ttests were performed to determine if there were changes from Phase 1 to 2 in the healthy
eating and physical activity outcomes (Table 2). Simple and hierarchical multiple linear
regressions were used to analyze Aims 1 and 2 respectively. Outcomes variables were the
change scores for EBQ+1 (denoted for the 3 items as ΔHE1, ΔHE2, ΔHE3) and PAS
(ΔPA1, ΔPA2) and GMQ (1, 2, 3). Separate models were calculated for the influence of
patient (Table 3), HP (Table 4) and DE (Table 5) characteristics. HPI variables, SIQ and
QOII were centered and entered into step 1. In step 2, three patient characteristic
variables were entered. To test moderation, interaction terms between step 1 and 2
variables were entered into step 3. The same process was repeated with three HP
characteristic variables, in step 2.

3. Results
3.1. Demographics
The total sample completing Phase 1 and 2 was 78 patients. Six patients (7.1%)
were lost to follow-up due to pregnancy loss, transfer of care, or relocation. Maternity
care was managed by physicians (n=48) and nurse-midwives (n=30). Patients reported
receiving GDM counseling from HPs (61.5%) and DEs (92.3%). Table 1 presents
demographic and descriptive data about the patient participants and HPs.

3.2. HPI and Outcomes
Table 2 presents mean scores on HPI measures and changes in outcome variables
from Phase 1 to Phase 2. Overall, patients reported that both HPs and DEs had some
professional influence on their health behaviors (SIQHP & SIQDE scores =149-151/225)
and the quality of interaction and information received from both was similar and
moderately high (QOII=7.8-8.0/10). The distribution of HP leadership style was 73.1 %
(N=57) transformational and 26.9% (N=21) transactional. Significant increases in
outcome measures between Phase 1 and Phase 2 occurred for breakfast frequency/weekly
(ΔHE1), portions of vegetables/daily (ΔHE3) and stretching/strengthening exercise
minutes/weekly (ΔPA1). Patients reported good adherence to glucose monitoring
recommendations, performing monitoring on average >6 day per week (GM1), >5 days
per week of monitoring 4 times/daily (GM2), and with <2 abnormal readings per week
(GM3).
Results of hierarchical regression analyses exploring the association between
HPI measures of HP professional influence (SIQHP) and quality of information and
interaction (QOIIHP) and the eight health behavior modification outcomes are presented
in table 3 (patient characteristics) and table 4 (HP characteristics). In table 3, the only
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significant model was for increased breakfast frequency/weekly (ΔHE1) where, in step 3,
SIQHP, QOIIHP, race and language concordance and an interaction effect between
SIQHP and language discordance were significant with improvement. In table 4, the
model for ΔPA2 and GM1 were significant in step 2, with gender concordance and HP
specialty-physician associated with improvement in aerobic exercise minutes/weekly
(ΔPA2), and gender discordance and transformational leadership associated with more
glucose monitoring days/weekly (GM1). At step 3, testing interaction effects, the only
significant model was for ΔPA1, where gender concordance, HP specialty-physician and
SIQHP/HP specialty-nurse-midwife and SIQHP/transformational leadership interactions
were significantly associated with improvements in stretching/strengthening
minutes/weekly (ΔPA1). Supplementary tables S1-S2 present the full analytic model
results for all eight outcomes.
Table 5 presents the significant model results between HPI measures of DE
professional influence (SIQDE) and quality of information and interaction (QOIIDE).
QOIIDE was positively associated with breakfast frequency/weekly (ΔHE1).
Supplementary table S3 presents the full analytic model results for all eight outcomes.

4. Discussion and Conclusion
4.1. Discussion
This is the first study to use measures of ‘professional influence’ in examining the
role of the healthcare provider on change in health behaviors. Professional influence
measures of social influence and quality of information and interaction were used as
predictors of eight health behaviors. There were no significant differences in professional
influence and quality of information and interaction scores between HPs and DEs.
However, DEs more frequently provided patients with their GDM counseling. Although
significant improvements were found in two healthy eating (ΔHE1, ΔHE3) and one
physical activity behavior (ΔPA1), only breakfast frequency/weekly (ΔHE1) was
associated with professional influence measures. Both physical activity (ΔPA1, ΔPA2)
and one glucose monitoring (GM1) behavior were associated with HP characteristics.
These findings highlight the complementary roles of the HP and DE in GDM
management and suggest that the influence of social/professional influence is an
important feature of their roles. The findings also point out that, while education is an
important professional strategy for behavior change, HP professional influence is an
interactional strategy with potentially positive benefits. The effect sizes in this study are
small suggesting lack of recognition and under-utilization of the power of influence. HPs
have a broader scope of maternity care management and counseling is generally targeted
to ameliorating glucose results. Healthy eating and physical activity are often not
addressed by HPs prenatally due to insufficient time and knowledge [45,46]; this
counseling in health behavior modification is left to the DE.
HP transformational leadership style influenced some outcomes, supporting it as a
potential mechanism for influencing health behavior modification. This style concentrates
on influencing individual personal transformation via inspirational motivation and
intellectual stimulation [28]. In this study, professional influence by HPs who used
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transformational leadership skills predicted increased stretching/strengthening exercises
and HPs who used these same leadership styles also increased glucose monitoring
frequency. Glucose monitoring provides biofeedback that can increase motivation during
the pregnancy for active engagement in self-managing GDM. While transactional
leadership style theoretically could promote the reward of a healthy pregnancy and baby
for improvement in healthy behavior outcomes, the absence of association supports the
role of transformational leadership as necessary for professional influence.
Gender concordance may also be an influencing factor on health behavior
improvements in GDM. Female providers were stronger influencers of increasing or
maintaining exercise in pregnancy, a challenge for many women as pregnancy advances
due to increased fatigue and discomfort and decreased energy. Female HPs may be more
comfortable in addressing exercise and female patients may be more receptive to a
gender concordant provider. Professional influence by nurse-midwives (HP specialty)
was positively associated with increased stretching/strengthening exercises. Many of the
female providers in this study were nurse-midwives, which may have prompted a greater
influence on health promoting behaviors. Although research has shown that pregnancy
aerobic exercise recommendations are not always consistently reviewed or known by
HPs, nurse-midwives were more likely than physicians to recommend exercise [45,46].
The association of gender concordance with increased physical activity and decreased
glucose monitoring may reflect the correlation between improved glycemic control and
decreased need for the same frequency of monitoring. It is important to consider in future
studies whether this finding is reflective of the HP specialty (physician/nurse-midwife) or
gender [47,48].
Language concordance and race discordance were associated with improved
breakfast frequency (HE1) as was professional influence when there was language
discordance between the HP and patient. Professional influence predicts improvement
when an interpreter is used in patient encounters or the value of concordance may be lost
if the provider is trying to interact in a concordant language but is not fluent. Similarly,
race concordance may be interpreted differently by different patients. The referent power
may be more influential in some HP/patient race pairs but not others. Evidence to
support the association of race concordance to positive health outcomes in minority
populations has been inconsistent and inconclusive in patient-provider communication
concordance research [49,50].
Taken together, the findings provide beginning evidence that HPs can be
professional influencers of patient health behavior change through social influence,
quality of information and interaction, leadership style and concordant factors.
4.1.1. Limitations
This study was an exploration of relationships between provider factors and GDM
patient health behavior outcomes. To facilitate the exploratory purpose of the study, aims
were tested separately. The numerous equations raise the possibility of type 1 error. Based
on projected availability of the target sample, the study was powered for p<0.10; thus,
increasing the possibility of type 1 errors. The associations identified in this analysis should
be considered opportunities for further study.
Additional limitations include the use of a convenience sample and self-reported
outcome measures which have been associated with response and accuracy bias in
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reporting expectations versus reality [51,52]. Many single items were used for the
outcome measures which produced inconsistent results across the various measures. The
availability of a single composite measure of health eating and physical activity specific
to GDM would improve future research in this area. While outcome measures previously
tested with English/Spanish-speaking patients in DM studies were selected, the MLQ is a
lengthy and time intensive questionnaire which has not been used for patient perspective
of their HPs and thus may not be the optimal measure of leadership in this context.
4.1.2. Future Research
The results of this study raise additional questions that warrant further exploration
into HPI and set the trajectory for future research. What factors are associated with better
social facilitation of health behavior modification in GDM and other health conditions?
Do other factors associated with the provision of health care services (such as visit time,
number of encounters), additional patient and healthcare provider characteristics (such as
patient-perceived age-range, BMI-range, values and beliefs concordance) impact the
health providers ability to influence health behavior modification? In the context of
pregnancy or other illness in which morbidity and mortality is a greater risk, other
components of the conceptual model of professional influence (e.g. patient fear for own
or baby’s health, an emotive component of the HPI model), should be considered. To
understand if and how different HP leadership styles influence proximal and distal
outcomes, a leadership questionnaire specific to healthcare providers, is needed to
evaluate patient perceptions of HPs specific to HPI. Including other influencers, such as
family or community health workers, may contribute to the effect of professional
influence for increased behavior change as seen in other research [34].
4.2. Conclusion
This exploratory study provided initial insight into the role of healthcare provider
influence on health behavior modification in GDM patients and beginning evidence that
HPs can be professional influencers through social influence, quality of information and
interaction, and transformational leadership in facilitating patient health behavior change.
The study demonstrated that patient’s perceptions of the professional influence, quality of
information and interaction, leadership style, and concordance factors can play a role in
healthy eating (breakfast frequency), physical activity (stretching/strengthening and
aerobic exercise) and daily glucose monitoring.
4.3. Practice Implications
The findings support the recommendation that health care providers need to better
understand how health behavior change is adopted and their role in facilitating these
changes via their professional influence [26]. This influence derives from their social
influence (their beliefs in patient’s ability to overcome barriers and make optimal changes
in behaviors and the degree of influence exerted) and the quality of interaction and
information in patient-provider interactions including styles used. To improve influence,
HPs and DEs should engage in reflective practice [53,54] to evaluate their current beliefs
about their role in health behavior modification, the degree of influence they actively
bring to the patient-provider encounters, their current and desired leadership style, the
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nature of the information content and interaction style in patient-provider encounters and
the role of concordance factors with patients. Greater awareness sets the stage for
intentional modifications to leadership style and content that can improve influencing
potential.
Transformational leadership skills can be useful to increase self-knowledge of
how behavior modification in pregnancy can reach far beyond the benefits of treating
GDM, into the lifelong outcomes of prevention/delaying DM, decreasing personal and
child risks, and improving overall maternal mental/physical health, well-being, and
quality of life. An awareness of how glucose results correlate to timing, type and amount
of foods, and type and duration of physical activity provide specific self-management
guidelines. Using strategies to increase listening and sensitivity, answer respectfully,
inquire about and decrease anxiety, increase self-efficacy, improve patient confidence in
abilities, and inquire about what works best for patients will assist in empowering and
influencing decisions could transform their future.
Most importantly, healthcare providers should be effective professional
influencers of health behavior. They must recognize their power to influence and should
engage proactively throughout the childbearing cycle and lifelong to contribute to the
prevention of GDM/DM and related chronic health problems while optimizing patient
quality of life.
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Table 1
Demographics and Descriptors

Age
Education
HP Practice Years
Year in US
BMI Pre-pregnant
Gender
Female
Male
HP specialty
Nurse-Midwife
Physician
Race/Ethnicity
White
Black
Asian
Latina
Other
Primary language
English
Spanish
Other
Language Used by HP
English
Spanish
Interpreter Used
Insurance
Medicaid
Private
Nulliparity
Intended pregnancy
GDM counseling
HP
. DE
HP+DE
Personal history
of GDM

Participants
(N=78)
Mean(SD) Range
32.06(5.14) 18-41
14.75(4.48) 3-23

HPs
(N=32)
Mean(SD)
Range
41.69(6.74) 28-55
11.89(5.45)

22.3(12.05)
30.07(7.28)
N(%)
78(100)

.3-41
19.4-59.3
N(%)
54(69.2)
24(30.8)
30(38.5)
48(61.5)

35(44.9)
11(14.4)
9(11.5)
22(28.2)
1(1.3)

69(88.5)
3(3.8)

6(7.7)

48(61.5)
19(24.4)
11(14.1)
72(92.3)
6 (7.7)
18(23.1)
34(43.6)
44(56.4)
26(33.3)
56(71.8)
48(61.5)
72(92.3)
44(56.4)
20(25.6)

Notes: BMI: Body Mass Index; GDM: Gestational Diabetes Mellitus; HP: Healthcare Provider

2-27
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Table 2
Healthcare Provider Influence and Outcome Measures (N=78)

SIQHP (10)

HPI Measures (Phase 2)
Potential Range
Actual
Item
Range
Total/Mean score
Item: 1-5
9-225

148.5(53.9)

SIQDE (10)

Total: 9-225

21-225

150.9(58.41)

QOIIHP (13)

Item: 0-10

2.38-10

8.01(1.98)

QOIIDE (16)

Mean: 0-10

2.5-10

7.79(1.87)

MLQ
TFL (5)
TAL (2)

Item: 0-4

Instrument (# items)

Instrument (# items)

EBQ+1
HE1 (1)
P1
P2
∆HE1(P2-P1)
HE2 (1)
P1
P2
∆HE2 (P2-P1)
HE3 (1)
P1
P2
∆HE3 (P2-P1)
PAS
PA1(1)
P1
P2
∆PA1(P2-P1)
PA2 (5)
P1
P2
∆PA2 (P2-P1)
GMQ
P2 GMQ1 (1)
P2 GMQ2 (1)
P2 GMQ3 (1)

Mean(SD)

.88-4
3.06(.74)
Mean: 0-4
.5-4
2.56(.83)
Outcome Measures (Phases 1 and 2)
Potential Range
Actual
Mean(SD)
P value for
Range
∆ (P2-P1)
∆ (P2-P1)
t (1,77) sig (p)
0-7
0-7
0-7
-7- +6

5.43(2.23)
5.94(1.78)
.51(2.03)

2.23

.03

0-1
0-1
-1- +1

.82(.39)
.88(.32)
.06(.49)

1.15

.25

0-8.5
0-8
-3.5- +4.5

2.3(1.51)
2.78(1.34)
.48(1.12)

3.79

.000

0-180
0-180
-165- +180

25.58(44.98)
44.62(53.24)
19.04(47.91)

3.51

.001

.04

.97

0-1

0-no limit

0-180

0-900
0- +720
124.42(134.95)
0- +660
125(119.01)
-420- +360
.58(119.45)
Outcome Measures (Phase 2)
0-7
0-7
0-28

0-7
0-7
0-8

6.33(1.52)
5.25(2.43)
1.75(1.71)

Notes. ∆HE1: Healthy Eating 1 Change Score, ∆HE2: Healthy Eating 2 Change Score, ∆HE3: Healthy Eating 3 Change Score,
∆PA1: Physical Activity 1 Change Score, ∆PA2: Physical Activity 2 Change Score, EBQ+1: Eating Breakfast Questionnaire,
GM1: Glucose Monitoring 1, GM2: Glucose Monitoring 2, GM3: Glucose Monitoring 3, GMQ: Glucose Monitoring Questionnaire,
MLQ: Multifactor Leadership Questionnaire, P1: Phase 1, P2: Phase 2, QOIIDE: Quality of Information/Interaction-Diabetic Educator,
QOIIHP: Quality of Information/Interaction-Healthcare Provider, PAS: Physical Activity Scale; SIQDE: Social Influence-Diabetic Educator,
SIQHP: Social Influence- Healthcare Provider; TAL: Transactional Leadership, TFL: Transformational Leadership
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Table 3
Hierarchical Regression of Health Behavior Modifications on Healthcare Providers
Professional Influence and Patient Characteristics
Healthcare Provider Professional Influence and
Patient Characteristics
Model Statistics

Health Behaviors

Step 1

∆HE1
R2 =
.04
Adj R2=
.02
p=
.21

SIQHP
QOIIHP
Step 2

SIQHP
QOIIHP
Race Concordance: 0=discordant, 1= concordant
Language Concordance: 0= discordant, 1= concordant
GDMPFH: 0= negative, 1= positive
Step 3

SIQHP
QOIIHP
Race Concordance: 0=discordant; 1= concordant
Language Concordance: 0= discordant, 1= concordant
GDMPFH: 0= negative, 1= positive
Race Concordance*SIQHP
Race Concordance*QOIIHP
Language Concordance*SIQHP
Language Concordance*QOIIHP
GDMPFH*SIQHP
GDMPFH*QOIIHP

Healthy Eating

β
-.03
.21
R 2=
Adj R2=
R2∆=.
p=
-.002
.2
-.29
.2
-.03
R 2=
Adj R2=
R2∆=
p=
.5
.7
-.28
.22
-.06
.16
-.22
-.52
-.1
-.25
-.24

p
.84
.09
.11
.05
.07
.15
.99
.12
.03
.14
.83
.27
.14
.16
.04
.05
.04
.03
.10
.58
.34
.23
.04
.78
.31
.36

Notes: GDMPFH: Gestational Diabetes Mellitus/Diabetes Mellitus Personal/Family History, ∆HE1: Healthy Eating 1 Change Score,
QOIIHP: Quality of Information/Interaction- Healthcare Provider, SIQHP: Social Influence- Healthcare Provider,
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Table 4
Hierarchical Regressions on Healthcare Provider Professional Influence and Healthcare Provider
Characteristics
Healthcare Provider Characteristics
Model Statistics
Step 1

SIQHP
QOIIHP
Step 2

SIQHP
QOIIHP
Gender concordance: 0=discordant, 1=concordant
MLQ: 0=Transactional, 1=Transformational
HP specialty: 0=physician, 1=nurse-midwife
Step 3

SIQHP
QOIIHP
Gender concordance: 0=discordant, 1=concordant
MLQ :0=Transactional, 1=Transformational
HP specialty: 0=physician, 1=nurse-midwife)
Gender Concordance*SIQHP
Gender Concordance*QOIIHP
MLQ*SIQHP
MLQ*QOIIHP
HP specialty*SIQHP

Health Behaviors
Physical Activity
∆PA1
R2=
.02
Adj R2= -.01
p=
.48
β
p
-.05
.67
-.11
.37
R2=
.08
Adj R2= .02
.06
R2∆=
p=
.19
-.1
.46
-.11
.40
.28
.04
.03
.81
-.23
.1
2
R=
.22
Adj R2= .09
R2∆=.
.14
p=
.09
-.5
.16
.19
.52
.27
.05
.06
.61
-.24
.08
-.3
.28
.03
.91
.43
.1
-.34
.2
.48
.02

∆PA2
R2=
.001
Adj R2= -.03
p=
.95
β
p
.04
.74
-.02
.89
R2=
.09
Adj R2= .03
.09
R2∆=
p=
.07
.05
.67
-.03
.84
.19
.05
-.16
.17
-.25
.06
2
R=
.18
Adj R2= .05
R2∆=
.09
p=
.32
-.26
.47
.61
.05
.27
.19
-.2
.12
-.22
.12
.08
.77
-.31
.17
.18
.49
-.49
.08
.16
.42

Glucose
Monitoring
GM1
R2=
.02
Adj R2= -.003
p=
.43
β
p
-.13
.31
-.05
.71
R2=
.12
Adj R2= .06
.09
R2∆=
p=
.06
-.17
.19
-.02
.84
-.23
.09
.23
.05
.18
.19
2
R=
.21
Adj R2= .08
R2∆=
.10
p=
.26
-.68
.06
.38
.2
-.28
.05
.28
.03
.17
.21
-.01
.98
-.23
.31
.56
.04
-.33
.22
.06
.74
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HP specialty*QOIIHP

-.1

.53

.05

.75

.06

.73

Notes GM1: Glucose Monitoring 1, MLQ: Healthcare Provider Leadership Style, ∆PA1: Physical Activity 1 Change Score,
∆PA2: Physical Activity 2 Change Score, QOIIHP: Quality of Information/Interaction- Healthcare Provider,
SIQHP: Social Influence- Healthcare Provider

Table 5
Multiple Linear Regression of Health Behavior Modifications on Diabetic Educators Professional Influence
Model

SIQDE
QOIIDE

Healthy Eating
∆HE1
R2=
.08
Adj R2= .06
p=
.04
β
p
-.12
.37
.34
.01

Notes: ∆HE1: Healthy Eating 1 Change Score, QOIIDE: Quality of Information/Interaction-Diabetic Nurse Educator,
SIQDE: Social Influence-Diabetic Educator, All other models p>0.1
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Conceptual Constructs
*Integrated Theory of Health
Behavior Change (ITBHC)
*Transformational Leadership
Theory (TLT)
Theory Concepts
*Healthcare Provider
Influence (HPI)

Social facilitation

Proximal health outcomes

Social Influence (ITHBC)
via
Referent Power (TLT)
=
HPI

Concordance-Logistics

Patient
Characteristics

Knowledge-beliefs

Social-Communication

Emotive-Cognitive

Healthcare Provider
Characteristics/
Leadership (TLT)

Behavioral
[GDM]
Health Behavior
Modification

Empirical Measures
Instruments

*Patient
Demographic

*Healthcare
Provider
Demographic

*Multifactor
Leadership

*Social Influence

*Quality of
Information and
Interaction

*Eating Breakfast+1
*Physical Activity Scale
*Glucose Monitoring

Fig 1. Conceptual Model for Professional Influence
Notes: * Theories/concepts and measures included in the study; GDM: Gestational Diabetes Mellitus
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Appendix A: Online Supplemental Tables

Table S1
Healthcare Provider Professional Influence and Patient Characteristics Healthcare Provider Professional Influence and Patient Characteristics
Patient Characteristics
Model Statistics
Model 1
R2=
Adj R2=
p=
SIQHP
QOIIHP
Model 2

β
-.03
.21
R2=
Adj R2=
R2∆=
p=

SIQHP
QOIIHP
RC
0=discordant
1 = concordant
LC
0= discordant
1= concordant
GDMPFH 0= negative
1= positive
Model 3
R2=
Adj R2=
R2∆=
p=
SIQHP
QOIIHP

∆HE1
.04
.02
.21
p
.84
.09
.11
.05
.07
.15
β
-.002
.2
-.29

p
.99
.12
.03

.2

.14

.11

-.03

.83

.18

.27
.14
.16
.04
β
.5
.7

β
-.01
.13
.15

p
.95
.31
.25

Health Behaviors
Physical Activity
∆PA1
∆PA2
.02
.001
-.01
-.03
.48
.95
β
p
β
p
-.05
.67 .04
.74
-.11
.37 -.02
.89
.05
.03
-.02
-.03
.03
.03
.59
.50
β
p
β
p
-.05
.68 .06
.61
-.12
.36 -.07
.61
-.11
.40 -.09
.49

.40

-.03

.83

.07

.60

-.1

.46

.05

.70

.06

.69

-.003

.98

.14

.22

.06

.11

.37

-.09

.47

-.03

.81

-.01

.96

.1

.42

Healthy Eating
∆HE2
.02
-.01
.46
β
p
-.12
.35
.14
.27
.07
.01
.05
.27
β
p
-.12
.32
.14
.28
-.11
.42

.13
-.02
.06
.65
p
.05
.04

β
-.06
.6

∆HE3
.02
-.01
.57
β
.02
.11

p
.85
.37
.07
.01
.06
.22

.14
-.01
.07
.56
p
.84
.11

β
-.002
.44

p
1.0
.23

.07
-.09
.02
.94
β
-.21
-.32

β
-.14
-.001
.12

Glucose Monitoring
GM2
GM3
.03
.01
.004
-.02
.33
.79
p
β
p
β
p
.31 -.18
.15 -.08
.52
.71 .03
.80
.002
.99
.03
.04
-.04
-.02
.003
.04
.98
.42
p
β
p
β
p
.26 -.18
.15 -.07
.58
.99 .05
.72 -.04
.76
.37 -.002
.99 -.16
.23

GM1
.02
-.003
.43
β
-.13
-.05
.05
-.02
.02
.64

.05
-.11
.02
.98
p
.46
.40

β
.07
.08

.06
-.1
.01
.99
p
.79
.84

β
-.28
-.04

.13
-.02
.09
.33
p
.32
.92

β
-.49
-.05

.13
-.01
.09
.36
p
.07
.89

β
-.05
-.13

p
.87
.72
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RC

0=discordant
1 = concordant
LC
0= discordant
1= concordant
GDMPFH 0= negative
1= positive
RC*SIQHP
RC*QOIIHP
LC*SIQHP
LC*QOIIHP
GDMPFH*SIQHP
GDMPFH*QOIIHP

-.28

.03

-.12

.38

.16

.25

-.13

.35

-.07

.61

.11

.43

.03

.83

-.15

.28

.22

.10

.19

.20

-.03

.83

. 06

.70

-.11

.47

.06

.68

-.01

.95

-.11

.44

-.06

.58

.17

.17

.25

.04

.13

.29

-.1

.44

-.02

.88

.000

.10

.13

.30

.16
-.22
-.52
-.1
-.25
-.24

.34
.23
.04
.78
.31
.36

.11
-.08
-.07
-.47
-.12
.07

.54
.67
.79
.20
.65
.81

-.21
-.21
.09
-.02
.04
-.22

.26
.28
.73
.96
.86
.42

.02
-.08
.1
.11
.06
.16

.91
.68
.73
.77
.83
.58

.02
.06
.04
-.01
-.04
-.2

.93
.76
.89
.99
.89
.48

.01
.04
.18
-.12
-.01
.13

.94
.84
.53
.75
.96
.65

.05
.05
.04
.43
.32
-.43

.78
.79
.89
.24
.22
.13

.24
-.38
-.2
.77
-.02
-.42

.20
.05
.46
.04
.94
.13

Notes: : : significant finding p≤.1, GDMPFH: Gestational Diabetes Mellitus/Diabetes Mellitus Personal/Family History, GM1: Glucose Monitoring 1, GM2: Glucose Monitoring 2, GM3: Glucose Monitoring 3, ∆HE1: Healthy
Eating 1 Change Score, ∆HE2: Healthy Eating 2 Change Score, ∆HE3: Healthy Eating 3 Change Score, LC: Language Concordance, ∆PA1: Physical Activity 1 Change Score, ∆PA2: Physical Activity 2 Change Score, QOIIHP:
Quality of Information/Interaction- Healthcare Provider, RC: Race Concordance, SIQHP: Social Influence- Healthcare Provider
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Table S2
Hierarchical Regressions of Healthy Eating (HE) Physical Activity (PA) and Glucose Monitoring (GM) Behaviors on
Healthcare Provider Professional Influence and Healthcare Provider Characteristics
Healthcare Provider
Characteristics
Model Statistics
Model 1

∆HE1
.04
.02
.21

SIQHP
QOIIHP
GC:0=discordant;
1 = concordant
MLQ: 0=Transactional,
1=Transformational
HP specialty:0= physician
1=nurse-midwife

∆PA2
.001
-.03
.95
β
p
.04
.74
-.02
.89
.09
.03
.09
.07
β
p
.05
.67
-.03
.84
.19
.05

p
.79
.13
.71

-.24

.04

.05

.67

-.05

.68

.03

.81

-.16

-.08

.70

-.01

.93

.02

.90

-.23

.1

-.25

R2=
Adj R2=
R2∆=
p=

SIQHP
QOIIHP
GC:0=discordant;
1 = concordant
MLQ: 0=Transactional,
1=Transformational
HP specialty :0= physician
1=nurse-midwife
Model 3
R2=
Adj R2=
R2∆=
p=

∆PA1
.02
-.01
.48
β
p
-.05
.67
-.11
.37
.08
.02
.06
.19
β
p
-.1
.46
-.11
.40
.28
.04

β
.03
.19
.08

β
-.03
.21

p
.84
.09
.1
.04
.06
.18

.19
.05
.08
.37

Glucose Monitoring

∆HE3
.02
-.01
.57
β
p
.02
.85
.11
.37
.02
-.05
.01
.91
β
p
.04
.79
.1
.46
.06
.66

∆HE2
.02
-.01
.46
β
p
-.12
.35
.14
.27
.03
-.04
.01
.88
β
p
-.14
.30
.13
.30
.09
.53

R2=
Adj R2=
p=
SIQHP
QOIIHP
Model 2

Healthy Behaviors
Physical Activity

Healthy Eating

.09
-.07
.06
.67

.15
.01
.13
.14

.22
.09
.14
.09

GM1
.02
-.003
.43
β
-.13
-.05

p
.31
.71

GM2
.03
.004
.33
β
-.18
.03

.12
.06
.09
.06

GM3
.01
-.02
.79

p
.15
.8

β
-.08
.002

.04
-.03
.01
.84

p
.52
.99
.08
.01
.07
.15

β
-.17
-.02
-.23

p
.19
.84
.09

β
-.21
.05
-.04

p
.12
.71
.78

β
-.03
.02
-.27

p
.84
.90
.05

.17

.23

.05

.1

.41

-.11

.35

.06

.18

.19

-.01

.94

.06

.64

.18
.05
.09
.32

.21
.08
.10
.26

.17
.03
.13
.14

.09
-.06
.01
.99

β
.45
.04
.12

p
.22
.91
.40

β
.31
-.04
.13

p
.42
.90
.40

β
.2
.52
-.02

p
.58
.10
.90

β
-.5
.19
.27

p
.16
.52
.05

β
-.26
.61
.27

p
.47
.05
.19

β
-.68
.38
-.28

p
.06
.2
.05

β
-.87
.26
-.05

p
.02
.41
.75

β
-.25
.03
-.27

p
.52
.94
.07

-.31

.01

-.03

.83

-.09

.48

.06

.61

-.2

.12

.28

.03

.18

.16

-.09

.5

-.12

.40

-.04

.78

.12

.40

-.24

.08

-.22

.12

.17

.21

-.03

.82

.05

.74
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GC*SIQHP
GC*QOIIHP
MLQ*SIQHP
MLQ*QOIIHP
HP specialty*SIQHP
HP specialty*QOIIHP

-.24
-.06
-.43
.09
.2
.29

.39
.78
.11
.74
.31
.09

-.2
-.14
-.46
.22
.13
.22

.5
.56
.1
.44
.53
.22

.12
.2
-.28
-.48
.07
-.31

.67
.38
.3
.08
.75
.07

-.3
.03
.43
-.34
.48
-.1

.28
.91
.1
.2
.02
.53

.08
-.31
.18
-.49
.16
.05

.77
.17
.49
.08
.42
.75

-.01
-.23
.56
-.33
.06
.06

.98
.31
.04
.22
.74
.73

-.09
.07
.64
-.27
.3
-.11

.76
.75
.02
.32
.13
.5

.06
-.01
.18
-.03
.03
.04

.85
.97
.52
.91
.9
.79

Notes: significant finding p≤.1, GC: Gender Concordance, GM1: Glucose Monitoring 1, GM2: Glucose Monitoring 2, GM3: Glucose Monitoring 3, ∆HE1: Healthy Eating 1 Change Score, ∆HE2:
Healthy Eating 2 Change Score, ∆HE3: Healthy Eating 3 Change Score, MLQ: Healthcare Provider Leadership Style, ∆PA1: Physical Activity 1 Change Score, ∆PA2: Physical Activity 2 Change Score,
QOIIHP: Quality of Information/Interaction- Healthcare Provider, SIQHP: Social Influence- Healthcare Provider

Table S3
Multiple Linear Regression of Healthy Eating (HE) Physical Activity (PA) and Glucose Monitoring (GM) Behaviors on
Diabetic Nurse Educator Professional Influence
Model Statistics
Model

∆HE1
.08
.06
.04

R2=
Adj R2=
p=
SIQDE
QOIIDE

β
-.12
.34

p
.37
.01

Healthy Eating
∆HE2
.02
-.004
.43
β
p
-.15
.27
.16
.24

∆HE3
.004
-.02
.85
β
.05
.03

p
.74
.83

Healthy Behaviors
Physical Activity
∆PA1
∆PA2
.03
.00
.01
-.03
.28
1.0
β
p
β
p
-.13
.35 .01
.95
-.08
.58 .003
.98

GM1
.01
-.02
.66
β
.13
-.07

Glucose Monitoring
GM2
GM3
.02
.002
-.01
-.02
.49
.92
p
β
p
β
p
.37 .15
.29 .04
.78
.59 -.14
.3
-.05
.7

Notes: significant finding p≤.1, GM1: Glucose Monitoring 1, GM2: Glucose Monitoring 2, GM3: Glucose Monitoring 3, ∆HE1: Healthy Eating 1 Change Score, ∆HE2: Healthy Eating 2 Change
Score, ∆HE3: Healthy Eating 3 Change Score, ∆PA1: Physical Activity 1 Change Score, ∆PA2: Physical Activity 2 Change Score, QOIIDE: Quality of Information/Interaction-Diabetic Educator,
SIQDE: Social Influence- Diabetic Educator

